,Gene/Region,GRCh37,"HI Score","TS Score",OMIM,Morbid,%HI,pLI,LOEUF,"Last Eval."
G,ZWILCH,15:66797664-66842468,"1 (Little Evidence)","0 (No Evidence)",,,35.84,0,1.02,04/24/2019
G,ZNF81,X:47696301-47785026,"0 (No Evidence)","0 (No Evidence)",,,71.33,0.55,0.51,10/29/2012
G,ZNF711,X:84498997-84528363,"2 (Emerging Evidence)","0 (No Evidence)",,,30.43,0.98,0.31,08/29/2013
G,ZNF674,X:46357160-46404856,"1 (Little Evidence)","0 (No Evidence)",,,80.29,0,1.31,08/29/2012
G,ZNF592,15:85291823-85349676,"0 (No Evidence)","0 (No Evidence)",,,48.68,1,0.13,10/14/2021
G,ZNF462,9:109625447-109775915,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.96,1,0.09,01/16/2020
G,ZNF41,X:47304577-47342621,"1 (Little Evidence)","0 (No Evidence)",,,72.46,0.04,0.62,10/24/2012
G,ZNF407,18:72265106-72777627,"0 (No Evidence)","0 (No Evidence)",,,53.21,1,0.09,07/11/2012
G,ZNF264,19:57702868-57734214,"0 (No Evidence)","0 (No Evidence)",,,88.53,0,0.99,05/10/2012
G,ZNF141,4:331603-378657,"30 (Autosomal Recessive)","Not Yet Evaluated",,,89.36,0.1,1.25,08/22/2016
G,ZMYND15,17:4643128-4649414,"30 (Autosomal Recessive)","0 (No Evidence)",,,52.22,0,0.89,08/22/2016
G,ZMYND11,10:176028-300577,"3 (Sufficient Evidence)","0 (No Evidence)",,,16.99,1,0.12,03/28/2018
G,ZMYM3,X:70459474-70475047,"0 (No Evidence)","0 (No Evidence)",,,26.32,1,0.11,07/25/2012
G,ZIM2,19:57285915-57352094,"0 (No Evidence)","0 (No Evidence)",,,88.9,0,0.84,05/17/2012
G,ZIC4,3:147103833-147124330,"0 (No Evidence)","0 (No Evidence)",,,12.76,0,0.87,08/25/2021
G,ZIC3,X:136648286-136659850,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.79,0.92,0.36,12/02/2020
G,ZIC2,13:100634038-100639019,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.3,0.97,0.27,08/24/2022
G,ZIC1,3:147127152-147134506,"0 (No Evidence)","0 (No Evidence)",,,7.94,0.93,0.36,07/19/2021
G,ZFYVE26,14:68213239-68283307,"30 (Autosomal Recessive)","Not Yet Evaluated",,,42.96,0,0.6,08/22/2016
G,ZFPM2,8:106330666-106816767,"1 (Little Evidence)","0 (No Evidence)",,,0.93,1,0.15,09/20/2021
G,ZEB2,2:145141648-145277686,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.37,1,0.11,06/24/2020
G,ZDHHC9,X:128937264-128977862,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.32,0.74,0.48,10/12/2021
G,ZDHHC15,X:74588262-74742872,"0 (No Evidence)","0 (No Evidence)",,,20.85,0.84,0.43,07/25/2012
G,ZC4H2,X:64135687-64254621,"3 (Sufficient Evidence)","0 (No Evidence)",,,20.36,0.91,0.39,04/22/2020
G,ZBTB24,6:109783797-109804422,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.44,0,0.66,08/22/2016
G,ZBTB18,1:244211955-244220778,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.38,1,0.18,04/24/2019
G,YWHAE,17:1247569-1303516,"0 (No Evidence)","0 (No Evidence)",,,1.8,0.98,0.24,06/19/2014
G,YTHDC1,4:69176105-69215808,"1 (Little Evidence)","0 (No Evidence)",,,10.1,1,0.09,04/24/2019
R,"Yq11.223 population region (gnomAD-SV_v2.1_DUP_Y_55057)",Y:24024199-24070000,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Yq11.223 population region (gnomAD-SV_v2.1_DUP_Y_55049)",Y:23656999-23713300,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Yq11.223 population region (DGV_Gold_Standard_June_2021_gssvL138428)",Y:25853189-26146959,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Yq11.223 population region (DGV_Gold_Standard_June_2021_gssvL138419)",Y:24361866-24465171,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
G,YAP1,11:101981178-102104155,"1 (Little Evidence)","0 (No Evidence)",,,9.76,1,0.19,11/13/2014
G,XYLT1,16:17195626-17564817,"30 (Autosomal Recessive)","0 (No Evidence)",,,36.69,0.92,0.34,08/22/2016
R,"Xq28 region (includes MECP2)",X:153273980-153375749,"0 (No Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,02/22/2021
R,"Xq28 recurrent region (int22h1/int22h2-flanked) (includes RAB39B)",X:154118603-154564401,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,08/31/2018
R,"Xq28 recurrent region (includes GDI1)",X:153624564-153783898,"0 (No Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,05/26/2016
R,"Xq28 population region (gnomAD-SV_v2.1_DEL_X_190964)",X:155238299-155249500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq28 population region (gnomAD-SV_v2.1_DEL_X_190749)",X:153511999-153522000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq28 population region (gnomAD-SV_v2.1_DEL_X_190688)",X:152240999-152251200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq28 population region (DGV_Gold_Standard_June_2021_gssvG41365)",X:153409846-153460630,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Xq27.3 population region (DGV_Gold_Standard_June_2021_gssvL137799)",X:142601775-142800327,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq26.3 population region (gnomAD-SV_v2.1_DEL_X_189893)",X:134948399-134964600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq26.3 population region (gnomAD-SV_v2.1_DEL_X_189886)",X:134872199-134878900,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq24 population region (gnomAD-SV_v2.1_DEL_X_189263)",X:120077116-120120000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq24 population region (gnomAD-SV_v2.1_DEL_X_189262)",X:120063234-120090000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xq24 population region (DGV_Gold_Standard_June_2021_gssvG41158)",X:120006512-120123897,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Xq21.1 population region (DGV_Gold_Standard_June_2021_gssvL136501)",X:76137628-76141022,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
G,XPNPEP3,22:41253152-41328819,"30 (Autosomal Recessive)","0 (No Evidence)",,,37.01,0,0.88,08/22/2016
G,XPC,3:14186647-14220101,"30 (Autosomal Recessive)","Not Yet Evaluated",,,63.33,0,0.78,08/22/2016
G,XPA,9:100437191-100459622,"30 (Autosomal Recessive)","0 (No Evidence)",,,25.19,0,0.97,08/22/2016
R,"Xp22.31 recurrent region (includes STS)",X:6455812-8124954,"3 (Sufficient Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,07/01/2021
R,"Xp21.2 region (includes NR0B1)",X:30195000-30355000,"0 (No Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,07/22/2020
R,"Xp11.23 region (includes MAOA and MAOB)",X:43514154-43741720,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,10/11/2017
R,"Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53157)",X:49338999-49356900,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53155)",X:49328999-49343400,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53151)",X:49292999-49318650,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Xp11.23 population region (gnomAD-SV_v2.1_DUP_X_53149)",X:49197299-49208400,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"Xp11.23 population region (gnomAD-SV_v2.1_DEL_X_186156)",X:49176299-49186050,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xp11.23 population region (DGV_Gold_Standard_June_2021_gssvL136075)",X:47880294-47952112,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"Xp11.22p11.23 recurrent region (includes SHROOM4)",X:48306152-52103258,"0 (No Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,12/14/2017
R,"Xp11.22 region (includes HUWE1)",X:53363456-53793054,"0 (No Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,11/20/2018
G,XIST,X:73040486-73072588,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,04/22/2020
G,XIAP,X:122993558-123047822,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.36,0.92,0.37,07/27/2022
G,XDH,2:31557187-31637608,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.11,0,0.86,08/22/2016
G,WWOX,16:78133551-79246564,"30 (Autosomal Recessive)","0 (No Evidence)",,,0.38,0,1.53,11/08/2017
G,WT1,11:32409321-32457085,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.09,1,0.25,01/25/2022
G,WRN,8:30891326-31033654,"30 (Autosomal Recessive)","0 (No Evidence)",,,17.41,0,0.95,03/25/2015
G,WRAP53,17:7589389-7606820,"30 (Autosomal Recessive)","0 (No Evidence)",,,65.51,0,0.69,12/15/2017
G,WNT7A,3:13857755-13921568,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.9,0.04,0.71,08/22/2016
G,WHRN,9:117164360-117267753,"30 (Autosomal Recessive)","0 (No Evidence)",,,38.98,0,0.67,08/22/2016
G,WFS1,4:6271577-6304992,"0 (No Evidence)","0 (No Evidence)",,,33.79,0,1.93,02/08/2012
G,WDR72,15:53805938-54055075,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.26,0,1.07,08/22/2016
G,WDR62,19:36545799-36596010,"30 (Autosomal Recessive)","Not Yet Evaluated",,,51.08,0,0.86,08/22/2016
G,WDR45,X:48932101-48958116,"3 (Sufficient Evidence)","0 (No Evidence)",,,49.99,0.99,0.21,04/09/2015
G,WDR35,2:20110024-20189866,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.05,0,0.82,06/19/2013
G,WDR26,1:224572848-224622499,"3 (Sufficient Evidence)","0 (No Evidence)",,,10.72,1,0.09,04/27/2022
G,WDPCP,2:63346694-63815611,"30 (Autosomal Recessive)","0 (No Evidence)",,,24.69,0,0.78,08/22/2016
G,WAC,10:28821708-28912041,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.64,1,0.08,02/28/2018
G,VPS53,17:411908-618079,"30 (Autosomal Recessive)","Not Yet Evaluated",,,20.07,0,0.61,08/22/2016
G,VPS37A,8:17104467-17190964,"30 (Autosomal Recessive)","0 (No Evidence)",,,43.37,0,0.72,08/22/2016
G,VPS26C,21:38595721-38640409,"0 (No Evidence)","0 (No Evidence)",,,53.11,0,1.06,04/25/2012
G,VPS13B,8:100025502-100889808,"30 (Autosomal Recessive)","0 (No Evidence)",,,4.55,0,0.65,06/26/2013
G,VPS13A,9:79792450-80036453,"30 (Autosomal Recessive)","Not Yet Evaluated",,,33.87,0,0.48,08/22/2016
G,VLDLR,9:2621787-2660056,"30 (Autosomal Recessive)","Not Yet Evaluated",,,13.41,0,0.72,08/22/2016
G,VHL,3:10183462-10195351,"3 (Sufficient Evidence)","0 (No Evidence)",,,45.43,0.08,0.93,05/11/2022
G,VEGFA,6:43737946-43754224,"1 (Little Evidence)","0 (No Evidence)",,,0.1,0,0.84,04/25/2012
G,VCX3A,X:6451659-6453159,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,94.12,0.31,1.87,10/12/2012
G,VAMP7,Y:59214014-59276439,"0 (No Evidence)","0 (No Evidence)",,,56.22,0.01,0.86,09/06/2012
G,UVSSA,4:1340996-1381837,"30 (Autosomal Recessive)","Not Yet Evaluated",,,81.41,0,1.48,08/22/2016
G,USP9X,X:40944698-41095832,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.82,1,0.05,03/28/2018
G,USH2A,1:215796233-216596790,"30 (Autosomal Recessive)","Not Yet Evaluated",,,4.18,0,0.86,08/22/2016
G,USH1G,17:72912175-72919350,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.67,0,1.09,08/22/2016
G,USH1C,11:17515447-17565963,"30 (Autosomal Recessive)","0 (No Evidence)",,,22.32,0,0.89,04/07/2012
G,UROS,10:127473549-127511827,"30 (Autosomal Recessive)","Not Yet Evaluated",,,69.16,0.03,0.73,08/22/2016
G,UPF3B,X:118967985-118986926,"3 (Sufficient Evidence)","0 (No Evidence)",,,33.04,0.98,0.29,02/09/2021
G,UPF2,10:11962021-12085169,"0 (No Evidence)","0 (No Evidence)",,,12.07,1,0.1,02/13/2019
G,UPB1,22:24891300-24924358,"30 (Autosomal Recessive)","Not Yet Evaluated",,,65,0,1.26,08/22/2016
G,UNC93A,6:167704803-167729502,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,85.98,0,1.69,02/03/2021
G,UBR1,15:43235095-43398236,"30 (Autosomal Recessive)","Not Yet Evaluated",,,21.91,0.01,0.35,08/22/2016
G,UBN2,7:138915983-138992982,"1 (Little Evidence)","0 (No Evidence)",,,23.88,1,0.21,05/22/2019
G,UBE3B,12:109915439-109974507,"30 (Autosomal Recessive)","0 (No Evidence)",,,57.19,0,0.55,08/22/2016
G,UBE3A,15:25578875-25684203,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.11,1,0.21,08/23/2012
G,UBE2T,1:202300785-202311064,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.95,0,1.3,09/01/2020
G,UBE2A,X:118708526-118718386,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.57,0.82,0.54,05/22/2019
G,TYRP1,9:12693385-12710285,"30 (Autosomal Recessive)","Not Yet Evaluated",,,21.84,0,1.89,08/22/2016
G,TYROBP,19:36395305-36399197,"30 (Autosomal Recessive)","0 (No Evidence)",,,59.61,0.2,0.92,08/22/2016
G,TYMP,22:50964181-50968514,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.24,0,0.92,08/22/2016
G,TWIST2,2:239756726-239832230,"30 (Autosomal Recessive)","0 (No Evidence)",,,6.73,0.56,1.15,08/22/2016
G,TWIST1,7:19152670-19157259,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.34,0.34,1.06,12/16/2020
G,TUSC3,8:15397596-15624158,"30 (Autosomal Recessive)","Not Yet Evaluated",,,34.41,0,0.93,12/01/2021
G,TUFM,16:28853732-28857669,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.48,0,0.74,08/22/2016
G,TUBGCP6,22:50656123-50683452,"30 (Autosomal Recessive)","0 (No Evidence)",,,77.41,0,0.93,08/22/2016
G,TUBB4A,19:6494330-6502859,"0 (No Evidence)","0 (No Evidence)",,,42.56,0.11,0.67,11/19/2014
G,TUBB3,16:89988333-90002505,"0 (No Evidence)","0 (No Evidence)",,,61.93,0,1.11,08/30/2017
G,TUBA1A,12:49578578-49582863,"0 (No Evidence)","0 (No Evidence)",,,4.83,0.97,0.32,04/14/2016
G,TTN,2:179390716-179672150,"3 (Sufficient Evidence)","0 (No Evidence)",,,25.39,0,0.35,08/02/2021
G,TTLL5,14:76127589-76421422,"30 (Autosomal Recessive)","0 (No Evidence)",,,12.66,0,0.76,08/22/2016
G,TTC8,14:89290497-89347423,"30 (Autosomal Recessive)","Not Yet Evaluated",,,23.34,0,0.74,08/22/2016
G,TTC7A,2:47143005-47303262,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.91,0,1.29,08/22/2016
G,TTC37,5:94799598-94890681,"30 (Autosomal Recessive)","Not Yet Evaluated",,,22.59,0,0.78,08/22/2016
G,TTC21B,2:166729872-166810286,"30 (Autosomal Recessive)","0 (No Evidence)",,,30.49,0,0.85,08/22/2016
G,TTC19,17:15903138-15932718,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.14,0,1.12,08/22/2016
G,TSPEAR,21:45917776-46131487,"30 (Autosomal Recessive)","0 (No Evidence)",,,67.21,0,1.2,08/22/2016
G,TSPAN7,X:38420795-38548172,"1 (Little Evidence)","0 (No Evidence)",,,17.96,0.75,0.54,06/22/2022
G,TSEN54,17:73512609-73520816,"30 (Autosomal Recessive)","Not Yet Evaluated",,,62.63,0,0.88,08/22/2016
G,TSEN2,3:12525979-12581123,"30 (Autosomal Recessive)","0 (No Evidence)",,,85.38,0,1.14,08/22/2016
G,TSC2,16:2097986-2139492,"3 (Sufficient Evidence)","0 (No Evidence)",,,10.92,1,0.07,06/10/2020
G,TSC1,9:135766736-135820003,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.9,1,0.12,10/13/2020
G,TRRAP,7:98476155-98610864,"1 (Little Evidence)","0 (No Evidence)",,,19.5,1,0.06,04/24/2019
G,TRPS1,8:116420724-116681202,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.26,1,0.11,07/08/2020
G,TRPM1,15:31293268-31453363,"30 (Autosomal Recessive)","Not Yet Evaluated",,,57.82,0,1.07,08/22/2016
G,TRMU,22:46731611-46753237,"30 (Autosomal Recessive)","0 (No Evidence)",,,63.58,0,1.56,08/22/2016
G,TRMT10A,4:100467868-100485196,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.48,0,1.18,08/22/2016
G,TRIP4,15:64680035-64747502,"30 (Autosomal Recessive)","0 (No Evidence)",,,18.24,0,0.67,08/17/2018
G,TRIP12,2:230628553-230787902,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.78,1,0.06,04/02/2018
G,TRIOBP,22:38093055-38172563,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.57,0,0.71,08/22/2016
G,TRIO,5:14143451-14510313,"3 (Sufficient Evidence)","0 (No Evidence)",,,25.7,1,0.14,01/24/2018
G,TRIM37,17:57060010-57184241,"30 (Autosomal Recessive)","0 (No Evidence)",,,2.79,0,0.64,08/22/2016
G,TRIM32,9:119449584-119463578,"30 (Autosomal Recessive)","0 (No Evidence)",,,26.93,0,0.86,08/22/2016
G,TRIM2,4:154073315-154260469,"30 (Autosomal Recessive)","0 (No Evidence)",,,21.81,1,0.27,08/22/2016
G,TRHR,8:110098814-110133794,"30 (Autosomal Recessive)","Not Yet Evaluated",,,21.25,0.27,0.64,08/22/2016
G,TRDN,6:123537484-123958095,"30 (Autosomal Recessive)","Not Yet Evaluated",,,49.08,0,1.02,08/22/2016
G,TRAPPC9,8:140739968-141468678,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.39,0,0.73,08/06/2015
G,TRAPPC2,X:13730364-13752739,"3 (Sufficient Evidence)","0 (No Evidence)",,,21.53,0,1.75,01/16/2014
G,TRAPPC10,21:45432190-45526433,"0 (No Evidence)","0 (No Evidence)",,,47.8,1,0.2,09/06/2012
G,TPSD1,16:1306070-1309009,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,94.69,0,1.85,02/03/2021
G,TPRN,9:140086071-140095193,"30 (Autosomal Recessive)","0 (No Evidence)",,,84.93,0.01,0.8,08/22/2016
G,TPO,2:1417235-1547445,"30 (Autosomal Recessive)","Not Yet Evaluated",,,76.12,0,1.11,08/22/2016
G,TPM1,15:63334946-63364114,"0 (No Evidence)","0 (No Evidence)",,,1.5,0,0.78,11/09/2015
G,TPK1,7:144149034-144533146,"30 (Autosomal Recessive)","0 (No Evidence)",,,43.3,0.09,0.7,08/22/2016
G,TP73,1:3569080-3652765,"0 (No Evidence)","0 (No Evidence)",,,25.95,1,0.26,07/06/2012
G,TP63,3:189314535-189615065,"1 (Little Evidence)","0 (No Evidence)",,,1.11,1,0.27,09/06/2012
G,TP53,17:7571739-7590808,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.2,0.53,0.47,11/10/2021
G,TOP3B,22:22311397-22337184,"0 (No Evidence)","0 (No Evidence)",,,15.87,0,0.54,07/13/2022
G,TNRC6B,22:40440838-40731812,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.62,1,0.17,06/26/2019
G,TNNT2,1:201328142-201346808,"0 (No Evidence)","0 (No Evidence)",,,56.44,0,0.64,11/16/2015
G,TNNT1,19:55644066-55660574,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.99,0,1.48,08/22/2016
G,TNNI3,19:55663135-55669100,"1 (Little Evidence)","0 (No Evidence)",,,40.95,0.1,0.69,11/20/2015
G,TNFRSF11B,8:119935796-119964124,"30 (Autosomal Recessive)","Not Yet Evaluated",,,13.92,0.16,0.55,08/22/2016
G,TMPRSS6,22:37461476-37505753,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.76,0,0.72,08/22/2016
G,TMPRSS3,21:43791999-43816161,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.12,0,1.12,08/22/2016
G,TMLHE,X:154718672-154842613,"1 (Little Evidence)","0 (No Evidence)",,,63.26,0,1.18,08/01/2013
G,TMEM67,8:94767072-94831466,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.26,0,0.94,08/22/2016
G,TMEM43,3:14166552-14185180,"0 (No Evidence)","0 (No Evidence)",,,43,0,1.28,11/08/2015
G,TMEM237,2:202484909-202508226,"30 (Autosomal Recessive)","0 (No Evidence)",,,49.64,0,1.25,04/09/2015
G,TMEM231,16:75570639-75590184,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.93,0,1.21,08/22/2016
G,TMEM135,11:86748976-87039866,"0 (No Evidence)","0 (No Evidence)",,,17.19,0.78,0.39,11/02/2015
G,TMEM127,2:96914252-96931735,"3 (Sufficient Evidence)","0 (No Evidence)",,,19.66,0.01,1.15,07/13/2021
G,TMCO1,1:165693528-165738159,"30 (Autosomal Recessive)","Not Yet Evaluated",,,14.08,0,1.36,08/22/2016
G,TMC8,17:76126852-76139049,"30 (Autosomal Recessive)","0 (No Evidence)",,,81.31,0,1.12,08/22/2016
G,TMC6,17:76103478-76128508,"30 (Autosomal Recessive)","0 (No Evidence)",,,79.04,0,0.75,08/22/2016
G,TLX3,5:170736252-170739143,"0 (No Evidence)","0 (No Evidence)",,,16.47,0.26,0.82,09/25/2018
G,TJP2,9:71736180-71870124,"30 (Autosomal Recessive)","Not Yet Evaluated",,,31.7,0,0.64,08/22/2016
G,TIMM8A,X:100600649-100603730,"3 (Sufficient Evidence)","0 (No Evidence)",,,16.93,0.65,0.87,03/24/2021
G,TIGD6,5:149372681-149380217,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,70.79,0,1.21,02/03/2021
G,THRA,17:38218446-38250120,"0 (No Evidence)","0 (No Evidence)",,,3.21,0.33,0.45,08/22/2013
G,TGM5,15:43524788-43559126,"30 (Autosomal Recessive)","Not Yet Evaluated",,,58.03,0,1.44,08/22/2016
G,TGM1,14:24718320-24732383,"30 (Autosomal Recessive)","Not Yet Evaluated",,,48.02,0,0.93,08/22/2016
G,TGIF1,18:3412007-3459976,"3 (Sufficient Evidence)","0 (No Evidence)",,,30.39,0.01,0.91,05/10/2012
G,TGFBR2,3:30647994-30735634,"2 (Emerging Evidence)","0 (No Evidence)",,,2.72,0.13,0.52,04/11/2012
G,TGFBR1,9:101867395-101916474,"2 (Emerging Evidence)","0 (No Evidence)",,,1.85,0.85,0.38,04/25/2012
G,TFR2,7:100218043-100239175,"30 (Autosomal Recessive)","0 (No Evidence)",,,46.16,0,0.77,08/22/2016
G,TFAP2B,6:50786584-50815332,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.98,0.99,0.26,08/13/2015
G,TEX26,13:31506793-31549637,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,89.11,0,1.4,02/03/2021
G,TERT,5:1253282-1295183,"1 (Little Evidence)","0 (No Evidence)",,,18.57,0.99,0.29,11/17/2011
G,TECTA,11:120971952-121062199,"30 (Autosomal Recessive)","0 (No Evidence)",,,11.78,0,0.58,02/07/2018
G,TECPR2,14:102829278-102968814,"30 (Autosomal Recessive)","0 (No Evidence)",,,73.01,0.58,0.35,08/22/2016
G,TDP1,14:90422271-90511108,"30 (Autosomal Recessive)","0 (No Evidence)",,,48.95,0,1.11,08/22/2016
G,TDGF1,3:46616025-46623947,"1 (Little Evidence)","0 (No Evidence)",,,77.65,0,1.92,12/27/2011
G,TCTN2,12:124155660-124192946,"30 (Autosomal Recessive)","0 (No Evidence)",,,87.7,0,0.99,08/22/2016
G,TCTN1,12:111051934-111087235,"30 (Autosomal Recessive)","0 (No Evidence)",,,75.52,0,1.23,03/23/2015
G,TCOF1,5:149737260-149779856,"3 (Sufficient Evidence)","0 (No Evidence)",,,69.76,0.95,0.31,04/28/2021
G,TCN2,22:31003161-31023258,"30 (Autosomal Recessive)","Not Yet Evaluated",,,66.38,0,0.93,08/22/2016
G,TCIRG1,11:67806492-67818362,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.47,0,0.87,08/22/2016
G,TCF7L2,10:114710006-114927437,"1 (Little Evidence)","0 (No Evidence)",,,0.77,1,0.27,03/27/2019
G,TCF4,18:52889416-53303188,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.38,1,0.22,07/08/2020
G,TCF20,22:42556019-42679933,"3 (Sufficient Evidence)","0 (No Evidence)",,,23.45,1,0.1,06/26/2019
G,TCF12,15:57210288-57583508,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.07,0.68,0.37,10/15/2015
G,TBX5,12:114791716-114846247,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.67,1,0.14,07/29/2020
G,TBX4,17:59529783-59562471,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.73,0.5,0.45,12/11/2019
G,TBX3,12:115108060-115121980,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.05,0.99,0.28,09/23/2020
G,TBX22,X:79270252-79287273,"3 (Sufficient Evidence)","0 (No Evidence)",,,43.82,0.98,0.3,03/24/2016
G,TBX20,7:35242042-35293711,"1 (Little Evidence)","0 (No Evidence)",,,5.83,0.97,0.32,04/26/2013
G,TBX2,17:59477204-59486827,"1 (Little Evidence)","0 (No Evidence)",,,5.16,0.99,0.25,08/08/2018
G,TBX1,22:19744226-19771116,"2 (Emerging Evidence)","0 (No Evidence)",,,4.92,0.84,0.43,04/12/2022
G,TBR1,2:162272808-162282381,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.97,1,0.19,01/24/2018
G,TBL1XR1,3:176737132-176915270,"3 (Sufficient Evidence)","1 (Little Evidence)",,,6.88,1,0.11,03/27/2019
G,TBCE,1:235530742-235615756,"30 (Autosomal Recessive)","0 (No Evidence)",,,28.98,0,0.81,05/17/2012
G,TBC1D5,3:17198654-17784123,"0 (No Evidence)","0 (No Evidence)",,,5.84,0,0.97,10/30/2015
G,TBC1D20,20:416124-443177,"30 (Autosomal Recessive)","0 (No Evidence)",,,34.62,0.93,0.36,08/22/2016
G,TARDBP,1:11072711-11085549,"0 (No Evidence)","0 (No Evidence)",,,12.94,0.99,0.28,09/25/2018
G,TAF2,8:120743014-120845081,"30 (Autosomal Recessive)","0 (No Evidence)",,,15.82,0,0.42,08/22/2016
G,TAF13,1:109606762-109618625,"1 (Little Evidence)","0 (No Evidence)",,,18.12,0.02,1.09,05/22/2019
G,TACSTD2,1:59041105-59042924,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.49,0,1.53,08/22/2016
G,TAB2,6:149539062-149732743,"1 (Little Evidence)","0 (No Evidence)",,,5.38,1,0.1,05/27/2020
G,SYT14,1:210111562-210344734,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.2,0.94,0.34,08/22/2016
G,SYP,X:49044268-49056652,"1 (Little Evidence)","0 (No Evidence)",,,3.93,0.92,0.39,09/26/2018
G,SYNGAP1,6:33387842-33421466,"3 (Sufficient Evidence)","0 (No Evidence)",,,19.65,1,0.05,07/06/2012
G,SYNE4,19:36494209-36499715,"30 (Autosomal Recessive)","0 (No Evidence)",,,81.2,0,1.29,08/22/2016
G,SYN1,X:47431300-47479256,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.89,0.99,0.25,07/12/2022
G,SUZ12,17:30264026-30328057,"0 (No Evidence)","0 (No Evidence)",,,3.13,1,0.13,07/06/2012
G,SURF1,9:136218613-136223363,"30 (Autosomal Recessive)","Not Yet Evaluated",,,65.94,0,1.72,08/22/2016
G,SUPT16H,14:21819635-21852178,"0 (No Evidence)","0 (No Evidence)",,,22.56,1,0.12,05/09/2012
G,SUMF1,3:4402830-4508953,"30 (Autosomal Recessive)","0 (No Evidence)",,,29.81,0,1.07,08/22/2016
G,SUCLG1,2:84650652-84686404,"30 (Autosomal Recessive)","0 (No Evidence)",,,4.91,0,0.88,08/22/2016
G,STXBP1,9:130374191-130458308,"3 (Sufficient Evidence)","0 (No Evidence)",,,21.32,1,0.09,06/20/2013
G,STX11,6:144471654-144513076,"30 (Autosomal Recessive)","Not Yet Evaluated",,,37.4,0,1.38,08/22/2016
G,STUB1,16:730410-732801,"30 (Autosomal Recessive)","Not Yet Evaluated",,,25.33,0.02,0.68,08/22/2016
G,STT3A,11:125462747-125492986,"30 (Autosomal Recessive)","0 (No Evidence)",,,5.47,0,0.49,08/29/2014
G,STS,X:7065331-7272682,"3 (Sufficient Evidence)","0 (No Evidence)",,,40.89,0.81,0.44,09/14/2018
G,STRC,15:43891761-43910998,"30 (Autosomal Recessive)","Not Yet Evaluated",,,40.85,0,0.88,08/22/2016
G,STK11,19:1205777-1228430,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.32,0.99,0.25,11/10/2021
G,STIL,1:47715811-47780568,"30 (Autosomal Recessive)","Not Yet Evaluated",,,31.88,0.2,0.38,08/22/2016
G,STAT1,2:191833875-191878897,"0 (No Evidence)","0 (No Evidence)",,,1.02,1,0.19,09/18/2013
G,ST3GAL5,2:86064243-86116157,"30 (Autosomal Recessive)","0 (No Evidence)",,,63.29,0,0.76,09/25/2014
G,ST14,11:130029677-130080257,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.79,0.56,0.38,08/22/2016
G,SRY,Y:2654896-2655723,"3 (Sufficient Evidence)","0 (No Evidence)",,,37.61,0,0,12/22/2020
G,SRPX2,X:99899196-99930785,"0 (No Evidence)","0 (No Evidence)",,,16.71,0.05,0.54,07/25/2012
G,SRD5A2,2:31747550-31806007,"30 (Autosomal Recessive)","0 (No Evidence)",,,‐,‐,‐,08/22/2012
G,SRCAP,16:30710492-30752730,"1 (Little Evidence)","0 (No Evidence)",,,34.43,1,0.1,05/31/2018
G,SPRED1,15:38545037-38649450,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.12,0.97,0.32,03/14/2013
G,SPP2,2:234959346-234985778,"0 (No Evidence)","0 (No Evidence)",,,87.97,0,1.89,02/27/2019
G,SPINK5,5:147443543-147516945,"30 (Autosomal Recessive)","Not Yet Evaluated",,,69.56,0,0.93,08/22/2016
G,SPINK1,5:147204145-147218759,"3 (Sufficient Evidence)","0 (No Evidence)",,,90,0.31,1.13,10/25/2021
G,SPG7,16:89574796-89624176,"30 (Autosomal Recessive)","Not Yet Evaluated",,,61.82,0,1.65,08/22/2016
G,SPG21,15:65255363-65282252,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.22,0,0.83,08/22/2016
G,SPEN,1:16174202-16266951,"1 (Little Evidence)","0 (No Evidence)",,,5.51,1,0.07,03/27/2019
G,SPEG,2:220299565-220358351,"30 (Autosomal Recessive)","0 (No Evidence)",,,37.41,0.92,0.29,08/22/2016
G,SPATA7,14:88852001-88904804,"30 (Autosomal Recessive)","0 (No Evidence)",,,75.54,0,1.15,08/22/2016
G,SPAST,2:32288625-32382706,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.51,1,0.22,09/25/2019
R,"SOX9 upstream enhancer region",17:67892996-69792434,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,06/07/2021
G,SOX8,16:1031770-1036979,"0 (No Evidence)","0 (No Evidence)",,,50.08,0.67,0.51,02/22/2012
G,SOX6,11:15987995-16760024,"0 (No Evidence)","0 (No Evidence)",,,0.59,1,0.22,03/22/2012
G,SOX5,12:23682438-24715425,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.74,1,0.19,08/19/2016
G,SOX2,3:181429713-181432224,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.54,0.71,0.57,07/06/2012
G,SOX11,2:5832516-5841517,"3 (Sufficient Evidence)","0 (No Evidence)",,,20.02,0.86,0.44,03/16/2017
G,SOX10,22:38368319-38380562,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.77,0.99,0.21,07/18/2013
G,SOST,17:41831106-41836159,"30 (Autosomal Recessive)","0 (No Evidence)",,,25.59,0.87,0.45,08/22/2012
G,SOS1,2:39208690-39352009,"0 (No Evidence)","0 (No Evidence)",,,4.03,1,0.14,03/30/2012
G,SON,21:34915344-34949787,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.75,1,0.12,04/24/2019
G,SOBP,6:107811321-107982510,"30 (Autosomal Recessive)","0 (No Evidence)",,,8.51,1,0.13,08/22/2016
G,SNURF,15:25200134-25223870,"1 (Little Evidence)","0 (No Evidence)",,,‐,0.46,0.84,09/06/2012
G,SNRPN,15:25068784-25223870,"0 (No Evidence)","0 (No Evidence)",,,73,0.04,0.83,10/26/2012
G,SNORD9,14:21860310-21860412,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,03/11/2015
G,SNORD8,14:21865452-21865560,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,03/11/2015
G,SNORD64,15:25230247-25230313,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,07/06/2012
G,SNORD109B,15:25523490-25523556,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,04/28/2012
G,SNORD108,15:25232072-25232140,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,07/06/2012
G,SNORD107,15:25227141-25227215,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,04/25/2012
G,SNAP29,22:21213295-21245502,"30 (Autosomal Recessive)","Not Yet Evaluated",,,61.36,0.01,0.86,08/22/2016
G,SMS,X:21958827-22012955,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.45,0.97,0.31,08/23/2012
G,SMOC2,6:168841864-169068672,"30 (Autosomal Recessive)","0 (No Evidence)",,,55.41,0,0.62,08/22/2016
G,SMOC1,14:70346133-70499083,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.73,0.01,0.59,08/22/2016
G,SMC1A,X:53401070-53449677,"3 (Sufficient Evidence)","0 (No Evidence)",,,14.23,1,0.06,07/23/2018
G,SMARCB1,22:24129153-24180196,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.07,1,0.22,04/22/2020
G,SMARCA4,19:11071706-11172949,"2 (Emerging Evidence)","0 (No Evidence)",,,2.95,1,0.06,07/13/2022
G,SMARCA2,9:2015347-2193624,"0 (No Evidence)","0 (No Evidence)",,,1.61,1,0.2,03/27/2013
G,SMAD4,18:48556583-48611412,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.21,1,0.22,12/16/2020
G,SMAD3,15:67357940-67487507,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.24,0.8,0.4,04/22/2020
G,SMAD2,18:45335328-45457243,"0 (No Evidence)","0 (No Evidence)",,,0.33,1,0.26,06/29/2018
G,SLURP1,8:143822367-143823824,"30 (Autosomal Recessive)","0 (No Evidence)",,,81.26,0.26,1.31,06/08/2017
G,SLC9A6,X:135067594-135129428,"3 (Sufficient Evidence)","0 (No Evidence)",,,22.85,1,0.21,12/08/2020
G,SLC7A9,19:33321417-33360673,"30 (Autosomal Recessive)","0 (No Evidence)",,,61.03,0,1.12,08/23/2021
G,SLC7A7,14:23242431-23289000,"30 (Autosomal Recessive)","Not Yet Evaluated",,,26.7,0,0.96,08/22/2016
G,SLC6A8,X:152953381-152962048,"3 (Sufficient Evidence)","0 (No Evidence)",,,22.63,1,0.21,11/10/2020
G,SLC6A4,17:28521337-28562715,"0 (No Evidence)","0 (No Evidence)",,,4.68,0.25,0.43,05/11/2012
G,SLC6A3,5:1392909-1445555,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.93,1,0.25,08/22/2016
G,SLC6A18,5:1225496-1246304,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,69.67,0,1.47,02/02/2021
G,SLC6A1,3:11034434-11080933,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.39,1,0.15,09/25/2019
G,SLC5A1,22:32439248-32509016,"30 (Autosomal Recessive)","Not Yet Evaluated",,,41.69,0,0.77,08/22/2016
G,SLC52A3,20:740724-756628,"30 (Autosomal Recessive)","Not Yet Evaluated",,,68.43,0.02,0.8,08/22/2016
G,SLC4A10,2:162480926-162841780,"1 (Little Evidence)","0 (No Evidence)",,,5.94,0.13,0.38,04/11/2012
G,SLC3A1,2:44502619-44548633,"30 (Autosomal Recessive)","0 (No Evidence)",,,61.26,0,1.62,03/21/2012
G,SLC38A8,16:84043272-84076400,"30 (Autosomal Recessive)","0 (No Evidence)",,,68.65,0,1.9,08/22/2016
G,SLC38A5,X:48316927-48328648,"0 (No Evidence)","0 (No Evidence)",,,59.25,0.98,0.3,09/26/2012
G,SLC37A4,11:118894822-118901587,"30 (Autosomal Recessive)","0 (No Evidence)",,,31.13,0,0.88,08/22/2016
G,SLC35D1,1:67465033-67519831,"30 (Autosomal Recessive)","0 (No Evidence)",,,22.91,0,0.78,04/11/2016
G,SLC35C1,11:45825623-45834567,"30 (Autosomal Recessive)","0 (No Evidence)",,,48.28,0.02,0.98,08/22/2016
G,SLC35A2,X:48760460-48769235,"3 (Sufficient Evidence)","0 (No Evidence)",,,32.21,0.72,0.56,01/24/2018
G,SLC34A2,4:25657473-25680370,"30 (Autosomal Recessive)","0 (No Evidence)",,,70.96,0,1.09,08/22/2016
G,SLC34A1,5:176811435-176825849,"30 (Autosomal Recessive)","Not Yet Evaluated",,,55.22,0,1.83,08/22/2016
G,SLC30A10,1:220083787-220132440,"30 (Autosomal Recessive)","0 (No Evidence)",,,73.7,0.98,0.25,08/22/2016
G,SLC2A10,20:45338288-45364986,"30 (Autosomal Recessive)","0 (No Evidence)",,,71.82,0,1.39,02/01/2018
G,SLC2A1,1:43391024-43424539,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.56,0.99,0.24,03/24/2016
G,SLC25A19,17:73269073-73285514,"30 (Autosomal Recessive)","0 (No Evidence)",,,55.79,0.65,0.52,08/22/2016
G,SLC25A13,7:95749532-95951410,"30 (Autosomal Recessive)","Not Yet Evaluated",,,25.1,0,1.24,08/22/2016
G,SLC25A12,2:172639915-172750754,"0 (No Evidence)","0 (No Evidence)",,,9.53,0.22,0.42,01/19/2012
G,SLC25A1,22:19163094-19166249,"30 (Autosomal Recessive)","Not Yet Evaluated",,,46.07,0.06,0.65,08/22/2016
G,SLC24A1,15:65903688-65953340,"30 (Autosomal Recessive)","0 (No Evidence)",,,79.17,0,0.57,08/22/2016
G,SLC22A18,11:2920921-2946476,"0 (No Evidence)","0 (No Evidence)",,,68.74,0,1.16,03/22/2012
G,SLC22A14,3:38323785-38360066,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,95,0,1.26,02/02/2021
G,SLC17A8,12:100750852-100815833,"1 (Little Evidence)","0 (No Evidence)",,,31.37,0,0.61,02/08/2022
G,SLC17A5,6:74303102-74363715,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.72,0,1.04,08/22/2016
G,SLC16A2,X:73641328-73753751,"3 (Sufficient Evidence)","0 (No Evidence)",,,25.73,0.99,0.22,06/28/2012
G,SLC16A12,10:91190056-91295351,"1 (Little Evidence)","0 (No Evidence)",,,29.69,0.49,0.48,12/21/2011
G,SLC13A5,17:6588038-6616688,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.88,0,0.67,08/22/2016
G,SLC12A3,16:56899119-56949762,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.42,0,1.2,02/23/2012
G,SLC12A1,15:48498499-48596275,"30 (Autosomal Recessive)","0 (No Evidence)",,,10.66,0,0.82,04/28/2012
G,SKI,1:2159758-2241652,"0 (No Evidence)","0 (No Evidence)",,,34.04,1,0.19,01/06/2012
G,SIX6,14:60975864-60979568,"0 (No Evidence)","0 (No Evidence)",,,5.88,0.52,0.6,03/22/2012
G,SIX4,14:61176257-61191069,"0 (No Evidence)","0 (No Evidence)",,,18.53,0.69,0.43,05/08/2012
G,SIX3,2:45168841-45173210,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.2,0.95,0.32,09/23/2020
G,SIX1,14:61110139-61116195,"0 (No Evidence)","0 (No Evidence)",,,1.35,0.65,0.52,03/22/2012
G,SIN3A,15:75661720-75748156,"3 (Sufficient Evidence)","0 (No Evidence)",,,7.32,1,0.07,01/13/2020
G,SIM1,6:100832885-100912797,"1 (Little Evidence)","0 (No Evidence)",,,2.5,1,0.25,04/25/2012
G,SIL1,5:138282413-138534057,"30 (Autosomal Recessive)","Not Yet Evaluated",,,17.56,0.01,0.64,08/23/2021
G,SIGLEC5,19:52114213-52133654,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,97.84,0,0.98,02/02/2021
G,SI,3:164696686-164796284,"30 (Autosomal Recessive)","Not Yet Evaluated",,,61.91,0,1.04,08/22/2016
G,SHROOM4,X:50334642-50557194,"0 (No Evidence)","0 (No Evidence)",,,44.15,1,0.23,10/10/2012
G,SHOX,Y:535079-570146,"3 (Sufficient Evidence)","0 (No Evidence)",,,76.05,0.67,0.52,10/15/2015
G,SHOC2,10:112679128-112773423,"0 (No Evidence)","0 (No Evidence)",,,5.7,1,0.14,09/25/2018
G,SHH,7:155592674-155605157,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.66,0.98,0.24,06/24/2020
G,SHANK3,22:51111251-51171640,"3 (Sufficient Evidence)","0 (No Evidence)",,,60.1,1,0.12,08/14/2018
G,SHANK2,11:70313959-70963623,"3 (Sufficient Evidence)","0 (No Evidence)",,,45.57,0,0.46,09/28/2022
G,SHANK1,19:51162512-51223059,"1 (Little Evidence)","0 (No Evidence)",,,76.11,1,0.18,03/27/2019
G,SH3TC2,5:148361713-148442625,"30 (Autosomal Recessive)","Not Yet Evaluated",,,47.72,0,0.81,08/22/2016
G,SH2D1A,X:123480413-123507010,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.82,0.39,0.96,01/27/2021
G,SH2B1,16:28857927-28885526,"1 (Little Evidence)","0 (No Evidence)",,,32.53,0.97,0.32,07/13/2021
G,SGSH,17:78183075-78194132,"30 (Autosomal Recessive)","0 (No Evidence)",,,69.12,0,0.8,02/12/2015
G,SGCG,13:23734647-23899301,"30 (Autosomal Recessive)","0 (No Evidence)",,,55.59,0,1.05,08/22/2016
G,SGCE,7:94214292-94285445,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.27,0.02,0.54,11/11/2021
G,SF3B4,1:149895209-149899695,"3 (Sufficient Evidence)","0 (No Evidence)",,,25.11,0.99,0.21,07/17/2014
G,SETD5,3:9439299-9519838,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.88,1,0.23,11/06/2014
G,SETD2,3:47057926-47205603,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.64,1,0.21,03/08/2022
G,SETD1A,16:30969075-30995985,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.55,1,0.14,02/28/2018
G,SETBP1,18:42260038-42648475,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.67,1,0.11,05/23/2018
G,SERPINF1,17:1665354-1680859,"30 (Autosomal Recessive)","Not Yet Evaluated",,,32.9,0,1.21,08/22/2016
G,SERPINE1,7:100770385-100782528,"30 (Autosomal Recessive)","Not Yet Evaluated",,,6.47,0.04,0.69,08/22/2016
G,SERPINB7,18:61420291-61472604,"30 (Autosomal Recessive)","0 (No Evidence)",,,63.85,0,1.31,11/13/2014
G,SERPINB6,6:2948393-2972027,"30 (Autosomal Recessive)","0 (No Evidence)",,,69,0,1.12,08/22/2016
G,SERPINA1,14:94843084-94856972,"30 (Autosomal Recessive)","0 (No Evidence)",,,88.1,0,1.63,05/09/2017
G,SERAC1,6:158530551-158589294,"30 (Autosomal Recessive)","Not Yet Evaluated",,,61.2,0,0.63,08/22/2016
G,SEPSECS,4:25121636-25162071,"30 (Autosomal Recessive)","Not Yet Evaluated",,,34.9,0,0.99,08/22/2016
G,SEMA3A,7:83585093-83824105,"1 (Little Evidence)","0 (No Evidence)",,,1.46,0.98,0.31,08/07/2017
G,SEM1,7:96110938-96339158,"0 (No Evidence)","0 (No Evidence)",,,7.71,0.02,1.53,05/14/2012
G,SEC23B,20:18488192-18542059,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.77,0,0.98,08/22/2016
G,SEC14L4,22:30884889-30901682,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,74.07,0,1.13,02/02/2021
G,SDR42E1,16:82022460-82045075,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,72.19,0,1.86,02/02/2021
G,SDHD,11:111957597-111966518,"3 (Sufficient Evidence)","0 (No Evidence)",,,39.67,0.34,0.73,08/11/2021
G,SDHC,1:161284171-161345130,"3 (Sufficient Evidence)","0 (No Evidence)",,,47.07,0,1.26,10/13/2021
G,SDHB,1:17345217-17380527,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.22,0,0.83,07/22/2020
G,SDHAF2,11:61197596-61214205,"3 (Sufficient Evidence)","0 (No Evidence)",,,7.74,0,1.81,05/11/2022
G,SDHAF1,19:36486090-36487214,"30 (Autosomal Recessive)","0 (No Evidence)",,,74.19,0.09,1.9,08/22/2016
G,SDCCAG8,1:243419343-243663393,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.89,0,0.78,08/22/2016
G,SCN8A,12:51985017-52206648,"0 (No Evidence)","0 (No Evidence)",,,5.53,1,0.13,04/11/2013
G,SCN5A,3:38589553-38691178,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.55,0.91,0.31,06/08/2021
G,SCN2A,2:166095924-166248814,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.08,1,0.13,04/22/2020
G,SCN1B,19:35521374-35531353,"0 (No Evidence)","0 (No Evidence)",,,48.18,0.1,1.27,09/04/2019
G,SCN1A,2:166841151-167005671,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.08,1,0.07,07/06/2012
G,SCARF2,22:20778874-20792112,"30 (Autosomal Recessive)","0 (No Evidence)",,,70.17,1,0.19,08/22/2016
G,SCARB2,4:77079890-77134977,"0 (No Evidence)","0 (No Evidence)",,,24.43,0,0.72,07/06/2012
G,SBF2,11:9800215-10315766,"30 (Autosomal Recessive)","Not Yet Evaluated",,,9.49,0,0.47,08/22/2016
G,SATB2,2:200134223-200335989,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.6,1,0.09,07/15/2020
G,SAMD9,7:92728831-92747292,"30 (Autosomal Recessive)","Not Yet Evaluated",,,77.6,0,1.24,08/22/2016
G,SALL4,20:50398870-50419060,"3 (Sufficient Evidence)","0 (No Evidence)",,,38.01,1,0.1,01/11/2021
G,SALL1,16:51169893-51185181,"1 (Little Evidence)","0 (No Evidence)",,,5.63,1,0.2,01/27/2021
G,SACS,13:23902969-24007841,"30 (Autosomal Recessive)","0 (No Evidence)",,,35.26,0,0.54,08/22/2016
G,RYR2,1:237205484-237997288,"0 (No Evidence)","0 (No Evidence)",,,14.03,1,0.25,11/06/2015
G,RYR1,19:38924331-39078204,"0 (No Evidence)","0 (No Evidence)",,,15.43,0,0.46,11/12/2015
G,RXFP2,13:32313663-32377526,"0 (No Evidence)","0 (No Evidence)",,,32.97,0,1,07/06/2012
G,RUNX1,21:36160098-36421599,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.45,0.65,0.44,08/14/2012
G,RTTN,18:67670267-67872923,"30 (Autosomal Recessive)","Not Yet Evaluated",,,64.2,0,0.74,08/22/2016
G,RSPO4,20:939095-982954,"30 (Autosomal Recessive)","Not Yet Evaluated",,,64.82,0,1.59,08/22/2016
G,RSPH4A,6:116937642-116954148,"30 (Autosomal Recessive)","Not Yet Evaluated",,,69.78,0,0.94,08/22/2016
G,RSPH1,21:43892596-43916334,"30 (Autosomal Recessive)","Not Yet Evaluated",,,83.46,0,0.99,08/22/2016
G,RS1,X:18657808-18690228,"3 (Sufficient Evidence)","0 (No Evidence)",,,28.71,0.96,0.3,08/02/2021
G,RPS6KA3,X:20168029-20285027,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.88,1,0.09,06/14/2022
G,RPS26,12:56435702-56438481,"3 (Sufficient Evidence)","0 (No Evidence)",,,45.57,0.85,0.48,10/23/2019
G,RPS24,10:79793621-79816564,"3 (Sufficient Evidence)","0 (No Evidence)",,,22.8,0.68,0.59,10/23/2019
G,RPS19,19:42364325-42376993,"3 (Sufficient Evidence)","0 (No Evidence)",,,23.95,0.92,0.37,03/24/2021
G,RPS17,15:83205501-83209208,"3 (Sufficient Evidence)","0 (No Evidence)",,,60.09,0.33,1.85,12/10/2015
G,RPL15,3:23958036-23966122,"1 (Little Evidence)","0 (No Evidence)",,,21.68,0.97,0.27,07/16/2014
G,RPL10,X:153626406-153630680,"0 (No Evidence)","0 (No Evidence)",,,36.48,0.91,0.39,10/24/2018
G,RPH3A,12:113013040-113336686,"1 (Little Evidence)","0 (No Evidence)",,,42.44,0,0.47,07/25/2018
G,RPGRIP1,14:21748242-21819460,"30 (Autosomal Recessive)","0 (No Evidence)",,,59.78,0,0.88,08/22/2016
G,RP2,X:46696478-46741793,"3 (Sufficient Evidence)","0 (No Evidence)",,,33.66,0.96,0.31,10/04/2012
G,ROR2,9:94484883-94712510,"0 (No Evidence)","0 (No Evidence)",,,53.78,0,0.56,03/27/2013
G,ROGDI,16:4846969-4852634,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.95,0,1.42,02/12/2015
G,ROBO3,11:124735328-124751367,"30 (Autosomal Recessive)","0 (No Evidence)",,,48.29,0,0.71,08/22/2016
G,ROBO1,3:78646389-79817148,"0 (No Evidence)","0 (No Evidence)",,,3.33,0,0.6,09/25/2018
G,RNF32,7:156433468-156469824,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,75.12,0,1.54,02/02/2021
G,RNF168,3:196195654-196230639,"30 (Autosomal Recessive)","0 (No Evidence)",,,69.55,0,1.2,08/22/2016
G,RNF135,17:29298057-29326929,"0 (No Evidence)","0 (No Evidence)",,,90.13,0,1.44,09/22/2021
G,RNASEH2A,19:12917398-12924454,"30 (Autosomal Recessive)","Not Yet Evaluated",,,3.39,0,0.88,08/22/2016
G,RMRP,9:35657748-35658015,"30 (Autosomal Recessive)","Not Yet Evaluated",,,‐,‐,‐,08/22/2016
G,RMND1,6:151725897-151773261,"30 (Autosomal Recessive)","0 (No Evidence)",,,36.01,0,1.11,08/22/2016
G,RIPK4,21:43159533-43187212,"30 (Autosomal Recessive)","0 (No Evidence)",,,43.77,0,0.59,08/22/2016
G,RIN2,20:19738902-19983100,"30 (Autosomal Recessive)","Not Yet Evaluated",,,39.64,0,0.55,08/22/2016
G,RIMS1,6:72596253-73112847,"1 (Little Evidence)","0 (No Evidence)",,,9.51,0.99,0.29,01/24/2018
G,RFX6,6:117198405-117253324,"30 (Autosomal Recessive)","0 (No Evidence)",,,28.8,0,0.47,09/18/2015
G,RETREG1,5:16473162-16617106,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.64,0,0.86,08/22/2016
G,RET,10:43572517-43625799,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.58,1,0.12,08/26/2020
G,RELN,7:103112236-103630105,"30 (Autosomal Recessive)","0 (No Evidence)",,,1.1,1,0.18,08/27/2012
G,RDX,11:110045647-110167339,"30 (Autosomal Recessive)","0 (No Evidence)",,,8.08,0.85,0.35,08/22/2016
G,RCAN1,21:35888740-35987412,"0 (No Evidence)","0 (No Evidence)",,,38.75,0.02,1.07,04/27/2012
G,RBP3,10:48381481-48390999,"30 (Autosomal Recessive)","0 (No Evidence)",,,56.69,0,0.65,08/22/2016
G,RBBP8,18:20513291-20606449,"30 (Autosomal Recessive)","Not Yet Evaluated",,,13.93,0,0.75,08/22/2016
G,RB1CC1,8:53535018-53626995,"1 (Little Evidence)","0 (No Evidence)",,,10.33,1,0.14,07/25/2018
G,RB1,13:48877887-49056026,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.53,1,0.13,03/09/2021
G,RAX,18:56934270-56940686,"30 (Autosomal Recessive)","Not Yet Evaluated",,,51.09,0.1,0.86,08/22/2016
G,RASA1,5:86563700-86687733,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.57,1,0.13,04/22/2020
G,RARS2,6:88223656-88299705,"30 (Autosomal Recessive)","0 (No Evidence)",,,21.71,0,0.92,04/09/2015
G,RALGAPB,20:37101486-37207501,"1 (Little Evidence)","0 (No Evidence)",,,12.23,1,0.11,02/27/2019
G,RAI1,17:17584772-17714767,"3 (Sufficient Evidence)","0 (No Evidence)",,,47.54,1,0.12,10/13/2020
G,RAG2,11:36613493-36619786,"30 (Autosomal Recessive)","Not Yet Evaluated",,,3.71,0.02,0.79,08/22/2016
G,RAG1,11:36531903-36601312,"30 (Autosomal Recessive)","Not Yet Evaluated",,,24.07,0,0.74,08/22/2016
G,RAF1,3:12625100-12705616,"0 (No Evidence)","0 (No Evidence)",,,14.17,0.85,0.35,09/13/2018
G,RAD51D,17:33419240-33446879,"2 (Emerging Evidence)","0 (No Evidence)",,,59.17,0,1.22,10/09/2019
G,RAD51C,17:56769934-56812972,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.19,0,1.49,07/08/2020
G,RAD21,8:117858173-117887015,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.51,1,0.26,03/08/2022
G,RABL2A,2:114384843-114400969,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,74.97,0,1.62,02/02/2021
G,RAB3GAP2,1:220321635-220445795,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.08,0.99,0.29,08/22/2016
G,RAB3GAP1,2:135809862-135928280,"30 (Autosomal Recessive)","Not Yet Evaluated",,,27.47,0,0.54,08/22/2016
G,RAB39B,X:154487520-154493776,"3 (Sufficient Evidence)","0 (No Evidence)",,,21.75,0.83,0.52,05/29/2020
G,RAB28,4:13369348-13485964,"30 (Autosomal Recessive)","Not Yet Evaluated",,,12.5,0.02,0.76,08/22/2016
G,RAB27A,15:55495164-55582011,"30 (Autosomal Recessive)","Not Yet Evaluated",,,5.04,0,1.65,08/22/2016
G,QDPR,4:17488018-17513713,"30 (Autosomal Recessive)","Not Yet Evaluated",,,24.03,0,1.06,08/22/2016
G,PYCR1,17:79890267-79895176,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.04,0,1.26,08/22/2016
G,PXDN,2:1635659-1748287,"30 (Autosomal Recessive)","0 (No Evidence)",,,61.43,0,0.52,08/22/2016
G,PURA,5:139493694-139505204,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.4,0.94,0.34,06/07/2017
G,PTS,11:112097151-112104696,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.05,0,1.69,08/22/2016
G,PTPRQ,12:80838015-81074052,"30 (Autosomal Recessive)","Not Yet Evaluated",,,43.92,0,0.7,08/22/2016
G,PTPN11,12:112856751-112947722,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.58,1,0.14,09/08/2020
G,PTHLH,12:28111017-28125666,"2 (Emerging Evidence)","1 (Little Evidence)",,,5.78,0.81,0.48,01/10/2019
G,PTEN,10:89623382-89731687,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.07,0.26,0.51,06/24/2020
G,PTCHD1,X:23352966-23422491,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.56,0.98,0.28,02/28/2018
G,PTCH1,9:98205262-98279253,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.48,1,0.08,07/01/2020
G,PSPH,7:56078757-56119137,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.89,0,1.19,08/22/2016
G,PSORS1C2,6:31105311-31106843,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,68.42,0,1.74,02/02/2021
G,PSD3,8:18384813-18871213,"0 (No Evidence)","0 (No Evidence)",,,45.05,0.01,0.45,12/07/2016
G,PSAT1,9:80912041-80945009,"30 (Autosomal Recessive)","Not Yet Evaluated",,,23.31,0,1.27,08/22/2016
G,PRSS1,7:142457323-142460923,"0 (No Evidence)","0 (No Evidence)",,,78.46,0,1.86,10/29/2012
G,PRRT2,16:29823514-29827202,"3 (Sufficient Evidence)","0 (No Evidence)",,,70.09,0.58,0.56,12/14/2021
G,PRPS1,X:106871740-106894256,"3 (Sufficient Evidence)","0 (No Evidence)",,,26.12,0.92,0.38,05/17/2012
G,PROP1,5:177419236-177423243,"30 (Autosomal Recessive)","0 (No Evidence)",,,82.55,0.09,0.9,08/22/2016
G,PRODH,22:18900294-18924066,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.38,0,1.1,11/08/2022
G,PRKN,6:161768449-163148798,"30 (Autosomal Recessive)","0 (No Evidence)",,,0.77,0,0.86,05/15/2018
G,PRKAG2,7:151253213-151574200,"0 (No Evidence)","0 (No Evidence)",,,27.16,1,0.26,11/05/2015
G,PRG4,1:186265405-186283699,"30 (Autosomal Recessive)","0 (No Evidence)",,,84.91,0,0.74,08/22/2016
G,PREPL,2:44544746-44589001,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.97,0,0.99,03/21/2012
G,PRDM6,5:122424936-122529960,"0 (No Evidence)","0 (No Evidence)",,,13.65,0.61,0.42,12/14/2017
G,PRCD,17:74523668-74541458,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.9,0.02,1.58,08/22/2016
G,PQBP1,X:48755213-48760420,"3 (Sufficient Evidence)","0 (No Evidence)",,,39.11,0.79,0.5,04/09/2020
G,PPT1,1:40537133-40562924,"30 (Autosomal Recessive)","0 (No Evidence)",,,21.97,0,0.89,08/22/2016
G,PPP2R5D,6:42952308-42980080,"1 (Little Evidence)","0 (No Evidence)",,,19.74,1,0.18,05/26/2021
G,PPP1R9A,7:94536906-94925727,"0 (No Evidence)","0 (No Evidence)",,,36.02,0,0.48,04/04/2012
G,PPIP5K1,15:43825660-43882451,"30 (Autosomal Recessive)","0 (No Evidence)",,,27.93,0,0.69,08/27/2012
G,PPIB,15:64448016-64455221,"30 (Autosomal Recessive)","0 (No Evidence)",,,18.75,0,1.6,08/22/2016
G,PORCN,X:48367380-48379202,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.63,1,0.14,08/23/2012
G,POR,7:75544473-75616173,"30 (Autosomal Recessive)","Not Yet Evaluated",,,68.94,0,0.84,08/22/2016
G,POMT2,14:77741299-77787226,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.09,0,0.8,08/22/2016
G,POMP,13:29233267-29253096,"30 (Autosomal Recessive)","0 (No Evidence)",,,11.76,0.91,0.39,08/27/2015
G,POLR1D,13:28194880-28241548,"3 (Sufficient Evidence)","0 (No Evidence)",,,31.76,0.36,1.01,06/23/2021
G,POLL,10:103338639-103348027,"0 (No Evidence)","0 (No Evidence)",,,20.37,0,1.06,12/21/2011
G,POLH,6:43543922-43588260,"30 (Autosomal Recessive)","0 (No Evidence)",,,29.98,0,0.84,08/22/2016
G,POLE,12:133200348-133263928,"1 (Little Evidence)","0 (No Evidence)",,,0.06,0,0.64,12/16/2019
G,POLD1,19:50887580-50921275,"1 (Little Evidence)","0 (No Evidence)",,,69.77,0,0.53,06/05/2020
G,POGZ,1:151375200-151431970,"3 (Sufficient Evidence)","0 (No Evidence)",,,29.96,1,0.12,12/27/2017
G,PNP,14:20937565-20945248,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.87,0,1.15,08/22/2016
G,PMS2,7:6010556-6048737,"3 (Sufficient Evidence)","0 (No Evidence)",,,59.43,0,1.27,11/16/2015
G,PMP22,17:15133096-15168643,"3 (Sufficient Evidence)","0 (No Evidence)",,,40.48,0.91,0.39,07/12/2012
G,PMM2,16:8891696-8943182,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.44,0,1.88,08/22/2016
G,PLP1,X:103031434-103047548,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,1.65,0.93,0.36,04/12/2021
G,PLOD3,7:100849265-100860862,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.13,0,0.82,08/22/2016
G,PLOD2,3:145787227-145878971,"30 (Autosomal Recessive)","Not Yet Evaluated",,,31.58,0,0.64,08/22/2016
G,PLOD1,1:11994774-12035594,"30 (Autosomal Recessive)","Not Yet Evaluated",,,29.26,0,0.94,08/22/2016
G,PLEKHG5,1:6526152-6580152,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.41,0,0.57,08/22/2016
G,PLCB1,20:8112913-8865547,"30 (Autosomal Recessive)","0 (No Evidence)",,,5.05,0.98,0.3,08/22/2016
G,PLAGL1,6:144261437-144385736,"0 (No Evidence)","0 (No Evidence)",,,60.44,0.98,0.26,08/27/2012
G,PLA2G6,22:38507502-38577837,"30 (Autosomal Recessive)","Not Yet Evaluated",,,35.59,0,0.86,08/22/2016
G,PKD2,4:88928787-88998929,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.05,0,0.5,07/06/2012
G,PKD1,16:2138709-2185899,"3 (Sufficient Evidence)","0 (No Evidence)",,,28.17,1,0.18,06/10/2020
G,PITX3,10:103989946-104001269,"0 (No Evidence)","0 (No Evidence)",,,6.41,0.81,0.48,11/06/2013
G,PITX2,4:111538579-111563279,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.8,0.98,0.26,10/24/2022
G,PITPNA,17:1421012-1466086,"0 (No Evidence)","0 (No Evidence)",,,9.09,0.97,0.33,06/07/2012
G,PIP5K1C,19:3630181-3700466,"30 (Autosomal Recessive)","Not Yet Evaluated",,,59.99,0.98,0.31,08/22/2016
G,PINK1,1:20959951-20978004,"30 (Autosomal Recessive)","Not Yet Evaluated",,,41.91,0,1.14,08/22/2016
G,PIK3R2,19:18263973-18281342,"0 (No Evidence)","0 (No Evidence)",,,48.46,0.02,0.49,06/25/2015
G,PIK3CA,3:178866145-178957881,"0 (No Evidence)","0 (No Evidence)",,,0.26,1,0.12,03/12/2015
G,PIGW,17:34890814-34895152,"30 (Autosomal Recessive)","0 (No Evidence)",,,42.97,0,1.08,08/22/2016
G,PIGO,9:35088685-35096588,"30 (Autosomal Recessive)","0 (No Evidence)",,,35.9,0,0.81,08/22/2016
G,PIGN,18:59708397-59854289,"30 (Autosomal Recessive)","Not Yet Evaluated",,,42.61,0,1.03,08/22/2016
G,PIGA,X:15337573-15353676,"2 (Emerging Evidence)","0 (No Evidence)",,,26.91,0.96,0.3,11/09/2021
G,PHYH,10:13319799-13342064,"30 (Autosomal Recessive)","Not Yet Evaluated",,,73.67,0,1.12,08/22/2016
G,PHLDA2,11:2949503-2950650,"0 (No Evidence)","0 (No Evidence)",,,63.76,0.15,1.73,03/22/2012
G,PHKG2,16:30759746-30772497,"30 (Autosomal Recessive)","Not Yet Evaluated",,,25.69,0,0.66,08/22/2016
G,PHKB,16:47495210-47735434,"30 (Autosomal Recessive)","0 (No Evidence)",,,27.2,0,0.84,08/22/2016
G,PHIP,6:79644136-79787971,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.52,1,0.11,04/13/2022
G,PHF8,X:53963113-54071569,"3 (Sufficient Evidence)","0 (No Evidence)",,,17.8,1,0.26,08/26/2020
G,PHF6,X:133507342-133562820,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.85,1,0.17,02/24/2021
G,PHF3,6:64345707-64435904,"1 (Little Evidence)","0 (No Evidence)",,,36.85,0.99,0.29,02/27/2019
G,PHF21A,11:45950870-46143005,"2 (Emerging Evidence)","0 (No Evidence)",,,2.85,1,0.08,05/27/2020
G,PHF2,9:96338866-96441869,"1 (Little Evidence)","0 (No Evidence)",,,54.82,1,0.18,02/27/2019
G,PHEX,X:22050443-22269427,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.97,1,0.14,06/28/2012
G,PHC1,12:9067105-9094063,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.66,1,0.24,08/22/2016
G,PGM3,6:83860447-83903619,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.16,0,0.65,08/22/2016
G,PGM1,1:64059082-64125916,"30 (Autosomal Recessive)","Not Yet Evaluated",,,20.5,0,1.32,08/22/2016
G,PGK1,X:77359745-77384792,"2 (Emerging Evidence)","0 (No Evidence)",,,2.46,0.77,0.47,05/26/2021
G,PGAP3,17:37827375-37844310,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.26,0,0.83,08/22/2016
G,PEX7,6:137143730-137235072,"30 (Autosomal Recessive)","Not Yet Evaluated",,,31.61,0,1.42,08/22/2016
G,PEX3,6:143771942-143811753,"30 (Autosomal Recessive)","0 (No Evidence)",,,27.6,0.02,0.56,08/22/2016
G,PEX26,22:18560756-18588162,"30 (Autosomal Recessive)","0 (No Evidence)",,,72.53,0.93,0.37,08/22/2016
G,PEX16,11:45931214-45939428,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.61,0,0.83,08/22/2016
G,PEX14,1:10535007-10690815,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.48,0.23,0.52,08/22/2016
G,PEX11B,1:145516372-145523732,"30 (Autosomal Recessive)","0 (No Evidence)",,,35.29,0,1.08,08/22/2016
G,PEX1,7:92116339-92157834,"30 (Autosomal Recessive)","Not Yet Evaluated",,,50.89,0,0.66,08/22/2016
G,PEPD,19:33877856-34012697,"30 (Autosomal Recessive)","Not Yet Evaluated",,,20.61,0,1.26,08/22/2016
G,PEG3,19:57321450-57352094,"0 (No Evidence)","0 (No Evidence)",,,77.96,0,0.51,05/17/2012
G,PEG10,7:94285637-94299007,"0 (No Evidence)","0 (No Evidence)",,,24.78,0.87,0.43,08/22/2012
G,PDX1,13:28494137-28500450,"30 (Autosomal Recessive)","0 (No Evidence)",,,15,0.02,1.05,08/22/2016
G,PDSS2,6:107473766-107780768,"30 (Autosomal Recessive)","Not Yet Evaluated",,,16.76,0,1.13,08/22/2016
G,PDP1,8:94929151-94938296,"30 (Autosomal Recessive)","Not Yet Evaluated",,,16.05,0.45,0.49,08/22/2016
G,PDHX,11:34937677-35017675,"30 (Autosomal Recessive)","Not Yet Evaluated",,,6.33,0,0.72,08/22/2016
G,PDHA1,X:19362045-19379836,"3 (Sufficient Evidence)","0 (No Evidence)",,,35.05,0.99,0.27,09/27/2022
G,PDE6C,10:95372294-95425767,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.7,0,0.87,08/22/2016
G,PDE4D,5:58264865-59792113,"0 (No Evidence)","0 (No Evidence)",,,4.24,1,0.21,02/02/2018
G,PCYT1A,3:195961239-196014597,"30 (Autosomal Recessive)","0 (No Evidence)",,,18.96,0,0.86,08/22/2016
G,PCSK9,1:55505221-55530525,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,73.06,0,1.34,12/17/2015
G,PCDHGA8,5:140772200-140892542,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,54.62,0,1.35,02/02/2021
G,PCDH9,13:66876966-67804468,"0 (No Evidence)","0 (No Evidence)",,,0.79,0.81,0.37,06/08/2012
G,PCDH19,X:99546642-99665271,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.65,1,0.13,06/06/2013
G,PCDH15,10:55562531-57387702,"30 (Autosomal Recessive)","0 (No Evidence)",,,23.23,0,0.79,08/22/2016
G,PCCA,13:100741347-101182689,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.12,0,0.91,08/22/2016
G,PCARE,2:29284561-29297389,"30 (Autosomal Recessive)","0 (No Evidence)",,,84.18,0,1.11,09/25/2014
G,PC,11:66615891-66725854,"30 (Autosomal Recessive)","Not Yet Evaluated",,,23.85,0.01,0.44,08/22/2016
G,PBX1,1:164528421-164855284,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.86,1,0.26,09/05/2019
G,PAX9,14:37126773-37148567,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.94,0.31,0.61,07/08/2020
G,PAX8,2:113973574-114036498,"1 (Little Evidence)","0 (No Evidence)",,,7.48,1,0.2,11/09/2021
G,PAX6,11:31810574-31839509,"3 (Sufficient Evidence)","1 (Little Evidence)",,,0.78,1,0.17,11/05/2015
G,PAX5,9:36833266-37034265,"1 (Little Evidence)","0 (No Evidence)",,,1.77,1,0.17,05/24/2022
G,PAX3,2:223064606-223163717,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.54,0.24,0.48,05/27/2020
G,PAX2,10:102495153-102589701,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.24,0.67,0.43,02/26/2020
G,PAX1,20:21686302-21699119,"30 (Autosomal Recessive)","0 (No Evidence)",,,38.4,0.7,0.5,08/22/2016
G,PARK7,1:8021771-8045565,"30 (Autosomal Recessive)","0 (No Evidence)",,,10.87,0.75,0.53,08/22/2016
G,PAK3,X:110187625-110470589,"2 (Emerging Evidence)","0 (No Evidence)",,,5.06,0.99,0.29,12/09/2019
G,PAK2,3:196466728-196559518,"1 (Little Evidence)","1 (Little Evidence)",,,16.98,0.97,0.32,12/27/2011
G,PAH,12:103230667-103352219,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.97,0,1.5,08/28/2014
G,PAFAH1B1,17:2496948-2588909,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.21,1,0.11,10/13/2020
G,PACS1,11:65837743-66012215,"0 (No Evidence)","0 (No Evidence)",,,38.02,1,0.19,12/14/2021
G,P3H1,1:43212045-43232699,"30 (Autosomal Recessive)","0 (No Evidence)",,,48.37,0,1.23,03/12/2015
G,OXCT1,5:41730167-41870527,"30 (Autosomal Recessive)","Not Yet Evaluated",,,26.58,0,0.54,08/22/2016
G,OTX2,14:57266623-57277197,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.72,0.92,0.38,09/08/2020
G,OTUD7A,15:31767601-32162876,"0 (No Evidence)","0 (No Evidence)",,,56.07,0.95,0.33,04/27/2018
G,OTOGL,12:80493317-80774660,"30 (Autosomal Recessive)","0 (No Evidence)",,,42.95,0,0.9,08/22/2016
G,OTOF,2:26680071-26781624,"30 (Autosomal Recessive)","Not Yet Evaluated",,,29.35,0,0.88,08/22/2016
G,OTOA,16:21675289-21772050,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.09,0,0.69,08/22/2016
G,OTC,X:38211857-38280699,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.31,0.87,0.41,06/28/2012
G,OSTM1,6:108362613-108395945,"30 (Autosomal Recessive)","0 (No Evidence)",,,33.37,0.01,0.74,08/22/2016
G,OSBPL5,11:3108337-3186540,"0 (No Evidence)","0 (No Evidence)",,,75.98,0,0.56,09/06/2012
G,ORC6,16:46723571-46732306,"30 (Autosomal Recessive)","Not Yet Evaluated",,,41.77,0,1.39,08/22/2016
G,ORC4,2:148687965-148779120,"30 (Autosomal Recessive)","0 (No Evidence)",,,6.12,0,1.13,11/06/2015
G,OR5AU1,14:21623024-21624222,"0 (No Evidence)","0 (No Evidence)",,,78.44,0,1.89,03/11/2015
G,OPHN1,X:67262186-67653337,"3 (Sufficient Evidence)","0 (No Evidence)",,,35.46,1,0.16,07/27/2012
G,OFD1,X:13752867-13787476,"3 (Sufficient Evidence)","0 (No Evidence)",,,70.25,0.96,0.32,04/13/2021
G,OCRL,X:128674236-128726533,"3 (Sufficient Evidence)","0 (No Evidence)",,,14.52,1,0.16,01/12/2021
G,OCLN,5:68788374-68853931,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.94,0,0.95,08/22/2016
G,OCA2,15:28000021-28344461,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.33,0,0.86,04/28/2012
G,OBSL1,2:220415450-220436261,"30 (Autosomal Recessive)","0 (No Evidence)",,,60.26,0,0.88,08/22/2016
G,OAT,10:126085872-126107492,"30 (Autosomal Recessive)","Not Yet Evaluated",,,31.64,0,0.96,08/22/2016
G,NYX,X:41306596-41334905,"3 (Sufficient Evidence)","0 (No Evidence)",,,58.33,0.13,1.13,01/22/2020
G,NXF5,X:101087085-101112549,"1 (Little Evidence)","0 (No Evidence)",,,89.99,0,1.69,05/17/2012
G,NUS1,6:117996632-118031890,"3 (Sufficient Evidence)","0 (No Evidence)",,,18.4,0.98,0.25,09/27/2022
G,NUDT13,10:74870213-74891581,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,47.18,0,1.38,02/02/2021
G,NTHL1,16:2089821-2097835,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.04,0,1.6,07/06/2020
G,NTAN1,16:15131714-15149931,"0 (No Evidence)","0 (No Evidence)",,,40.72,0,1.1,09/17/2018
G,NSDHL,X:151999607-152038273,"3 (Sufficient Evidence)","0 (No Evidence)",,,64.89,0.96,0.29,09/25/2019
G,NSD1,5:176560016-176727214,"3 (Sufficient Evidence)","0 (No Evidence)",,,29.19,1,0.1,07/27/2020
G,NRXN1,2:50145641-51259270,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.81,1,0.25,06/08/2021
G,NRG3,10:83634950-84746935,"0 (No Evidence)","0 (No Evidence)",,,10.48,0.11,0.46,12/21/2011
G,NR5A1,9:127243515-127269678,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.31,0.99,0.26,02/24/2021
G,NR4A2,2:157180949-157189233,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.28,1,0.13,09/27/2022
G,NR3C2,4:148999915-149365850,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.63,0.84,0.35,04/06/2020
G,NR2F2,15:96869275-96883492,"0 (No Evidence)","0 (No Evidence)",,,5.61,0.99,0.22,07/10/2012
G,NR2F1,5:92918928-92930317,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.69,0.99,0.19,08/09/2022
G,NR0B1,X:30322323-30327507,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.44,0.97,0.28,05/06/2020
G,NPTX2,7:98246597-98259181,"0 (No Evidence)","0 (No Evidence)",,,40.45,0.03,0.73,10/10/2012
G,NPHS1,19:36316274-36343406,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.89,0,0.7,08/22/2016
G,NPHP4,1:5922871-6052485,"30 (Autosomal Recessive)","Not Yet Evaluated",,,68.34,0,0.98,08/22/2016
G,NPHP1,2:110880925-110962590,"30 (Autosomal Recessive)","0 (No Evidence)",,,60.82,0,0.98,10/10/2012
G,NPC1,18:21111406-21166470,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.18,0,0.49,08/22/2016
G,NOTCH2,1:120454176-120612276,"0 (No Evidence)","0 (No Evidence)",,,3.21,1,0.12,07/17/2014
G,NOG,17:54671060-54672972,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.85,0.89,0.42,01/12/2021
G,NODAL,10:72191692-72207707,"1 (Little Evidence)","0 (No Evidence)",,,31.54,0.97,0.31,08/08/2013
G,NNAT,20:36149652-36152092,"0 (No Evidence)","0 (No Evidence)",,,21.87,0.4,0.94,04/28/2012
G,NLGN3,X:70364691-70391051,"0 (No Evidence)","0 (No Evidence)",,,10.65,0.98,0.31,07/25/2012
G,NLGN1,3:173113742-174012162,"0 (No Evidence)","0 (No Evidence)",,,1.37,0.85,0.37,03/25/2016
G,NKX3-2,4:13542454-13546132,"30 (Autosomal Recessive)","Not Yet Evaluated",,,53.62,0.64,0.63,08/22/2016
G,NKX2-5,5:172659112-172662209,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.67,0.95,0.33,07/22/2020
G,NIPBL,5:36876871-37066515,"3 (Sufficient Evidence)","1 (Little Evidence)",,,3.01,1,0.03,08/26/2020
G,NIPA2,15:23004684-23034402,"0 (No Evidence)","0 (No Evidence)",,,33.48,0.92,0.38,04/04/2012
G,NIPA1,15:23043279-23086843,"0 (No Evidence)","0 (No Evidence)",,,22,0.01,1.04,04/04/2012
G,NHS,X:17393323-17754114,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.57,1,0.09,04/28/2021
G,NHP2,5:177576464-177580886,"30 (Autosomal Recessive)","0 (No Evidence)",,,32.86,0.05,1.08,03/04/2015
G,NGLY1,3:25760435-25831530,"30 (Autosomal Recessive)","0 (No Evidence)",,,49.52,0,0.95,02/18/2015
G,NFIX,19:13106289-13209610,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.34,1,0.15,04/12/2022
G,NFIA,1:61542899-61928460,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.28,1,0.2,01/12/2017
G,NF2,22:29999545-30094589,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.2,1,0.09,09/08/2020
G,NF1,17:29421945-29704695,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.88,0.9,0.29,07/12/2012
G,NEXMIF,X:73952691-74145287,"3 (Sufficient Evidence)","0 (No Evidence)",,,29.47,1,0.2,06/26/2019
G,NELFA,4:1984450-2010701,"0 (No Evidence)","0 (No Evidence)",,,62.86,0.13,0.51,09/06/2012
G,NEK1,4:170313960-170533734,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.72,0,0.86,08/01/2013
G,NEFL,8:24808468-24814126,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,09/17/2018
G,NEDD9,6:11183531-11382581,"1 (Little Evidence)","0 (No Evidence)",,,29.54,0.13,0.44,02/27/2019
G,NEBL,10:21068902-21581979,"0 (No Evidence)","0 (No Evidence)",,,21.79,0,1.86,12/21/2011
G,NDUFV2,18:9102697-9134339,"30 (Autosomal Recessive)","0 (No Evidence)",,,15.31,0.01,0.83,08/22/2016
G,NDUFV1,11:67374407-67380025,"30 (Autosomal Recessive)","0 (No Evidence)",,,37.98,0,1.21,03/22/2012
G,NDUFS8,11:67798148-67804111,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.99,0.17,0.74,08/22/2016
G,NDUFS7,19:1383906-1395583,"30 (Autosomal Recessive)","0 (No Evidence)",,,69.79,0.91,0.39,08/22/2016
G,NDUFS6,5:1801521-1816162,"30 (Autosomal Recessive)","0 (No Evidence)",,,81.82,0.1,1.3,08/22/2016
G,NDUFS4,5:52856469-52979168,"30 (Autosomal Recessive)","Not Yet Evaluated",,,12.79,0,1.16,08/22/2016
G,NDUFB3,2:201936724-201950473,"30 (Autosomal Recessive)","Not Yet Evaluated",,,50.55,0,1.94,08/22/2016
G,NDUFAF5,20:13765674-13802226,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.44,0,1.2,08/22/2016
G,NDUFAF2,5:60241032-60448853,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.74,0,1.6,08/22/2016
G,NDUFAF1,15:41679551-41694694,"30 (Autosomal Recessive)","0 (No Evidence)",,,69.41,0,0.91,08/22/2016
G,NDUFA10,2:240831859-240964759,"30 (Autosomal Recessive)","0 (No Evidence)",,,85.89,0,1.1,08/22/2016
G,NDUFA1,X:119005795-119010625,"0 (No Evidence)","0 (No Evidence)",,,60.85,0.55,1.18,07/25/2012
G,NDRG1,8:134249418-134309495,"30 (Autosomal Recessive)","Not Yet Evaluated",,,26.62,0.01,0.58,08/22/2016
G,NDP,X:43808022-43832636,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.81,0.65,0.88,06/14/2012
G,NDN,15:23930547-23932452,"0 (No Evidence)","0 (No Evidence)",,,32.94,0.67,0.6,04/27/2012
G,NDE1,16:15737239-15820210,"30 (Autosomal Recessive)","0 (No Evidence)",,,35.66,0.01,0.69,04/29/2016
G,NCKAP1,2:183773843-183903185,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.37,1,0.04,12/27/2017
G,NCF4,22:37257048-37274057,"30 (Autosomal Recessive)","Not Yet Evaluated",,,74.45,0,1.2,08/22/2016
G,NCF2,1:183524697-183560049,"30 (Autosomal Recessive)","0 (No Evidence)",,,43.31,0,0.74,08/22/2016
G,NCF1,7:74188309-74203720,"30 (Autosomal Recessive)","0 (No Evidence)",,,67.53,0,1.13,10/10/2012
G,NBN,8:90945559-90996895,"3 (Sufficient Evidence)","0 (No Evidence)",,,19.03,0,1.01,08/21/2020
G,NBEA,13:35516407-36246873,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.83,1,0.07,06/26/2019
G,NBAS,2:15307040-15701458,"30 (Autosomal Recessive)","Not Yet Evaluated",,,58.54,0,0.78,08/22/2016
G,NAT8L,4:2061054-2070816,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.87,0.86,0.46,08/22/2016
G,NAALADL2,3:174577124-175528336,"0 (No Evidence)","0 (No Evidence)",,,9.95,0,0.71,01/07/2016
G,NAA15,4:140222659-140312538,"3 (Sufficient Evidence)","0 (No Evidence)",,,7.58,1,0.28,04/13/2021
G,NAA10,X:153194678-153200490,"1 (Little Evidence)","0 (No Evidence)",,,34.08,0.76,0.52,08/09/2022
G,MYT1L,2:1792885-2335047,"3 (Sufficient Evidence)","0 (No Evidence)",,,21.8,1,0.09,03/09/2017
G,MYO5B,18:47349159-47721517,"30 (Autosomal Recessive)","0 (No Evidence)",,,46.86,0,0.69,04/09/2015
G,MYO5A,15:52599480-52821247,"30 (Autosomal Recessive)","0 (No Evidence)",,,15.8,0.94,0.3,08/22/2016
G,MYO3A,10:26223158-26501461,"30 (Autosomal Recessive)","0 (No Evidence)",,,26.3,0,1.04,03/06/2018
G,MYO1E,15:59424633-59665070,"30 (Autosomal Recessive)","0 (No Evidence)",,,26.13,0,0.44,08/22/2016
G,MYO15A,17:18012070-18083114,"30 (Autosomal Recessive)","Not Yet Evaluated",,,39.27,0,0.8,08/22/2016
G,MYLK,3:123328896-123603179,"1 (Little Evidence)","0 (No Evidence)",,,15.7,0,0.53,01/14/2016
G,MYL3,3:46899362-46904934,"0 (No Evidence)","0 (No Evidence)",,,48.58,0.09,0.9,11/18/2015
G,MYL2,12:111348649-111358383,"30 (Autosomal Recessive)","0 (No Evidence)",,,18.05,0,1.75,11/20/2015
G,MYH7,14:23881949-23904869,"0 (No Evidence)","0 (No Evidence)",,,14.41,0,0.58,11/16/2015
G,MYH11,16:15796992-15950885,"0 (No Evidence)","0 (No Evidence)",,,7.87,0.77,0.31,11/12/2015
G,MYH10,17:8377530-8534043,"1 (Little Evidence)","0 (No Evidence)",,,34.06,1,0.17,01/23/2019
G,MYCN,2:16080672-16087126,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.93,0.89,0.41,07/12/2017
G,MYBPC3,11:47352957-47374253,"3 (Sufficient Evidence)","0 (No Evidence)",,,41.39,0,0.59,11/12/2015
G,MUTYH,1:45794914-45806112,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.32,0,1.19,11/11/2015
G,MTTP,4:100485287-100545154,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.96,0,0.59,08/22/2016
G,MTRR,5:7869261-7901226,"30 (Autosomal Recessive)","0 (No Evidence)",,,73.75,0,0.98,08/22/2016
G,MTR,1:236958581-237067281,"30 (Autosomal Recessive)","0 (No Evidence)",,,8.44,0,0.63,08/22/2016
G,MTO1,6:74171460-74218959,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.12,0,0.64,08/22/2016
G,MTMR2,11:95566044-95657271,"30 (Autosomal Recessive)","Not Yet Evaluated",,,23.95,0,0.65,08/22/2016
G,MTM1,X:149737071-149841616,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.54,1,0.18,01/11/2021
G,MTHFR,1:11845780-11866021,"30 (Autosomal Recessive)","Not Yet Evaluated",,,7.44,0,0.92,08/22/2016
G,MTFMT,15:65293850-65321977,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.66,0,1.01,08/22/2016
G,MTAP,9:21802635-21867080,"1 (Little Evidence)","0 (No Evidence)",,,38.31,0,1.39,10/12/2022
G,MSX1,4:4861392-4865663,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.21,0.17,1.01,01/12/2021
G,MSRB3,12:65672463-65860687,"30 (Autosomal Recessive)","0 (No Evidence)",,,15.61,0,1.16,08/23/2021
G,MSH6,2:48010284-48034092,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.24,0,0.5,10/13/2021
G,MSH3,5:79950471-80172634,"30 (Autosomal Recessive)","0 (No Evidence)",,,18.27,0,1.16,05/08/2020
G,MSH2,2:47630206-47710367,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.57,0.9,0.33,10/13/2021
G,MPLKIP,7:40165626-40174221,"30 (Autosomal Recessive)","Not Yet Evaluated",,,22.22,0,1.67,08/22/2016
G,MPDZ,9:13105706-13279691,"30 (Autosomal Recessive)","0 (No Evidence)",,,33.44,0,0.89,08/22/2016
G,MOV10,1:113216934-113243368,"0 (No Evidence)","0 (No Evidence)",,,45.41,0.81,0.34,03/12/2019
G,MOCS2,5:52391509-52405587,"30 (Autosomal Recessive)","0 (No Evidence)",,,38.56,0,1.39,08/22/2016
G,MNX1,7:156797548-156803357,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.84,0.79,0.5,10/04/2012
G,MMUT,6:49398073-49430966,"30 (Autosomal Recessive)","0 (No Evidence)",,,1.8,0,1.23,08/25/2016
G,MMADHC,2:150426151-150444289,"30 (Autosomal Recessive)","0 (No Evidence)",,,11.87,0,0.99,07/21/2016
G,MMACHC,1:45965972-45979054,"30 (Autosomal Recessive)","Not Yet Evaluated",,,53.83,0,1.76,08/22/2016
G,MMAB,12:109991520-110011309,"30 (Autosomal Recessive)","0 (No Evidence)",,,67.13,0,0.88,06/30/2017
G,MMAA,4:146540537-146581185,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.43,0,1.29,08/22/2016
G,MLYCD,16:83932720-83960636,"30 (Autosomal Recessive)","0 (No Evidence)",,,65.55,0,0.84,08/22/2016
G,MLPH,2:238395053-238463965,"30 (Autosomal Recessive)","Not Yet Evaluated",,,85.56,0,0.9,08/22/2016
G,MLH1,3:37035009-37092337,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.18,0,0.58,10/13/2021
G,MLC1,22:50497820-50524304,"30 (Autosomal Recessive)","Not Yet Evaluated",,,68.71,0,1.16,08/22/2016
G,MKS1,17:56282797-56296966,"30 (Autosomal Recessive)","0 (No Evidence)",,,34.89,0,1.04,08/22/2016
G,MKRN3,15:23810821-23813191,"0 (No Evidence)","0 (No Evidence)",,,87.91,0.28,0.63,04/25/2012
G,MKKS,20:10381657-10414870,"30 (Autosomal Recessive)","Not Yet Evaluated",,,38.61,0,1.29,08/22/2016
G,MITF,3:69788615-70017483,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.98,0.98,0.31,04/13/2021
G,MID2,X:107068965-107174867,"0 (No Evidence)","0 (No Evidence)",,,9.45,0.18,0.5,07/25/2012
G,MID1,X:10413350-10851802,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.13,0.98,0.3,08/23/2021
G,MGP,12:15033798-15038788,"30 (Autosomal Recessive)","0 (No Evidence)",,,8.46,0,1.66,02/08/2021
G,MFSD8,4:128838887-128887118,"30 (Autosomal Recessive)","0 (No Evidence)",,,58.39,0,1.07,08/22/2016
G,MFRP,11:119209652-119217415,"30 (Autosomal Recessive)","0 (No Evidence)",,,61.74,0,1.22,08/22/2016
G,MFN2,1:12040501-12073565,"0 (No Evidence)","0 (No Evidence)",,,12.08,0.99,0.28,02/02/2017
G,MFHAS1,8:8640864-8751140,"0 (No Evidence)","0 (No Evidence)",,,42.49,0,0.82,02/08/2012
G,METTL23,17:74722123-74729963,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.56,0,1.77,08/22/2016
G,MET,7:116312250-116438431,"0 (No Evidence)","0 (No Evidence)",,,1.18,0.97,0.31,09/06/2012
G,MEST,7:130126016-130146306,"0 (No Evidence)","0 (No Evidence)",,,7.94,0.4,0.47,04/04/2012
G,MEN1,11:64570986-64578766,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.63,1,0.17,01/12/2022
G,MEIS2,15:37181405-37393512,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.69,1,0.18,09/14/2021
G,MEG3,14:101292445-101327363,"1 (Little Evidence)","0 (No Evidence)",,,‐,‐,‐,04/25/2012
G,MEFV,16:3292027-3306633,"0 (No Evidence)","0 (No Evidence)",,,81.61,0,1.13,08/16/2018
G,MEF2C,5:88012934-88199922,"3 (Sufficient Evidence)","1 (Little Evidence)",,,0.26,0.02,0.61,02/26/2020
G,MED13L,12:116396381-116715498,"3 (Sufficient Evidence)","1 (Little Evidence)",,,7.11,1,0.06,11/11/2015
G,MED12,X:70338446-70362300,"0 (No Evidence)","0 (No Evidence)",,,6.34,1,0.07,08/22/2018
G,MECP2,X:153287024-153363174,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.39,0.89,0.41,02/22/2021
G,MCPH1,8:6264148-6506029,"30 (Autosomal Recessive)","Not Yet Evaluated",,,94.1,0,1.44,08/22/2016
G,MCFD2,2:47129009-47168994,"30 (Autosomal Recessive)","0 (No Evidence)",,,48.72,0.1,1.28,08/22/2016
G,MCEE,2:71336817-71357359,"30 (Autosomal Recessive)","0 (No Evidence)",,,63.92,0.03,1.34,03/25/2015
G,MCCC1,3:182733006-182817375,"30 (Autosomal Recessive)","0 (No Evidence)",,,46.37,0,0.9,08/22/2016
G,MC2R,18:13882043-13915706,"30 (Autosomal Recessive)","Not Yet Evaluated",,,63.21,0,1.85,08/22/2016
G,MBD5,2:148778580-149274540,"3 (Sufficient Evidence)","1 (Little Evidence)",,,8.24,1,0.14,08/11/2016
G,MAX,14:65472819-65569413,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.06,0.83,0.46,07/20/2021
G,MATN3,2:20191813-20212429,"0 (No Evidence)","0 (No Evidence)",,,62.15,0,1.25,03/12/2014
G,MASP2,1:11086580-11107296,"30 (Autosomal Recessive)","Not Yet Evaluated",,,72.87,0,1.15,08/22/2016
G,MARVELD2,5:68710943-68740157,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.8,0,1.18,08/22/2016
G,MAPT,17:43971920-44105700,"0 (No Evidence)","0 (No Evidence)",,,2.65,0.01,0.57,05/08/2012
G,MAP3K1,5:56111376-56191979,"0 (No Evidence)","0 (No Evidence)",,,13.53,1,0.21,08/22/2013
G,MAP2K2,19:4090319-4124119,"1 (Little Evidence)","0 (No Evidence)",,,38.94,0.97,0.33,05/27/2015
G,MAP2K1,15:66679250-66783882,"0 (No Evidence)","0 (No Evidence)",,,5.71,0.9,0.38,10/13/2015
G,MAOA,X:43514254-43606064,"1 (Little Evidence)","0 (No Evidence)",,,43.16,1,0.14,09/26/2012
G,MAN2B1,19:12757326-12777556,"30 (Autosomal Recessive)","0 (No Evidence)",,,76.46,0,0.97,08/22/2016
G,MALT1,18:56338697-56421709,"30 (Autosomal Recessive)","0 (No Evidence)",,,37.84,0.99,0.3,08/22/2016
G,MAGT1,X:77081244-77151065,"3 (Sufficient Evidence)","0 (No Evidence)",,,34.31,0.96,0.33,09/22/2021
G,MAGEL2,15:23888696-23893014,"1 (Little Evidence)","0 (No Evidence)",,,84.66,0.98,0.31,05/22/2018
G,MAFB,20:39314488-39317876,"0 (No Evidence)","0 (No Evidence)",,,5.59,0.9,0.4,05/21/2015
G,LYST,1:235824331-236047013,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.08,0.02,0.31,08/22/2016
G,LYRM7,5:130506637-130541121,"30 (Autosomal Recessive)","0 (No Evidence)",,,31.96,0.02,1.44,08/22/2016
G,LSS,21:47608360-47648688,"0 (No Evidence)","0 (No Evidence)",,,24.39,0,0.6,09/06/2012
G,LRPPRC,2:44113363-44223128,"30 (Autosomal Recessive)","0 (No Evidence)",,,34.01,0,0.53,03/20/2017
G,LRPAP1,4:3505339-3534149,"30 (Autosomal Recessive)","Not Yet Evaluated",,,81.97,0,1.17,08/22/2016
G,LRP5,11:68080059-68216743,"2 (Emerging Evidence)","0 (No Evidence)",,,8.86,0.51,0.34,12/20/2021
G,LRP2,2:169983619-170219044,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.5,1,0.25,04/24/2019
G,LRBA,4:151185587-151936879,"30 (Autosomal Recessive)","Not Yet Evaluated",,,1.79,0,0.42,08/22/2016
G,LRAT,4:155661990-155674272,"30 (Autosomal Recessive)","Not Yet Evaluated",,,31.39,0.03,1.32,08/22/2016
G,LPIN2,18:2916992-3013142,"30 (Autosomal Recessive)","0 (No Evidence)",,,38.45,0,0.51,08/22/2016
G,LPAR6,13:48985274-49018805,"30 (Autosomal Recessive)","Not Yet Evaluated",,,22.74,0,1.27,08/22/2016
G,LOXHD1,18:44056924-44237183,"30 (Autosomal Recessive)","0 (No Evidence)",,,33.62,0,1.01,08/22/2016
G,LMX1B,9:129376207-129463311,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.11,0.75,0.42,11/10/2020
G,LMTK3,19:48988528-49016446,"1 (Little Evidence)","0 (No Evidence)",,,70.62,1,0.18,07/25/2018
G,LMNB1,5:126112315-126172712,"0 (No Evidence)","3 (Sufficient Evidence)",,,11.52,0.55,0.41,07/06/2012
G,LMNA,1:156052364-156109872,"2 (Emerging Evidence)","0 (No Evidence)",,,1.72,1,0.21,01/18/2016
G,LMBR1,7:156461706-156685877,"30 (Autosomal Recessive)","0 (No Evidence)",,,24.09,0,0.83,10/18/2012
G,LMAN1,18:56995055-57026497,"30 (Autosomal Recessive)","Not Yet Evaluated",,,36.45,0,0.55,08/22/2016
G,LITAF,16:11641578-11681322,"0 (No Evidence)","0 (No Evidence)",,,51.7,0.03,1.28,10/21/2016
G,LIPA,10:90973329-91011532,"30 (Autosomal Recessive)","Not Yet Evaluated",,,78.66,0,1,08/22/2016
G,LINS1,15:101107129-101142389,"30 (Autosomal Recessive)","0 (No Evidence)",,,71.81,0,0.96,08/22/2016
G,LIMK1,7:73498134-73536855,"0 (No Evidence)","0 (No Evidence)",,,19.66,1,0.23,08/22/2012
G,LIG4,13:108859790-108870697,"30 (Autosomal Recessive)","0 (No Evidence)",,,23.18,0,0.8,08/22/2016
G,LHX4,1:180199399-180248119,"1 (Little Evidence)","0 (No Evidence)",,,6.37,0.02,0.69,04/25/2022
G,LHX3,9:139088096-139096974,"30 (Autosomal Recessive)","Not Yet Evaluated",,,23.38,0.01,0.74,08/22/2016
G,LFNG,7:2552163-2568811,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.77,0.1,0.69,08/22/2016
G,LETM1,4:1813206-1857883,"0 (No Evidence)","0 (No Evidence)",,,63.78,0,0.74,02/03/2012
G,LEPR,1:65886335-66107242,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.82,0.99,0.28,08/22/2016
G,LEMD3,12:65563363-65642135,"3 (Sufficient Evidence)","0 (No Evidence)",,,36.92,1,0.25,10/19/2020
G,LDLR,19:11200139-11244496,"3 (Sufficient Evidence)","0 (No Evidence)",,,17.35,0,1.13,10/27/2021
G,LCT,2:136545420-136594754,"30 (Autosomal Recessive)","0 (No Evidence)",,,10.47,0.06,0.36,08/22/2016
G,LCA5,6:80194708-80247147,"30 (Autosomal Recessive)","Not Yet Evaluated",,,45.14,0,0.65,08/22/2016
G,LBX1,10:102986751-102989220,"0 (No Evidence)","0 (No Evidence)",,,1.88,0.68,0.59,08/21/2014
G,LBR,1:225589204-225616523,"30 (Autosomal Recessive)","0 (No Evidence)",,,28.92,0.18,0.42,02/23/2015
G,LARGE1,22:33668495-34318812,"30 (Autosomal Recessive)","0 (No Evidence)",,,4.11,0.99,0.3,08/22/2016
G,LAMP2,X:119560003-119603204,"3 (Sufficient Evidence)","0 (No Evidence)",,,54.6,0.27,0.64,02/09/2021
G,LAMC2,1:183155399-183214262,"30 (Autosomal Recessive)","Not Yet Evaluated",,,41.89,0,0.65,08/22/2016
G,LAMA3,18:21269417-21535030,"30 (Autosomal Recessive)","Not Yet Evaluated",,,64.13,0,0.69,08/22/2016
G,LAMA2,6:129204283-129837711,"30 (Autosomal Recessive)","0 (No Evidence)",,,4.68,0,0.73,11/28/2018
G,LAMA1,18:6941741-7117796,"30 (Autosomal Recessive)","0 (No Evidence)",,,60.73,0,0.62,08/22/2016
G,L3MBTL1,20:42136337-42179594,"0 (No Evidence)","0 (No Evidence)",,,47.47,0,0.78,08/29/2012
G,L1CAM,X:153126969-153151627,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.59,1,0.13,12/02/2020
G,KRT37,17:39576799-39580837,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,74.92,0,1.31,02/02/2021
G,KRT24,17:38854243-38860004,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,66.8,0,1.45,02/02/2021
G,KRAS,12:25358180-25403863,"0 (No Evidence)","0 (No Evidence)",,,0.47,0,1.24,10/08/2015
G,KMT2E,7:104654652-104755466,"3 (Sufficient Evidence)","0 (No Evidence)",,,19.81,1,0.06,12/29/2021
G,KMT2D,12:49412761-49454577,"3 (Sufficient Evidence)","0 (No Evidence)",,,17.49,1,0.1,01/23/2020
G,KMT2C,7:151832010-152133088,"3 (Sufficient Evidence)","0 (No Evidence)",,,53.58,1,0.12,01/24/2018
G,KMT2B,19:36208905-36229779,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,1,0.07,05/11/2017
G,KMT2A,11:118307207-118397547,"3 (Sufficient Evidence)","0 (No Evidence)",,,17.01,1,0.07,05/23/2018
G,KLK12,19:51532350-51538258,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,83.13,0,1.36,02/02/2021
G,KLF8,X:55934556-56317964,"0 (No Evidence)","0 (No Evidence)",,,60.52,0,1.31,10/12/2012
G,KLF14,7:130415525-130418967,"0 (No Evidence)","0 (No Evidence)",,,82.59,0.02,1.59,04/28/2012
G,KISS1,1:204159469-204165619,"30 (Autosomal Recessive)","Not Yet Evaluated",,,85.61,0.49,1.41,08/22/2016
G,KIFBP,10:70748559-70776738,"30 (Autosomal Recessive)","Not Yet Evaluated",,,14.57,0.08,0.51,08/22/2016
G,KIF7,15:90171208-90198698,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.81,0,0.93,08/22/2016
G,KIF1C,17:4901245-4931696,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.84,0.72,0.34,08/22/2016
G,KIF1A,2:241653184-241760820,"0 (No Evidence)","0 (No Evidence)",,,50.62,1,0.14,08/08/2013
G,KIF11,10:94352887-94415152,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.02,1,0.12,08/01/2013
G,KHDC3L,6:74072381-74073894,"30 (Autosomal Recessive)","Not Yet Evaluated",,,94.36,0.12,1.16,08/22/2016
G,KERA,12:91444268-91451801,"30 (Autosomal Recessive)","Not Yet Evaluated",,,28.54,0,1.49,08/22/2016
G,KDM6B,17:7737535-7758114,"1 (Little Evidence)","0 (No Evidence)",,,40.32,1,0.14,11/28/2018
G,KDM6A,X:44732434-44972024,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.72,1,0.16,07/18/2013
G,KDM5C,X:53205459-53254389,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.71,1,0.17,08/23/2012
G,KDM5B,1:202693623-202778598,"1 (Little Evidence)","0 (No Evidence)",,,28,0,0.57,01/04/2018
G,KCTD7,7:66093868-66108216,"30 (Autosomal Recessive)","Not Yet Evaluated",,,35.12,0,0.65,08/22/2016
G,KCNV2,9:2717510-2730037,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.67,0,1.97,08/22/2016
G,KCNQ2,20:62031561-62104008,"3 (Sufficient Evidence)","0 (No Evidence)",,,39.78,1,0.16,07/18/2013
G,KCNQ1OT1,11:2629558-2721228,"1 (Little Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,03/22/2012
G,KCNQ1,11:2466238-2870340,"3 (Sufficient Evidence)","0 (No Evidence)",,,23.28,0,0.81,10/13/2020
G,KCNK9,8:140613081-140715366,"0 (No Evidence)","0 (No Evidence)",,,43.67,0.96,0.31,02/29/2012
G,KCNJ1,11:128707915-128737191,"30 (Autosomal Recessive)","0 (No Evidence)",,,21.79,0,1.29,03/22/2012
G,KCNH2,7:150642049-150675409,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.87,1,0.27,02/26/2020
G,KATNAL2,18:44497557-44628614,"1 (Little Evidence)","0 (No Evidence)",,,41.98,0,0.82,11/28/2018
G,KAT6B,10:76585013-76792382,"3 (Sufficient Evidence)","0 (No Evidence)",,,7.97,1,0.13,04/25/2018
G,KAT6A,8:41786997-41909505,"3 (Sufficient Evidence)","0 (No Evidence)",,,19,1,0.07,03/28/2018
G,KARS1,16:75661622-75681563,"30 (Autosomal Recessive)","0 (No Evidence)",,,2.51,0,0.91,08/22/2016
G,KANSL1,17:44107282-44302733,"3 (Sufficient Evidence)","0 (No Evidence)",,,16.23,1,0.24,04/11/2013
G,KANK1,9:470295-746103,"0 (No Evidence)","0 (No Evidence)",,,49.74,0,0.95,04/28/2016
G,JARID2,6:15246300-15522273,"0 (No Evidence)","0 (No Evidence)",,,12.14,1,0.19,11/07/2013
G,JAM3,11:133938967-134021896,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.11,0,0.84,06/11/2015
G,JAG1,20:10618332-10654647,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.06,1,0.15,10/19/2020
G,IYD,6:150690148-150727105,"30 (Autosomal Recessive)","0 (No Evidence)",,,67.58,0,0.88,08/22/2016
G,ITSN1,21:35014807-35272165,"1 (Little Evidence)","0 (No Evidence)",,,24.18,1,0.22,06/27/2018
G,ITK,5:156607851-156682195,"30 (Autosomal Recessive)","0 (No Evidence)",,,25.39,0,0.71,08/22/2016
G,ITGB3,17:45331193-45391109,"0 (No Evidence)","0 (No Evidence)",,,35.78,0,0.52,08/27/2012
G,ITGB2,21:46305868-46348730,"30 (Autosomal Recessive)","Not Yet Evaluated",,,59.06,0,0.99,08/22/2016
G,ITGA3,17:48133474-48167845,"30 (Autosomal Recessive)","0 (No Evidence)",,,25.55,0,0.53,08/22/2016
G,ITCH,20:32951079-33099578,"30 (Autosomal Recessive)","Not Yet Evaluated",,,7.04,1,0.22,08/22/2016
G,IRF6,1:209958962-209979487,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.03,1,0.13,07/06/2012
G,IRAK4,12:44152754-44183344,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.48,0,1.05,08/22/2016
G,IQSEC2,X:53262058-53350548,"3 (Sufficient Evidence)","0 (No Evidence)",,,26.16,1,0.13,04/07/2020
G,INS,11:2181009-2182439,"0 (No Evidence)","0 (No Evidence)",,,80.96,0.3,1.17,03/22/2012
G,INPP5E,9:139323071-139334297,"30 (Autosomal Recessive)","0 (No Evidence)",,,77.32,0,0.68,08/22/2016
G,IMPA1,8:82569149-82598560,"0 (No Evidence)","0 (No Evidence)",,,39.68,0,0.88,02/08/2012
G,IMMP2L,7:110302700-111202548,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,4.25,0.01,1.2,04/12/2022
G,IL2RA,10:6052652-6104330,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.75,0.05,0.66,08/22/2016
G,IL21R,16:27413495-27463363,"30 (Autosomal Recessive)","0 (No Evidence)",,,84.41,1,0.21,08/22/2016
G,IL1RAPL1,X:28605563-29974835,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.75,1,0.2,08/23/2012
G,IL17RA,22:17565890-17596583,"30 (Autosomal Recessive)","Not Yet Evaluated",,,84.96,0,0.63,08/22/2016
G,IL10RA,11:117857109-117873752,"30 (Autosomal Recessive)","0 (No Evidence)",,,81.79,0.02,0.69,08/22/2016
G,IKBKG,X:153769453-153793261,"3 (Sufficient Evidence)","0 (No Evidence)",,,41.6,0.08,1.37,11/10/2020
G,IGLL1,22:23915312-23922477,"30 (Autosomal Recessive)","0 (No Evidence)",,,81.01,0.01,1.64,08/22/2016
G,IGHMBP2,11:68671359-68708069,"30 (Autosomal Recessive)","0 (No Evidence)",,,80.78,0,0.95,08/22/2016
G,IGF2R,6:160390114-160532536,"0 (No Evidence)","0 (No Evidence)",,,53.96,1,0.21,06/07/2012
G,IGF2,11:2150342-2170833,"0 (No Evidence)","0 (No Evidence)",,,79.01,0.04,1.13,03/22/2012
G,IGF1R,15:99191768-99507759,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.29,0.97,0.31,11/08/2022
G,IFT43,14:76452106-76550416,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.39,0,1.6,08/22/2016
G,IFT27,22:37154255-37172163,"30 (Autosomal Recessive)","0 (No Evidence)",,,55.96,0,1.41,08/22/2016
G,IFT140,16:1560428-1662073,"30 (Autosomal Recessive)","Not Yet Evaluated",,,69.24,0,0.82,08/22/2016
G,IDUA,4:980785-998352,"30 (Autosomal Recessive)","Not Yet Evaluated",,,69.73,0,1.17,08/22/2016
G,IDS,X:148558519-148586836,"3 (Sufficient Evidence)","0 (No Evidence)",,,14.02,0.95,0.32,11/10/2020
G,HYMAI,6:144326053-144329867,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,09/06/2012
G,HYLS1,11:125753509-125770541,"30 (Autosomal Recessive)","Not Yet Evaluated",,,36.27,0,1.43,08/22/2016
G,HUWE1,X:53559057-53713664,"0 (No Evidence)","0 (No Evidence)",,,10.58,1,0.06,09/26/2018
G,HTN3,4:70894176-70902255,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,90.63,0,1.89,02/02/2021
G,HSPG2,1:22148737-22263803,"30 (Autosomal Recessive)","0 (No Evidence)",,,49.81,0,0.41,06/02/2016
G,HSD3B7,16:30996528-31000468,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.14,0,1.33,08/22/2016
G,HSD17B4,5:118788192-118878027,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.64,0,0.75,03/06/2018
G,HSD17B3,9:98997588-99064458,"30 (Autosomal Recessive)","Not Yet Evaluated",,,73.59,0,1.09,08/22/2016
G,HSD17B13,4:88224946-88244034,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,70.24,0,1.14,02/02/2021
G,HSD17B10,X:53458206-53461323,"0 (No Evidence)","0 (No Evidence)",,,21.63,0.94,0.34,09/06/2012
G,HRAS,11:532242-535576,"0 (No Evidence)","0 (No Evidence)",,,0.08,0.08,0.93,10/15/2015
G,HPSE2,10:100216834-100995632,"30 (Autosomal Recessive)","0 (No Evidence)",,,3.52,0,0.69,03/12/2015
G,HPS3,3:148847425-148891519,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.42,0,1.02,08/22/2016
G,HPS1,10:100175955-100206692,"30 (Autosomal Recessive)","Not Yet Evaluated",,,60.85,0,0.69,08/22/2016
G,HPRT1,X:133594195-133634698,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.48,0.94,0.34,01/13/2021
G,HPGD,4:175411326-175444044,"30 (Autosomal Recessive)","0 (No Evidence)",,,47,0,1.25,08/22/2016
G,HOXD9,2:176987447-176989665,"0 (No Evidence)","0 (No Evidence)",,,2.67,0.02,1.07,02/22/2012
G,HOXD13,2:176957449-176960672,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.62,0.01,0.95,09/23/2020
G,HNRNPK,9:86582998-86595530,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.97,1,0.1,08/11/2016
G,HNF1B,17:36046434-36105050,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.76,1,0.17,12/21/2020
G,HMGA2,12:66218240-66360071,"1 (Little Evidence)","0 (No Evidence)",,,1.82,0.87,0.45,09/14/2021
G,HMBS,11:118955591-118964259,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.34,0.95,0.34,01/08/2020
G,HLCS,21:38120926-38362511,"30 (Autosomal Recessive)","0 (No Evidence)",,,90.61,0,0.88,08/22/2016
G,HJV,1:145413278-145417543,"30 (Autosomal Recessive)","Not Yet Evaluated",,,43.91,0,0.88,08/22/2016
G,HIVEP3,1:41972036-42501605,"1 (Little Evidence)","0 (No Evidence)",,,41.45,0.91,0.31,01/23/2019
G,HIVEP2,6:143072606-143266313,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.96,1,0.08,04/25/2018
G,HIRA,22:19318221-19419256,"0 (No Evidence)","0 (No Evidence)",,,19.48,1,0.14,08/28/2012
G,HGSNAT,8:42995607-43057998,"30 (Autosomal Recessive)","Not Yet Evaluated",,,68.49,0,0.73,08/22/2016
G,HGF,7:81328326-81399363,"30 (Autosomal Recessive)","Not Yet Evaluated",,,0.6,1,0.25,08/22/2016
G,HFM1,1:91726323-91870394,"30 (Autosomal Recessive)","0 (No Evidence)",,,42.61,0,0.93,08/22/2016
G,HFE,6:26087657-26098571,"30 (Autosomal Recessive)","0 (No Evidence)",,,74.41,0,1.19,11/10/2016
G,HEXB,5:73935848-74017113,"30 (Autosomal Recessive)","Not Yet Evaluated",,,73.45,0,0.92,08/22/2016
G,HDAC8,X:71549366-71792693,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.01,0.98,0.3,03/28/2018
G,HDAC4,2:239969864-240323343,"1 (Little Evidence)","0 (No Evidence)",,,7.56,1,0.05,11/07/2011
G,HCCS,X:11129452-11141206,"3 (Sufficient Evidence)","0 (No Evidence)",,,40.92,0.89,0.41,05/10/2012
G,HBA2,16:222875-223709,"30 (Autosomal Recessive)","0 (No Evidence)",,,60.06,0,1.93,07/06/2012
G,HBA1,16:226679-227521,"30 (Autosomal Recessive)","0 (No Evidence)",,,69.88,0.01,1.85,04/19/2012
G,H6PD,1:9294833-9331396,"30 (Autosomal Recessive)","0 (No Evidence)",,,46.01,0,0.94,08/22/2016
G,H19,11:2016406-2022696,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,03/22/2012
G,H1-4,6:26156557-26157343,"0 (No Evidence)","0 (No Evidence)",,,49.38,0.19,1.59,07/27/2022
G,GYS2,12:21689041-21757781,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.21,0,1.13,08/22/2016
G,GUSB,7:65425671-65447200,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.3,0,0.75,10/12/2015
G,GUCY2C,12:14765566-14849533,"0 (No Evidence)","0 (No Evidence)",,,27.06,0,1.08,09/18/2013
G,GUCA1C,3:108626639-108672726,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,74.3,0,1.88,02/02/2021
G,GTF2IRD2,7:74210490-74267901,"0 (No Evidence)","0 (No Evidence)",,,85.33,0,1.17,12/04/2013
G,GTF2IRD1,7:73868236-74016931,"0 (No Evidence)","0 (No Evidence)",,,47.51,0.9,0.33,10/10/2012
G,GTF2I,7:74072044-74175022,"0 (No Evidence)","0 (No Evidence)",,,33.5,1,0.27,08/08/2012
G,GTF2H5,6:158589382-158620376,"30 (Autosomal Recessive)","0 (No Evidence)",,,30.21,0.05,1.71,08/22/2016
G,GRXCR1,4:42894730-43032675,"30 (Autosomal Recessive)","0 (No Evidence)",,,33.66,0,1.7,03/06/2018
G,GRM6,5:178405328-178422321,"30 (Autosomal Recessive)","0 (No Evidence)",,,55.3,0,1.17,08/22/2016
G,GRM1,6:146348843-146758737,"30 (Autosomal Recessive)","Not Yet Evaluated",,,7.83,0.14,0.42,08/22/2016
G,GRIP1,12:66741211-67463118,"30 (Autosomal Recessive)","0 (No Evidence)",,,18.89,0.51,0.36,07/10/2012
G,GRIN3B,19:1000418-1009731,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,80.29,0,0.98,02/02/2021
G,GRIN2B,12:13690271-14134536,"3 (Sufficient Evidence)","0 (No Evidence)",,,10.82,1,0.06,09/25/2019
G,GRIN2A,16:9847261-10276765,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.34,1,0.19,04/27/2022
G,GRIK2,6:101841584-102517958,"30 (Autosomal Recessive)","0 (No Evidence)",,,2.34,1,0.26,09/05/2012
G,GRID1,10:87359309-88126552,"0 (No Evidence)","0 (No Evidence)",,,13.06,1,0.24,12/21/2011
G,GRIA3,X:122318131-122624766,"2 (Emerging Evidence)","0 (No Evidence)",,,2.64,1,0.19,10/23/2019
G,GRHPR,9:37422693-37436987,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.6,0,1.17,08/22/2016
G,GREM1,15:33010205-33037307,"0 (No Evidence)","0 (No Evidence)",,,2.63,0.47,0.82,08/20/2020
G,GRB10,7:50657765-50861150,"0 (No Evidence)","0 (No Evidence)",,,6.48,0.94,0.34,03/23/2012
G,GPX4,19:1103993-1106778,"30 (Autosomal Recessive)","0 (No Evidence)",,,34.09,0,1.28,08/22/2016
G,GPSM2,1:109419607-109477167,"30 (Autosomal Recessive)","0 (No Evidence)",,,21.15,0,0.86,08/22/2016
G,GPR179,17:36480454-36499839,"30 (Autosomal Recessive)","0 (No Evidence)",,,79.16,0,0.82,08/22/2016
G,GPR148,2:131486643-131487909,"0 (No Evidence)","0 (No Evidence)",,,87.6,0,1.84,04/05/2018
G,GPIHBP1,8:144295093-144299044,"30 (Autosomal Recessive)","Not Yet Evaluated",,,96.22,0.14,1.1,08/22/2016
G,GPHN,14:66974865-67648520,"2 (Emerging Evidence)","0 (No Evidence)",,,2.69,1,0.18,06/22/2022
G,GPD1,12:50497791-50505096,"30 (Autosomal Recessive)","0 (No Evidence)",,,31.74,0.01,0.83,08/22/2016
G,GPC6,13:93879060-95060274,"30 (Autosomal Recessive)","0 (No Evidence)",,,1.28,0.14,0.51,11/17/2011
G,GPC5,13:92050875-93519490,"0 (No Evidence)","0 (No Evidence)",,,10.35,0,1.08,03/09/2012
G,GPC3,X:132669773-133119621,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.17,1,0.16,01/27/2021
G,GP6,19:55525073-55549632,"30 (Autosomal Recessive)","0 (No Evidence)",,,92.98,0,1.61,08/22/2016
G,GP1BB,22:19711062-19712294,"30 (Autosomal Recessive)","Not Yet Evaluated",,,78.01,0.51,1.33,08/22/2016
G,GORAB,1:170501307-170522975,"30 (Autosomal Recessive)","0 (No Evidence)",,,57.49,0,0.99,08/22/2016
G,GOLGA2P2Y,Y:26356114-26360978,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,08/22/2012
G,GNS,12:65107229-65153186,"30 (Autosomal Recessive)","Not Yet Evaluated",,,30.08,0,0.61,08/22/2016
G,GNRH1,8:25276774-25282556,"30 (Autosomal Recessive)","0 (No Evidence)",,,8.16,0.15,1.05,08/22/2016
G,GNPAT,1:231376958-231413719,"30 (Autosomal Recessive)","Not Yet Evaluated",,,57.89,0.3,0.42,08/22/2016
G,GNB1,1:1716725-1822526,"1 (Little Evidence)","0 (No Evidence)",,,22.4,1,0.15,01/23/2019
G,GNAS,20:57414803-57486247,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.83,0.68,0.37,01/12/2021
G,GNAO1,16:56225401-56391356,"1 (Little Evidence)","0 (No Evidence)",,,7.72,0.99,0.26,05/10/2022
G,GNAI3,1:110091237-110142817,"0 (No Evidence)","0 (No Evidence)",,,5.51,0.04,0.61,07/18/2013
G,GMPPA,2:220363613-220371711,"30 (Autosomal Recessive)","0 (No Evidence)",,,42.18,0,0.94,08/22/2016
G,GLUL,1:182347233-182360925,"30 (Autosomal Recessive)","0 (No Evidence)",,,9.54,1,0.19,06/04/2015
G,GLRB,4:157997302-158093242,"30 (Autosomal Recessive)","0 (No Evidence)",,,35.64,0,0.66,08/22/2016
G,GLMN,1:92711959-92764544,"3 (Sufficient Evidence)","0 (No Evidence)",,,14.69,0,0.91,07/18/2013
G,GLIS3,9:3824127-4300068,"30 (Autosomal Recessive)","0 (No Evidence)",,,2.6,0,0.74,08/22/2016
G,GLI3,7:42000547-42276808,"3 (Sufficient Evidence)","0 (No Evidence)",,,20.82,1,0.2,01/12/2021
G,GLI2,2:121493444-121750229,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.89,0.97,0.31,01/11/2021
G,GLDC,9:6532467-6645729,"30 (Autosomal Recessive)","0 (No Evidence)",,,30.92,0,1.11,06/10/2016
G,GLB1,3:33038109-33138638,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.88,0,0.86,03/25/2015
G,GLA,X:100652791-100662913,"3 (Sufficient Evidence)","0 (No Evidence)",,,42.34,1,0.18,03/24/2021
G,GK,X:30671540-30749579,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.79,0.99,0.29,09/06/2012
G,GJB6,13:20796101-20806458,"0 (No Evidence)","0 (No Evidence)",,,21.27,0,1.74,01/30/2014
G,GJB2,13:20761609-20767077,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,20.16,0,1.98,05/10/2012
G,GJA8,1:147374921-147381396,"1 (Little Evidence)","0 (No Evidence)",,,52.92,0,1,02/23/2012
G,GJA5,1:147228332-147245455,"1 (Little Evidence)","0 (No Evidence)",,,8.62,0.02,0.81,02/23/2012
G,GJA1,6:121756792-121770873,"0 (No Evidence)","0 (No Evidence)",,,1.17,0.16,0.62,11/20/2013
G,GIPC3,19:3585476-3593539,"30 (Autosomal Recessive)","0 (No Evidence)",,,63.46,0.01,0.93,08/22/2016
G,GIGYF2,2:233562041-233725315,"1 (Little Evidence)","0 (No Evidence)",,,14.01,1,0.08,08/24/2022
G,GFM1,3:158362316-158413370,"30 (Autosomal Recessive)","0 (No Evidence)",,,31.6,0,0.8,08/22/2016
G,GFER,16:2034194-2037750,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.65,0,1.65,08/22/2016
G,GEN1,2:17935136-17970213,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,58.31,0,0.95,02/02/2021
G,GDI1,X:153665500-153671814,"1 (Little Evidence)","0 (No Evidence)",,,30.35,0.99,0.19,06/22/2022
G,GDF5,20:34021145-34042571,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.52,0.67,0.47,02/24/2021
G,GDF2,10:48411774-48416908,"0 (No Evidence)","0 (No Evidence)",,,35.53,0,0.98,10/13/2016
G,GCSH,16:81115550-81130000,"30 (Autosomal Recessive)","Not Yet Evaluated",,,36.73,0,1.42,08/22/2016
G,GCH1,14:55308735-55369544,"3 (Sufficient Evidence)","0 (No Evidence)",,,28.56,0.9,0.4,05/12/2016
G,GCDH,19:13001943-13010813,"30 (Autosomal Recessive)","Not Yet Evaluated",,,60.73,0,0.64,08/22/2016
G,GBE1,3:81538854-81810796,"30 (Autosomal Recessive)","0 (No Evidence)",,,9.2,0,0.97,08/22/2016
G,GBA2,9:35736863-35749225,"30 (Autosomal Recessive)","Not Yet Evaluated",,,39.8,0,0.94,08/22/2016
G,GBA,1:155204243-155214418,"30 (Autosomal Recessive)","0 (No Evidence)",,,52.28,0,0.8,08/22/2016
G,GATAD2B,1:153777201-153895448,"3 (Sufficient Evidence)","0 (No Evidence)",,,10.42,1,0.1,12/27/2017
G,GATAD1,7:92076796-92089389,"30 (Autosomal Recessive)","Not Yet Evaluated",,,37.42,0.43,0.65,08/22/2016
G,GATA6,18:19749550-19782491,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.26,1,0.17,06/20/2013
G,GATA4,8:11534444-11617511,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.87,0.49,0.53,02/08/2017
G,GATA3,10:8096651-8117161,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.99,0.9,0.39,06/24/2020
G,GATA2,3:128198265-128212044,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.46,0.98,0.29,06/04/2015
G,GATA1,X:48644998-48652718,"0 (No Evidence)","0 (No Evidence)",,,45.59,0.95,0.32,10/14/2020
G,GAN,16:81348567-81424414,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.7,0.02,0.5,08/22/2016
G,GAMT,19:1397025-1401541,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.39,0.01,1.26,08/22/2016
G,GALT,9:34646672-34651032,"30 (Autosomal Recessive)","Not Yet Evaluated",,,30.87,0,0.96,08/22/2016
G,GALR1,18:74961804-74989856,"0 (No Evidence)","0 (No Evidence)",,,59.63,0,1.35,07/06/2012
G,GALNT3,2:166604098-166650757,"30 (Autosomal Recessive)","0 (No Evidence)",,,17.53,0,0.86,08/22/2016
G,GALNT12,9:101569952-101612363,"1 (Little Evidence)","0 (No Evidence)",,,59.91,0,0.94,09/09/2019
G,GALNS,16:88880142-88923355,"30 (Autosomal Recessive)","0 (No Evidence)",,,65.94,0,1.01,08/22/2016
G,GALK1,17:73747550-73761273,"30 (Autosomal Recessive)","0 (No Evidence)",,,28.42,0,1.09,08/22/2016
G,GALC,14:88399358-88460009,"30 (Autosomal Recessive)","Not Yet Evaluated",,,47.35,0,0.94,08/22/2016
G,GABRG2,5:161494471-161582545,"1 (Little Evidence)","0 (No Evidence)",,,11.88,0.74,0.4,09/25/2018
G,GABRB3,15:26788699-27018910,"0 (No Evidence)","0 (No Evidence)",,,8.38,0.95,0.34,04/25/2012
G,GABRA1,5:161274197-161326977,"1 (Little Evidence)","0 (No Evidence)",,,9.56,0.91,0.37,11/09/2021
G,GAB4,22:17442826-17489112,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,87.14,0,1.22,02/02/2021
G,GAA,17:78075380-78093680,"30 (Autosomal Recessive)","Not Yet Evaluated",,,75.35,0,0.98,08/22/2016
G,G6PC3,17:42148041-42153712,"30 (Autosomal Recessive)","0 (No Evidence)",,,43.93,0,1.03,04/30/2020
G,FZD4,11:86656721-86666437,"3 (Sufficient Evidence)","0 (No Evidence)",,,22.13,0.97,0.31,07/06/2012
G,FYCO1,3:45959395-46037316,"30 (Autosomal Recessive)","0 (No Evidence)",,,61.49,0,0.91,05/20/2015
G,FXN,9:71650668-71693992,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.77,0.34,0.72,08/22/2016
G,FTSJ1,X:48334409-48344752,"3 (Sufficient Evidence)","0 (No Evidence)",,,52.75,0.99,0.2,07/12/2012
G,FTL,19:49468566-49470136,"0 (No Evidence)","0 (No Evidence)",,,16.73,0,1.95,08/22/2013
G,FTCD,21:47556176-47575493,"30 (Autosomal Recessive)","0 (No Evidence)",,,71.26,0,1.23,08/22/2016
G,FSHB,11:30252561-30256741,"30 (Autosomal Recessive)","Not Yet Evaluated",,,15.77,0.34,1.06,08/22/2016
G,FRMD7,X:131211018-131262048,"3 (Sufficient Evidence)","0 (No Evidence)",,,28.47,0.73,0.42,04/09/2020
G,FREM1,9:14737150-14910993,"0 (No Evidence)","0 (No Evidence)",,,26.81,0,1.12,06/06/2013
G,FOXRED1,11:126139049-126148021,"30 (Autosomal Recessive)","0 (No Evidence)",,,55.38,0,1.32,08/22/2016
G,FOXP2,7:113726382-114333820,"1 (Little Evidence)","0 (No Evidence)",,,0.09,1,0.22,09/19/2012
G,FOXP1,3:71003859-71633129,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.14,1,0.18,01/22/2020
G,FOXL2,3:138663066-138665979,"3 (Sufficient Evidence)","0 (No Evidence)",,,21.55,0.88,0.44,02/09/2021
G,FOXG1,14:29235993-29239483,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.12,0.94,0.33,03/09/2021
G,FOXF1,16:86544133-86549028,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.93,0.96,0.3,06/20/2013
G,FOXE3,1:47881957-47883724,"0 (No Evidence)","0 (No Evidence)",,,68.36,0.18,1.61,12/13/2017
G,FOXE1,9:100615508-100618999,"30 (Autosomal Recessive)","Not Yet Evaluated",,,37.73,0.79,0.58,08/22/2016
G,FOXC2,16:86600435-86603334,"3 (Sufficient Evidence)","0 (No Evidence)",,,5.65,0.13,0.79,11/26/2013
G,FOXC1,6:1610150-1614132,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.01,0.95,0.31,07/29/2020
G,FOLR1,11:71900753-71907367,"30 (Autosomal Recessive)","0 (No Evidence)",,,71.28,0.13,0.65,06/25/2019
G,FMR1,X:146993437-147032645,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.45,0.65,0.42,12/16/2020
G,FMO2,1:171154347-171181825,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,56.93,0,1.06,02/02/2021
G,FLVCR2,14:76044963-76114510,"30 (Autosomal Recessive)","0 (No Evidence)",,,46.63,0,0.93,08/22/2016
G,FLNC,7:128470460-128499326,"3 (Sufficient Evidence)","0 (No Evidence)",,,21.56,1,0.25,07/13/2021
G,FLNB,3:57994149-58157978,"0 (No Evidence)","0 (No Evidence)",,,12.25,0,0.44,07/25/2013
G,FLNA,X:153576899-153603002,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.01,1,0.08,12/02/2020
G,FLG,1:152274641-152297715,"3 (Sufficient Evidence)","0 (No Evidence)",,,99.71,0,1.96,02/26/2020
G,FLCN,17:17115526-17140482,"3 (Sufficient Evidence)","0 (No Evidence)",,,46.02,0.79,0.39,11/10/2016
G,FKBP14,7:30050203-30066318,"30 (Autosomal Recessive)","0 (No Evidence)",,,24.26,0,1.66,08/22/2016
G,FHIT,3:59733003-61237126,"0 (No Evidence)","0 (No Evidence)",,,0.43,0.01,1.45,10/24/2018
G,FH,1:241660903-241683055,"3 (Sufficient Evidence)","0 (No Evidence)",,,15.21,0.09,0.54,07/06/2020
G,FGFRL1,4:1005414-1020686,"0 (No Evidence)","0 (No Evidence)",,,61.34,0.01,0.73,08/01/2013
G,FGFR3,4:1795020-1810594,"0 (No Evidence)","0 (No Evidence)",,,6.4,0,0.6,11/09/2011
G,FGFR1,8:38268661-38326153,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.42,1,0.22,04/05/2021
G,FGF3,11:69624736-69634184,"30 (Autosomal Recessive)","Not Yet Evaluated",,,57.44,0,1.78,08/22/2016
G,FGF12,3:191857179-192445330,"0 (No Evidence)","1 (Little Evidence)",,,3.96,0.62,0.54,12/01/2021
G,FGF10,5:44300349-44389522,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.55,0.94,0.34,02/23/2022
G,FGD4,12:32552492-32798984,"30 (Autosomal Recessive)","0 (No Evidence)",,,50.19,0.01,0.46,08/22/2016
G,FGD1,X:54471887-54522667,"3 (Sufficient Evidence)","0 (No Evidence)",,,18.2,1,0.2,05/26/2021
G,FBXW4,10:103370423-103455052,"0 (No Evidence)","0 (No Evidence)",,,16.23,0,0.72,10/08/2014
G,FBXW11,5:171288553-171433642,"0 (No Evidence)","1 (Little Evidence)",,,10.37,0.98,0.31,12/07/2011
G,FBXO7,22:32870798-32894816,"30 (Autosomal Recessive)","Not Yet Evaluated",,,38.24,0,0.88,08/22/2016
G,FBP1,9:97365415-97402545,"30 (Autosomal Recessive)","0 (No Evidence)",,,36.83,0.08,0.72,08/22/2016
G,FBN1,15:48700510-48937906,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.53,1,0.05,12/04/2019
G,FASLG,1:172628243-172636016,"30 (Autosomal Recessive)","0 (No Evidence)",,,7.98,0.18,0.72,08/25/2016
G,FAS,10:90750555-90776816,"1 (Little Evidence)","0 (No Evidence)",,,93.15,0.81,0.44,02/08/2022
G,FARS2,6:5261240-5771816,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.7,0,1.15,08/22/2016
G,FANCI,15:89787210-89860490,"30 (Autosomal Recessive)","Not Yet Evaluated",,,23.8,0,1.02,08/22/2016
G,FANCG,9:35073836-35079939,"30 (Autosomal Recessive)","0 (No Evidence)",,,50.76,0,1.09,11/15/2020
G,FANCF,11:22644079-22647369,"30 (Autosomal Recessive)","0 (No Evidence)",,,79.88,0.46,1.53,08/22/2016
G,FANCE,6:35420115-35434879,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.05,0,0.89,06/12/2020
G,FANCD2,3:10068121-10143616,"30 (Autosomal Recessive)","Not Yet Evaluated",,,32.01,0,0.89,08/22/2016
G,FANCC,9:97861336-98079991,"30 (Autosomal Recessive)","0 (No Evidence)",,,43.39,0,1.04,08/22/2016
G,FANCB,X:14861527-14891191,"3 (Sufficient Evidence)","0 (No Evidence)",,,57.28,1,0.23,06/23/2021
G,FANCA,16:89803957-89883055,"30 (Autosomal Recessive)","0 (No Evidence)",,,82.85,0,1.37,02/23/2012
G,FAN1,15:31196055-31235311,"30 (Autosomal Recessive)","0 (No Evidence)",,,86.96,0,1.12,08/22/2016
G,FAM20C,7:192571-300738,"30 (Autosomal Recessive)","Not Yet Evaluated",,,39.39,0.31,0.49,08/22/2016
G,FAM161A,2:62051983-62081195,"30 (Autosomal Recessive)","0 (No Evidence)",,,75.75,0,1.01,08/22/2016
G,FAH,15:80445131-80479291,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.92,0,1.41,09/02/2020
G,FADD,11:70049402-70053496,"30 (Autosomal Recessive)","0 (No Evidence)",,,68.73,0.53,1.28,08/22/2016
G,FA2H,16:74746867-74808718,"30 (Autosomal Recessive)","Not Yet Evaluated",,,59.01,0.15,0.56,08/22/2016
G,F9,X:138612898-138645618,"3 (Sufficient Evidence)","0 (No Evidence)",,,40.27,1,0.17,01/12/2021
G,F8,X:154064067-154250998,"3 (Sufficient Evidence)","0 (No Evidence)",,,30.72,1,0.09,10/13/2020
G,F7,13:113760102-113774999,"30 (Autosomal Recessive)","Not Yet Evaluated",,,80.84,0,0.9,08/22/2016
G,F5,1:169481189-169555719,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.18,0,0.56,01/11/2018
G,F13B,1:197007871-197036390,"30 (Autosomal Recessive)","0 (No Evidence)",,,74.15,0,0.85,08/22/2016
G,F13A1,6:6144317-6320895,"30 (Autosomal Recessive)","0 (No Evidence)",,,36.61,0,0.74,08/22/2016
G,F10,13:113777113-113803843,"30 (Autosomal Recessive)","Not Yet Evaluated",,,72.12,0,0.97,08/22/2016
G,EYS,6:64429876-66417119,"30 (Autosomal Recessive)","Not Yet Evaluated",,,25.63,0,0.83,08/22/2016
G,EYA4,6:133562495-133853266,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.86,0.05,0.45,01/22/2020
G,EYA1,8:72109668-72460329,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.33,0.95,0.33,08/26/2020
G,EXT2,11:44117228-44273512,"3 (Sufficient Evidence)","0 (No Evidence)",,,14.77,0,0.77,06/23/2020
G,EXT1,8:118806729-119124065,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.49,1,0.26,06/17/2020
G,EXPH5,11:108376162-108464495,"30 (Autosomal Recessive)","0 (No Evidence)",,,83.2,0,0.94,08/22/2016
G,EXOSC3,9:37779711-37785089,"30 (Autosomal Recessive)","0 (No Evidence)",,,29.34,0,1.21,08/22/2016
G,EXO5,1:40974439-40981710,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,64.2,0,1.43,02/02/2021
G,EVX2,2:176944835-176948690,"0 (No Evidence)","0 (No Evidence)",,,19.69,0.4,0.68,04/04/2012
G,EVC2,4:5564166-5711275,"30 (Autosomal Recessive)","0 (No Evidence)",,,74.81,0,1.06,07/18/2013
G,ETFDH,4:159593448-159630775,"30 (Autosomal Recessive)","Not Yet Evaluated",,,46.5,0,1.04,08/22/2016
G,ETFB,19:51848409-51869642,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.88,0.02,0.83,08/22/2016
G,ESPN,1:6484836-6521004,"30 (Autosomal Recessive)","0 (No Evidence)",,,46.09,0,0.93,02/07/2018
G,ESCO2,8:27632071-27662833,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.83,0,0.83,08/22/2016
G,ERMARD,6:170151718-170181696,"1 (Little Evidence)","0 (No Evidence)",,,84.87,0,1.02,11/13/2013
G,ERF,19:42751721-42759280,"3 (Sufficient Evidence)","0 (No Evidence)",,,36.32,0.99,0.26,06/08/2021
G,ERCC8,5:60162281-60240897,"30 (Autosomal Recessive)","0 (No Evidence)",,,17.24,0,1.36,08/22/2016
G,ERCC6L2,9:98637973-98803374,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.16,0,0.68,08/22/2016
G,ERCC5,13:103498382-103528345,"30 (Autosomal Recessive)","Not Yet Evaluated",,,52.57,0,0.81,08/22/2016
G,ERCC3,2:128014866-128051720,"30 (Autosomal Recessive)","0 (No Evidence)",,,16.21,0,0.79,06/30/2020
G,ERCC2,19:45853095-45873831,"30 (Autosomal Recessive)","Not Yet Evaluated",,,16.33,0,1.09,08/22/2016
G,ERCC1,19:45910592-45954805,"30 (Autosomal Recessive)","Not Yet Evaluated",,,39.74,0,1.3,08/22/2016
G,EPS8,12:15773068-15942322,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.96,0.97,0.31,02/07/2018
G,EPM2A,6:145946441-146057159,"30 (Autosomal Recessive)","0 (No Evidence)",,,38.74,0,1.34,08/22/2016
G,EPCAM,2:47596450-47614159,"30 (Autosomal Recessive)","0 (No Evidence)",,,60.55,0,1.16,10/08/2019
G,EPB42,15:43489425-43513216,"30 (Autosomal Recessive)","0 (No Evidence)",,,67.14,0,0.77,08/22/2016
G,EP300,22:41488596-41576081,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.67,1,0.1,03/14/2013
G,ENPP1,6:132129160-132216295,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.17,0,0.59,08/22/2016
G,ENO3,17:4853847-4860424,"30 (Autosomal Recessive)","Not Yet Evaluated",,,4.38,0,1.69,08/22/2016
G,ENG,9:130577291-130617052,"3 (Sufficient Evidence)","0 (No Evidence)",,,23.71,1,0.24,12/08/2016
G,EN2,7:155250824-155257526,"0 (No Evidence)","0 (No Evidence)",,,23.56,0.63,0.63,08/26/2012
G,EMX2,10:119302257-119309057,"1 (Little Evidence)","0 (No Evidence)",,,7.32,0.95,0.32,11/09/2021
G,ELOA3P,18:44554573-44556449,"0 (No Evidence)","0 (No Evidence)",,,98.17,0,0,02/22/2012
G,ELN,7:73442503-73484237,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.62,0,0.87,07/10/2012
G,ELK1,X:47494919-47510003,"0 (No Evidence)","0 (No Evidence)",,,43.41,0.94,0.34,09/26/2012
G,ELAVL2,9:23690102-23850599,"1 (Little Evidence)","0 (No Evidence)",,,1.24,1,0.19,11/28/2018
G,ELANE,19:852303-856243,"1 (Little Evidence)","0 (No Evidence)",,,34.42,0,1.13,07/13/2022
G,EIF4A3,17:78108168-78120927,"30 (Autosomal Recessive)","0 (No Evidence)",,,31.52,1,0.12,08/22/2016
G,EIF2B3,1:45316194-45452267,"30 (Autosomal Recessive)","0 (No Evidence)",,,14.41,0.57,0.43,08/22/2016
G,EIF2B1,12:124104953-124118233,"30 (Autosomal Recessive)","Not Yet Evaluated",,,49.37,0,0.98,08/22/2016
G,EIF2AK3,2:88856259-88926982,"30 (Autosomal Recessive)","Not Yet Evaluated",,,4.63,0,0.45,08/22/2016
G,EHMT1,9:140513457-140730579,"3 (Sufficient Evidence)","1 (Little Evidence)",,,62.96,1,0.07,07/06/2012
G,EGR2,10:64571756-64578927,"0 (No Evidence)","0 (No Evidence)",,,6.85,0.5,0.6,11/28/2011
G,EGFR,7:55086710-55279321,"0 (No Evidence)","0 (No Evidence)",,,0.3,0.37,0.35,05/11/2022
G,EFTUD2,17:42927316-42976813,"3 (Sufficient Evidence)","0 (No Evidence)",,,24.19,1,0.09,05/23/2013
G,EFNB1,X:68048864-68062003,"3 (Sufficient Evidence)","1 (Little Evidence)",,,5.79,0.93,0.35,07/26/2012
G,EFL1,15:82422574-82555075,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.96,0,0.56,04/13/2022
G,EFCAB13,17:45401321-45518678,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,86.7,0,1.37,02/02/2021
G,EDNRB,13:78469616-78549662,"1 (Little Evidence)","0 (No Evidence)",,,5.87,0.01,0.59,02/07/2022
G,EDA,X:68835957-69259322,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.43,0.97,0.27,07/26/2012
G,EBP,X:48380196-48387104,"3 (Sufficient Evidence)","0 (No Evidence)",,,58.58,0.94,0.34,01/22/2020
G,EARS2,16:23532075-23568696,"30 (Autosomal Recessive)","0 (No Evidence)",,,49.25,0,1.02,08/22/2016
G,DYRK1A,21:38737875-38898660,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.69,1,0.21,12/16/2020
G,DYNC2I1,7:158631936-158738880,"30 (Autosomal Recessive)","Not Yet Evaluated",,,89.69,0,0.67,08/22/2016
G,DYNC2H1,11:102980155-103350591,"30 (Autosomal Recessive)","Not Yet Evaluated",,,29.66,0,0.58,08/22/2016
G,DYM,18:46562757-46987015,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.38,0,0.91,02/23/2012
G,DSPP,4:88529681-88538025,"0 (No Evidence)","0 (No Evidence)",,,61.42,0,1.17,03/27/2013
G,DSP,6:7541904-7586947,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.87,1,0.26,10/12/2021
G,DSG4,18:28956740-28994872,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.44,0,0.82,08/22/2016
G,DSG2,18:29078140-29128971,"1 (Little Evidence)","0 (No Evidence)",,,62.78,0,0.79,11/16/2015
G,DSE,6:116575334-116766024,"30 (Autosomal Recessive)","Not Yet Evaluated",,,5.23,0.63,0.38,08/22/2016
G,DSCAM,21:41382926-42219084,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.07,1,0.19,01/24/2018
G,DSC3,18:28569331-28622708,"30 (Autosomal Recessive)","Not Yet Evaluated",,,29.87,0,1.2,08/22/2016
G,DSC2,18:28638806-28682384,"2 (Emerging Evidence)","0 (No Evidence)",,,70.44,0,0.69,01/14/2016
G,DRD5,4:9783258-9785633,"0 (No Evidence)","0 (No Evidence)",,,48.72,0,1.94,05/15/2012
G,DPYS,8:105391659-105479283,"30 (Autosomal Recessive)","Not Yet Evaluated",,,50.47,0,1.17,08/22/2016
G,DPYD,1:97543299-98386615,"30 (Autosomal Recessive)","0 (No Evidence)",,,1.82,0,1.01,01/24/2018
G,DPP6,7:153445218-154685995,"1 (Little Evidence)","0 (No Evidence)",,,42.27,0.34,0.38,06/26/2019
G,DPM3,1:155112367-155113007,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.99,0.23,1.4,04/09/2015
G,DPM1,20:49551392-49575101,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.24,0,0.87,08/22/2016
G,DPAGT1,11:118967220-118972563,"30 (Autosomal Recessive)","0 (No Evidence)",,,14.87,0,1.08,08/22/2016
G,DOK7,4:3465033-3503209,"30 (Autosomal Recessive)","Not Yet Evaluated",,,75.35,0,0.93,08/22/2016
G,DOCK8,9:214865-465255,"30 (Autosomal Recessive)","Not Yet Evaluated",,,35.69,0,0.48,08/22/2016
G,DOCK7,1:62920397-63154057,"30 (Autosomal Recessive)","0 (No Evidence)",,,28.59,0,0.38,08/22/2016
G,DNMT3A,2:25450743-25565459,"1 (Little Evidence)","0 (No Evidence)",,,3.99,0,1.58,04/29/2018
G,DNASE1,16:3661761-3715462,"0 (No Evidence)","0 (No Evidence)",,,65.82,0,1.95,02/22/2012
G,DNAJC6,1:65730432-65881554,"30 (Autosomal Recessive)","0 (No Evidence)",,,34.73,1,0.22,08/22/2016
G,DNAJC28,21:34860362-34864023,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,63.77,0,1.39,02/02/2021
G,DNAJC21,5:34929664-34959069,"1 (Little Evidence)","0 (No Evidence)",,,49.28,0,0.72,10/14/2020
G,DNAJB6,7:157129698-157210133,"0 (No Evidence)","0 (No Evidence)",,,47.78,0.85,0.4,10/29/2012
G,DNAI2,17:72270373-72311023,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.18,0,0.98,08/22/2016
G,DNAI1,9:34458803-34520982,"30 (Autosomal Recessive)","0 (No Evidence)",,,11.63,0,0.73,08/22/2016
G,DNAH5,5:13690437-13944797,"30 (Autosomal Recessive)","0 (No Evidence)",,,32.91,0,0.7,08/22/2016
G,DNAH11,7:21582657-21941457,"30 (Autosomal Recessive)","0 (No Evidence)",,,21.9,0,0.67,08/22/2016
G,DNAAF11,8:133582664-133687791,"30 (Autosomal Recessive)","Not Yet Evaluated",,,66.48,0,1.08,08/22/2016
G,DNAAF1,16:84178913-84211526,"30 (Autosomal Recessive)","0 (No Evidence)",,,98.51,0,1,08/22/2016
G,DMXL2,15:51739988-51914968,"0 (No Evidence)","0 (No Evidence)",,,41.6,1,0.16,04/04/2012
G,DMRT2,9:1050357-1057552,"0 (No Evidence)","0 (No Evidence)",,,53.86,0.01,0.76,08/22/2012
G,DMRT1,9:841697-969090,"2 (Emerging Evidence)","0 (No Evidence)",,,18.6,0.74,0.48,06/06/2012
G,DMP1,4:88571432-88585509,"30 (Autosomal Recessive)","Not Yet Evaluated",,,81.24,0,1.14,08/22/2016
G,DMD,X:31137339-33357505,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.27,1,0.15,11/20/2019
G,DLX6,7:96634865-96640352,"0 (No Evidence)","0 (No Evidence)",,,3.97,0.92,0.38,05/14/2012
G,DLX5,7:96649708-96654143,"0 (No Evidence)","0 (No Evidence)",,,0.99,0.22,0.68,05/14/2012
G,DLX2,2:172964166-172967628,"0 (No Evidence)","0 (No Evidence)",,,19.55,0.98,0.25,01/19/2012
G,DLX1,2:172950235-172954402,"0 (No Evidence)","0 (No Evidence)",,,1.08,0.96,0.29,03/30/2012
G,DLL1,6:170591294-170600166,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.66,1,0.1,03/09/2021
R,"DLK1-MEG3 Intergenic DMR",14:101191391-101294616,"1 (Little Evidence)","0 (No Evidence)",,,‐,‐,‐,05/10/2012
G,DLK1,14:101193229-101204561,"0 (No Evidence)","0 (No Evidence)",,,24.61,0.03,0.71,04/28/2012
G,DLGAP2,8:687628-1656642,"0 (No Evidence)","0 (No Evidence)",,,58.64,1,0.2,03/22/2012
G,DLG3,X:69664685-69725340,"2 (Emerging Evidence)","0 (No Evidence)",,,14.46,1,0.09,11/21/2019
G,DLG2,11:83166055-85339417,"1 (Little Evidence)","0 (No Evidence)",,,1.29,0.71,0.34,11/28/2018
G,DKC1,X:153991139-154005964,"1 (Little Evidence)","0 (No Evidence)",,,6.32,1,0.19,04/25/2012
G,DISP1,1:222988381-223179337,"0 (No Evidence)","0 (No Evidence)",,,49.82,0,0.6,07/06/2012
G,DISC1,1:231762536-232177018,"0 (No Evidence)","0 (No Evidence)",,,81.6,0,0.79,03/06/2012
G,DIS3L2,2:232826423-233209060,"1 (Little Evidence)","0 (No Evidence)",,,37.78,0.94,0.33,10/14/2020
G,DIRAS3,1:68511569-68517314,"0 (No Evidence)","0 (No Evidence)",,,90.89,0,0,10/19/2011
G,DIP2A,21:47878804-47991139,"1 (Little Evidence)","0 (No Evidence)",,,58.86,0.11,0.35,01/23/2019
G,DICER1,14:95552565-95624347,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.99,1,0.17,02/09/2022
G,DHX57,2:39024871-39103075,"0 (No Evidence)","0 (No Evidence)",,,46.62,0,0.68,06/28/2018
G,DHODH,16:72042643-72061558,"30 (Autosomal Recessive)","0 (No Evidence)",,,25.78,0,0.78,08/22/2016
G,DHCR7,11:71145457-71159439,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.8,0,1.35,04/04/2012
G,DGUOK,2:74154007-74186073,"30 (Autosomal Recessive)","Not Yet Evaluated",,,54.68,0,1.19,08/22/2016
G,DGKE,17:54911512-54946928,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.28,0,0.71,08/22/2016
G,DDX41,5:176938578-176943962,"3 (Sufficient Evidence)","0 (No Evidence)",,,25.66,0,0.74,02/09/2022
G,DDX3X,X:41192561-41223725,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.73,1,0.12,11/22/2017
G,DDOST,1:20978270-20987862,"30 (Autosomal Recessive)","0 (No Evidence)",,,29.71,0,0.73,08/22/2016
G,DDHD1,14:53503473-53620041,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.86,0.9,0.34,09/25/2014
G,DDB2,11:47236525-47260768,"30 (Autosomal Recessive)","Not Yet Evaluated",,,26.33,0,0.85,08/22/2016
G,DCXR,17:79993734-79995573,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.61,0,1.49,08/22/2016
G,DCX,X:110537007-110655420,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.65,0.3,0.62,07/06/2012
G,DCLRE1C,10:14939358-14996431,"30 (Autosomal Recessive)","0 (No Evidence)",,,58.59,0,0.71,08/22/2016
G,DCHS1,11:6642561-6677040,"1 (Little Evidence)","0 (No Evidence)",,,44.76,1,0.24,08/31/2018
G,DBT,1:100652475-100715390,"30 (Autosomal Recessive)","Not Yet Evaluated",,,14.95,0,0.82,08/22/2016
G,DBH,9:136501485-136524451,"30 (Autosomal Recessive)","0 (No Evidence)",,,53.24,0,1.01,08/22/2016
G,DAZ1,Y:25275502-25345241,"0 (No Evidence)","0 (No Evidence)",,,76.54,‐,‐,10/17/2012
G,DARS2,1:173793811-173827684,"30 (Autosomal Recessive)","0 (No Evidence)",,,28.68,0,0.92,08/22/2016
G,D2HGDH,2:242674045-242708226,"30 (Autosomal Recessive)","Not Yet Evaluated",,,73.35,0.05,0.58,08/22/2016
G,CYP4V2,4:187112721-187134617,"30 (Autosomal Recessive)","Not Yet Evaluated",,,70.46,0,1.03,08/22/2016
G,CYP4F22,19:15619336-15663128,"30 (Autosomal Recessive)","Not Yet Evaluated",,,70.99,0,0.78,08/22/2016
G,CYP3A43,7:99425636-99463716,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,35.98,0,1.11,02/02/2021
G,CYP27A1,2:219646870-219680016,"30 (Autosomal Recessive)","Not Yet Evaluated",,,64.32,0,1.38,08/22/2016
G,CYP24A1,20:52769985-52790525,"30 (Autosomal Recessive)","Not Yet Evaluated",,,56.17,0,1.54,08/22/2016
G,CYP21A2,6:32006192-32009421,"30 (Autosomal Recessive)","0 (No Evidence)",,,65.79,0,0.82,07/06/2012
G,CYLD,16:50775997-50835846,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.21,1,0.2,02/10/2021
G,CYBB,X:37639312-37672714,"3 (Sufficient Evidence)","0 (No Evidence)",,,10.63,1,0.19,05/27/2020
G,CYB5A,18:71918081-71959198,"30 (Autosomal Recessive)","0 (No Evidence)",,,56.3,0,1.43,08/22/2016
G,CUL4B,X:119657713-119709387,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.31,1,0.09,02/09/2021
G,CUL3,2:225334867-225450080,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.57,1,0.23,01/24/2018
G,CUBN,10:16865965-17171810,"30 (Autosomal Recessive)","0 (No Evidence)",,,67.86,0,0.65,08/22/2016
G,CTSB,8:11700033-11725596,"0 (No Evidence)","0 (No Evidence)",,,36.44,0,1.33,02/08/2012
G,CTNS,17:3539753-3566397,"30 (Autosomal Recessive)","0 (No Evidence)",,,58.83,0,0.8,08/22/2012
G,CTNND2,5:10971948-11904558,"1 (Little Evidence)","0 (No Evidence)",,,5.83,1,0.1,10/12/2021
G,CTNNB1,3:41240996-41281934,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.18,1,0.13,11/22/2017
G,CTNNA3,10:67672281-69455953,"0 (No Evidence)","0 (No Evidence)",,,2.58,0,0.85,10/24/2018
G,CTNNA1,5:138089114-138270723,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.28,0.97,0.31,10/12/2022
G,CTH,1:70876951-70905534,"30 (Autosomal Recessive)","0 (No Evidence)",,,52.82,0,0.96,08/22/2016
G,CTDP1,18:77439803-77516625,"30 (Autosomal Recessive)","Not Yet Evaluated",,,76.13,0,0.53,08/22/2016
G,CTCF,16:67596429-67673088,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.59,1,0.15,09/22/2021
G,CTC1,17:8128133-8151374,"30 (Autosomal Recessive)","0 (No Evidence)",,,69.4,0,0.63,10/08/2019
G,CSTB,21:45193831-45196189,"30 (Autosomal Recessive)","0 (No Evidence)",,,86.14,0.01,1.85,08/22/2016
G,CSPP1,8:67976603-68108849,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.84,0,0.93,08/22/2016
G,CSNK2A1,20:453142-524434,"2 (Emerging Evidence)","0 (No Evidence)",,,2.89,0.99,0.3,09/27/2022
G,CSMD1,8:2792883-4852436,"1 (Little Evidence)","0 (No Evidence)",,,47.53,1,0.21,10/24/2018
G,CSF2RB,22:37309670-37336481,"30 (Autosomal Recessive)","Not Yet Evaluated",,,89.46,0.18,0.44,08/22/2016
G,CSF2RA,Y:1337707-1394111,"30 (Autosomal Recessive)","0 (No Evidence)",,,91.07,0,1.12,08/23/2021
G,CRYGC,2:208992861-208994552,"0 (No Evidence)","0 (No Evidence)",,,31.55,0,1.31,05/22/2013
G,CRYBB2,22:25615606-25627836,"1 (Little Evidence)","0 (No Evidence)",,,48.55,0.39,0.57,03/13/2013
G,CRYBA1,17:27573877-27581512,"0 (No Evidence)","0 (No Evidence)",,,8.17,0,1,06/06/2013
G,CRTAP,3:33155506-33189265,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.18,0,0.86,08/22/2016
G,CRPPA,7:16127150-16461163,"30 (Autosomal Recessive)","Not Yet Evaluated",,,58.01,0,0.82,08/22/2016
G,CRKL,22:21271695-21308035,"1 (Little Evidence)","0 (No Evidence)",,,4.35,0.45,0.64,04/13/2020
G,CRIPT,2:46844354-46857315,"30 (Autosomal Recessive)","0 (No Evidence)",,,13.94,0,1.58,08/22/2016
G,CRHR1,17:43861686-43913194,"0 (No Evidence)","0 (No Evidence)",,,4.8,0,0.71,07/06/2012
G,CREBBP,16:3775055-3930714,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.62,1,0.07,10/23/2019
G,CRADD,12:94071151-94288616,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.34,0.88,0.44,08/22/2016
G,CPT1A,11:68522088-68609384,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.76,0,0.66,08/22/2016
G,CPS1,2:211342409-211543831,"30 (Autosomal Recessive)","Not Yet Evaluated",,,5.16,0,0.52,08/22/2016
G,CPN1,10:101801950-101841626,"30 (Autosomal Recessive)","0 (No Evidence)",,,57.42,0,1.06,08/22/2016
G,CPLANE1,5:37106337-37249478,"30 (Autosomal Recessive)","0 (No Evidence)",,,76.94,0,0.67,08/22/2016
G,CPA6,8:68334273-68658595,"0 (No Evidence)","0 (No Evidence)",,,29.99,0,1.24,09/04/2019
G,CPA4,7:129933001-129964020,"0 (No Evidence)","0 (No Evidence)",,,54.59,0,1.4,07/25/2012
G,CP,3:148880201-148939616,"30 (Autosomal Recessive)","Not Yet Evaluated",,,46.99,0,0.65,08/22/2016
G,COX6B1,19:36139225-36149684,"30 (Autosomal Recessive)","0 (No Evidence)",,,28.4,0.12,1.17,08/22/2016
G,COX20,1:244998608-245008365,"30 (Autosomal Recessive)","Not Yet Evaluated",,,46.76,0.02,1.48,08/22/2016
G,COX15,10:101454050-101491884,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.87,0,1.33,08/22/2016
G,COX14,12:50506019-50514236,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.4,0.36,1.8,08/22/2016
G,COX10,17:13972821-14111994,"30 (Autosomal Recessive)","Not Yet Evaluated",,,60.22,0.08,0.61,08/22/2016
G,CORO1A,16:30194923-30200397,"30 (Autosomal Recessive)","0 (No Evidence)",,,26.02,0.97,0.32,08/22/2016
G,COQ2,4:84184977-84206287,"30 (Autosomal Recessive)","0 (No Evidence)",,,68.33,0,0.89,08/22/2016
G,COLQ,3:15491640-15563213,"30 (Autosomal Recessive)","0 (No Evidence)",,,5.64,0,1.1,08/22/2016
G,COLEC11,2:3642702-3692234,"30 (Autosomal Recessive)","0 (No Evidence)",,,55.58,0.02,0.82,08/22/2016
G,COL9A2,1:40766161-40782958,"0 (No Evidence)","0 (No Evidence)",,,42.16,0,0.64,10/09/2013
G,COL9A1,6:70924764-71012787,"0 (No Evidence)","0 (No Evidence)",,,23.89,0,0.81,11/06/2013
G,COL6A5,3:130064359-130203690,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,76.88,0,0.92,02/02/2021
G,COL5A1,9:137533649-137736689,"3 (Sufficient Evidence)","0 (No Evidence)",,,35.85,1,0.06,12/14/2017
G,COL4A5,X:107683068-107940775,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.97,1,0.19,09/08/2020
G,COL4A3,2:228029340-228179508,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.51,0,0.52,05/22/2013
G,COL3A1,2:189839099-189877472,"3 (Sufficient Evidence)","0 (No Evidence)",,,14.75,1,0.1,01/12/2017
G,COL2A1,12:48366750-48398259,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.04,1,0.13,07/29/2020
G,COL1A2,7:94024207-94060539,"0 (No Evidence)","0 (No Evidence)",,,4.09,1,0.2,10/12/2012
G,COL1A1,17:48261462-48278992,"3 (Sufficient Evidence)","0 (No Evidence)",,,7.09,1,0.11,08/23/2012
G,COL16A1,1:32117864-32169618,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,41.54,0,0.63,02/01/2021
G,COL11A1,1:103342029-103574078,"1 (Little Evidence)","0 (No Evidence)",,,8.57,1,0.22,10/19/2011
G,COG8,16:69360331-69373467,"30 (Autosomal Recessive)","0 (No Evidence)",,,32.72,0,1.13,03/25/2015
G,COG7,16:23399814-23464510,"30 (Autosomal Recessive)","0 (No Evidence)",,,68.01,0,0.66,04/09/2015
G,COG4,16:70514470-70557457,"30 (Autosomal Recessive)","Not Yet Evaluated",,,21.66,0,0.71,08/22/2016
G,COG1,17:71189194-71204646,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.93,0,0.65,08/22/2016
G,CNTNAP2,7:145813893-148118090,"1 (Little Evidence)","0 (No Evidence)",,,4.94,0,0.55,10/23/2019
G,CNTN6,3:1134708-1445901,"0 (No Evidence)","0 (No Evidence)",,,39.69,0,1.15,09/28/2022
G,CNTN4,3:2140550-3099643,"0 (No Evidence)","0 (No Evidence)",,,6.9,0,0.52,06/14/2022
G,CNTN2,1:205012077-205047417,"30 (Autosomal Recessive)","0 (No Evidence)",,,20.14,0,0.44,08/22/2016
G,CNTN1,12:41086241-41466217,"30 (Autosomal Recessive)","Not Yet Evaluated",,,22.29,0.15,0.37,08/22/2016
G,CNOT3,19:54641478-54659419,"0 (No Evidence)","0 (No Evidence)",,,49.76,1,0.08,06/27/2018
G,CNOT2,12:70636798-70748773,"1 (Little Evidence)","0 (No Evidence)",,,4.39,1,0.19,11/08/2022
G,CNNM4,2:97426639-97477611,"30 (Autosomal Recessive)","Not Yet Evaluated",,,64.14,0,0.94,08/22/2016
G,CNKSR2,X:21392536-21672807,"3 (Sufficient Evidence)","0 (No Evidence)",,,7.56,1,0.19,01/12/2021
G,CNGB1,16:57916244-58005032,"30 (Autosomal Recessive)","Not Yet Evaluated",,,68.86,0,1.15,08/22/2016
G,CLTC,17:57697256-57774317,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.77,1,0.1,09/27/2022
G,CLRN1,3:150643950-150690786,"30 (Autosomal Recessive)","0 (No Evidence)",,,42.65,0,1.81,08/22/2016
G,CLPP,19:6361542-6370253,"30 (Autosomal Recessive)","0 (No Evidence)",,,37.05,0.57,0.57,03/06/2018
G,CLNK,4:10488019-10686392,"0 (No Evidence)","0 (No Evidence)",,,84.67,0,1.77,06/02/2016
G,CLN8,8:1711955-1734736,"30 (Autosomal Recessive)","Not Yet Evaluated",,,76.78,0,1.17,08/22/2016
G,CLN3,16:28477974-28503403,"30 (Autosomal Recessive)","Not Yet Evaluated",,,55,0,0.91,08/22/2016
G,CLMP,11:122940580-123065956,"30 (Autosomal Recessive)","0 (No Evidence)",,,26.76,0,1,08/22/2016
G,CLDN14,21:37832919-37948867,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.29,0,1.75,08/22/2016
G,CLCNKB,1:16370277-16383821,"30 (Autosomal Recessive)","0 (No Evidence)",,,71.85,0,1.24,11/17/2011
G,CLCNKA,1:16348531-16360545,"30 (Autosomal Recessive)","0 (No Evidence)",,,75.9,0,1.12,05/17/2012
G,CLCN5,X:49687206-49863887,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.07,0.99,0.28,10/18/2012
G,CLCN4,X:10125015-10205700,"1 (Little Evidence)","0 (No Evidence)",,,28.47,1,0.15,07/27/2022
G,CLCF1,11:67131639-67141648,"30 (Autosomal Recessive)","Not Yet Evaluated",,,30.27,0.95,0.32,08/22/2016
G,CITED2,6:139692944-139695785,"2 (Emerging Evidence)","0 (No Evidence)",,,3.47,0.76,0.63,06/22/2022
G,CIDEC,3:9908394-9921937,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.02,0.01,0.94,08/22/2016
G,CIC,19:42772682-42799948,"3 (Sufficient Evidence)","0 (No Evidence)",,,37.93,1,0.18,11/08/2022
G,CHSY1,15:101715932-101792253,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.01,0.71,0.41,08/22/2016
G,CHST6,16:75505940-75529339,"30 (Autosomal Recessive)","0 (No Evidence)",,,57.77,0,1.82,08/22/2016
G,CHRNA7,15:32322686-32465219,"0 (No Evidence)","0 (No Evidence)",,,40.52,0,0.77,05/10/2018
G,CHRM3,1:239549868-240078750,"1 (Little Evidence)","0 (No Evidence)",,,33.36,0.99,0.25,03/11/2015
G,CHRDL1,X:109917084-110039045,"3 (Sufficient Evidence)","0 (No Evidence)",,,24.72,0.22,0.52,12/08/2016
G,CHMP7,8:23101150-23119512,"0 (No Evidence)","0 (No Evidence)",,,23,0.86,0.38,09/27/2022
G,CHMP1A,16:89710843-89724116,"30 (Autosomal Recessive)","0 (No Evidence)",,,33.54,0,1.18,08/22/2016
G,CHM,X:85116185-85302562,"3 (Sufficient Evidence)","0 (No Evidence)",,,25.28,1,0.19,03/24/2021
G,CHKB,22:51017392-51021278,"30 (Autosomal Recessive)","0 (No Evidence)",,,60.19,0,0.92,08/22/2016
G,CHEK2,22:29083731-29137822,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.9,0,1.53,01/08/2020
G,CHEK1,11:125495031-125546150,"0 (No Evidence)","0 (No Evidence)",,,3.14,0,0.93,11/10/2021
G,CHD8,14:21853358-21924282,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.24,1,0.08,04/25/2018
G,CHD7,8:61591299-61780587,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.4,1,0.08,07/06/2012
G,CHD5,1:6161847-6240381,"1 (Little Evidence)","Not Yet Evaluated",,,47.85,1,0.16,09/27/2022
G,CHD2,15:93443554-93571226,"3 (Sufficient Evidence)","0 (No Evidence)",,,20.62,1,0.07,10/23/2019
G,CHD1L,1:146644326-146767443,"0 (No Evidence)","0 (No Evidence)",,,45.36,0,1.3,08/30/2018
G,CHAT,10:50817141-50875988,"30 (Autosomal Recessive)","Not Yet Evaluated",,,10,0,0.88,08/22/2016
G,CHAMP1,13:115079978-115092797,"2 (Emerging Evidence)","0 (No Evidence)",,,52.86,0.99,0.27,03/25/2020
G,CFTR,7:117120079-117308719,"30 (Autosomal Recessive)","Not Yet Evaluated",,,2.33,0,1.31,08/22/2016
G,CFL2,14:35178319-35183799,"30 (Autosomal Recessive)","Not Yet Evaluated",,,4.83,0,1.53,08/22/2016
G,CFD,19:859664-863641,"30 (Autosomal Recessive)","0 (No Evidence)",,,76.28,0,1.68,08/22/2016
G,CFC1,2:131349738-131357148,"0 (No Evidence)","0 (No Evidence)",,,88.86,0.11,1.25,09/22/2021
G,CFAP53,18:47753563-47792865,"30 (Autosomal Recessive)","0 (No Evidence)",,,72.99,0,1.34,08/22/2016
G,CFAP418,8:96257141-96281429,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.96,0,1.42,08/22/2016
G,CERS3,15:100940600-101084888,"30 (Autosomal Recessive)","Not Yet Evaluated",,,62.26,0.01,0.63,08/22/2016
G,CEP78,9:80850991-80894606,"30 (Autosomal Recessive)","0 (No Evidence)",,,49.15,0,1.02,10/23/2017
G,CEP290,12:88442793-88535865,"30 (Autosomal Recessive)","0 (No Evidence)",,,13.34,0,0.99,08/22/2012
G,CEP164,11:117192494-117283982,"30 (Autosomal Recessive)","0 (No Evidence)",,,29.41,0,0.84,08/22/2016
G,CENPP,9:95087750-95382811,"0 (No Evidence)","0 (No Evidence)",,,76.86,0.05,0.68,09/19/2012
G,CENPJ,13:25456417-25496999,"30 (Autosomal Recessive)","Not Yet Evaluated",,,54.37,0,0.97,08/22/2016
G,CEBPE,14:23586515-23588464,"30 (Autosomal Recessive)","Not Yet Evaluated",,,30.23,0.01,1,08/22/2016
G,CEBPA,19:33790840-33793470,"0 (No Evidence)","0 (No Evidence)",,,47.24,0.55,1.18,06/09/2022
G,CDY1,Y:27768264-27771049,"0 (No Evidence)","0 (No Evidence)",,,93.18,‐,‐,08/22/2012
G,CDT1,16:88870197-88875666,"30 (Autosomal Recessive)","Not Yet Evaluated",,,45.26,0,1.22,08/22/2016
G,CDKN2A,9:21967751-21995323,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.81,0.39,0.95,03/18/2022
G,CDKN1C,11:2904448-2907005,"3 (Sufficient Evidence)","0 (No Evidence)",,,24.52,0.82,0.53,09/25/2020
G,CDKN1B,12:12870302-12875303,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.36,0.62,0.65,07/08/2020
G,CDKL5,X:18443728-18671749,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.18,1,0.23,07/12/2012
G,CDK6,7:92234235-92465887,"30 (Autosomal Recessive)","Not Yet Evaluated",,,1.6,0.98,0.28,08/22/2016
G,CDK5RAP2,9:123151153-123342445,"30 (Autosomal Recessive)","Not Yet Evaluated",,,55.08,0,0.66,08/22/2016
G,CDK4,12:58141510-58146093,"0 (No Evidence)","0 (No Evidence)",,,1.03,0.06,0.64,09/02/2020
G,CDK13,7:39989855-40139179,"2 (Emerging Evidence)","Not Yet Evaluated",,,11.16,0.91,0.32,02/23/2022
G,CDIN1,15:36871827-37102445,"30 (Autosomal Recessive)","Not Yet Evaluated",,,2.88,0,1.06,08/22/2016
G,CDHR1,10:85954293-85979377,"30 (Autosomal Recessive)","Not Yet Evaluated",,,54.74,0,1.31,08/22/2016
G,CDH23,10:73156677-73575704,"30 (Autosomal Recessive)","Not Yet Evaluated",,,15.83,0,0.57,08/22/2016
G,CDH15,16:89238156-89261900,"0 (No Evidence)","0 (No Evidence)",,,74.65,0,1.11,08/08/2013
G,CDH1,16:68771195-68869440,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.51,0.15,0.43,04/10/2020
G,CDC73,1:193091161-193223945,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.74,1,0.19,04/13/2022
G,CDC42BPB,14:103398717-103523886,"1 (Little Evidence)","0 (No Evidence)",,,65.08,1,0.12,10/24/2018
G,CDAN1,15:43015742-43029326,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.71,0,0.68,08/22/2016
G,CD8A,2:87011728-87035519,"30 (Autosomal Recessive)","0 (No Evidence)",,,84.5,0,1.5,08/22/2016
G,CD59,11:33724556-33758025,"30 (Autosomal Recessive)","Not Yet Evaluated",,,97.5,0.61,1,08/22/2016
G,CD40LG,X:135730317-135742549,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.39,0.72,0.56,04/08/2020
G,CD3G,11:118215059-118225876,"30 (Autosomal Recessive)","Not Yet Evaluated",,,82.39,0,1.22,08/22/2016
G,CD3E,11:118175445-118186888,"30 (Autosomal Recessive)","0 (No Evidence)",,,86.63,0,0.92,05/09/2017
G,CD3D,11:118209669-118213420,"30 (Autosomal Recessive)","Not Yet Evaluated",,,84.89,0,1.46,08/22/2016
G,CD36,7:80231523-80308593,"30 (Autosomal Recessive)","Not Yet Evaluated",,,15.69,0,2,08/22/2016
G,CD27,12:6554121-6560879,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.27,0.01,0.92,08/22/2016
G,CD19,16:28943292-28950663,"30 (Autosomal Recessive)","Not Yet Evaluated",,,36.07,0.9,0.36,08/22/2016
G,CCT5,5:10250033-10266524,"30 (Autosomal Recessive)","0 (No Evidence)",,,23.05,1,0.19,08/22/2016
G,CCNQ,X:152853383-152864595,"2 (Emerging Evidence)","0 (No Evidence)",,,61.79,0.9,0.4,12/01/2021
G,CCN6,6:112375307-112390889,"30 (Autosomal Recessive)","Not Yet Evaluated",,,48.76,0,0.84,08/22/2016
G,CCDC8,19:46913586-46916821,"30 (Autosomal Recessive)","0 (No Evidence)",,,90.02,0.25,0.83,08/22/2016
G,CCDC40,17:78010441-78074412,"30 (Autosomal Recessive)","Not Yet Evaluated",,,95.52,0,0.85,08/22/2016
G,CCDC39,3:180331796-180397277,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.04,0,0.75,08/22/2016
G,CCDC103,17:42977097-42982758,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.25,0,1.36,08/22/2016
G,CCBE1,18:57098171-57364655,"30 (Autosomal Recessive)","Not Yet Evaluated",,,44.75,0,1.01,08/22/2016
G,CC2D2A,4:15471489-15603180,"30 (Autosomal Recessive)","0 (No Evidence)",,,79.39,0,0.78,07/17/2013
G,CBY2,13:46276455-46288694,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,62.14,0,1.09,02/03/2021
G,CBS,21:44473301-44496983,"30 (Autosomal Recessive)","0 (No Evidence)",,,40.28,0,0.73,08/22/2016
G,CBL,11:119077049-119178859,"0 (No Evidence)","0 (No Evidence)",,,3.6,0,0.5,04/24/2019
G,CBFB,16:67063052-67134961,"0 (No Evidence)","0 (No Evidence)",,,9.25,0.96,0.33,02/22/2012
G,CATSPER2,15:43920701-43941082,"30 (Autosomal Recessive)","0 (No Evidence)",,,73.76,0,1.22,09/20/2012
G,CASZ1,1:10696661-10856703,"1 (Little Evidence)","0 (No Evidence)",,,12.36,1,0.15,04/25/2019
G,CASR,3:121902515-122010476,"0 (No Evidence)","0 (No Evidence)",,,3.37,0.05,0.45,03/02/2012
G,CASQ2,1:116242642-116311335,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.61,0,1.38,08/22/2016
G,CASP10,2:202047864-202094129,"1 (Little Evidence)","0 (No Evidence)",,,89.09,0,1.29,04/10/2020
G,CASK,X:41374187-41782807,"3 (Sufficient Evidence)","0 (No Evidence)",,,3.08,1,0.07,06/28/2012
G,CARD14,17:78143829-78183130,"0 (No Evidence)","0 (No Evidence)",,,75.93,0,1,08/01/2013
G,CAPN3,15:42651699-42704515,"30 (Autosomal Recessive)","0 (No Evidence)",,,21.69,0,0.97,08/22/2016
G,CANT1,17:76987798-77005846,"30 (Autosomal Recessive)","Not Yet Evaluated",,,65.38,0,1.31,08/22/2016
G,CAMTA1,1:6845514-7829766,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.22,1,0.17,12/14/2017
G,CAMK2B,7:44256753-44365193,"2 (Emerging Evidence)","0 (No Evidence)",,,16.28,0.74,0.36,06/28/2018
G,CAMK2A,5:149599054-149669693,"1 (Little Evidence)","0 (No Evidence)",,,5.97,1,0.25,09/04/2019
G,CADPS2,7:121958465-122526514,"0 (No Evidence)","0 (No Evidence)",,,4.53,0.37,0.34,07/10/2012
G,CACNA1S,1:201008640-201081554,"0 (No Evidence)","0 (No Evidence)",,,25.88,0,0.52,01/18/2016
G,CACNA1C,12:2162153-2807116,"1 (Little Evidence)","0 (No Evidence)",,,8.42,1,0.1,03/24/2016
G,CACNA1A,19:13317256-13617293,"3 (Sufficient Evidence)","0 (No Evidence)",,,35.52,1,0.13,05/21/2017
G,CABP4,11:67219874-67229223,"30 (Autosomal Recessive)","0 (No Evidence)",,,71.95,0,1.54,08/22/2016
G,CABP2,11:67286383-67290917,"30 (Autosomal Recessive)","0 (No Evidence)",,,58.19,0,0.97,08/20/2021
G,CA8,8:61097971-61193959,"30 (Autosomal Recessive)","0 (No Evidence)",,,10.02,0.01,0.67,08/22/2016
G,CA5A,16:87915155-87970135,"30 (Autosomal Recessive)","0 (No Evidence)",,,88.4,0,0.97,08/22/2016
G,CA12,15:63613577-63674045,"30 (Autosomal Recessive)","Not Yet Evaluated",,,56.48,0,1.33,08/22/2016
G,C1QB,1:22979729-22988130,"30 (Autosomal Recessive)","0 (No Evidence)",,,69.46,0.15,1.04,01/17/2017
G,C19orf12,19:30189793-30206696,"30 (Autosomal Recessive)","0 (No Evidence)",,,77.08,0.34,1.06,08/22/2016
G,BUB1B,15:40453270-40513324,"30 (Autosomal Recessive)","0 (No Evidence)",,,14.21,0,0.58,02/02/2022
G,BTK,X:100604438-100645784,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.3,1,0.1,03/24/2021
G,BTD,3:15642859-15764023,"30 (Autosomal Recessive)","0 (No Evidence)",,,76.15,0,1.3,05/21/2015
G,BSND,1:55464606-55482845,"30 (Autosomal Recessive)","0 (No Evidence)",,,78.77,0,1.78,05/17/2012
G,BRWD3,X:79925002-80065376,"3 (Sufficient Evidence)","0 (No Evidence)",,,28.63,1,0.08,08/24/2022
G,BRIP1,17:59756500-59940889,"3 (Sufficient Evidence)","0 (No Evidence)",,,17.47,0,0.79,02/15/2019
G,BRCA2,13:32889645-32974405,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.3,0,0.64,07/14/2021
G,BRCA1,17:41196312-41277381,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.2,0,0.92,09/23/2021
G,BRAT1,7:2577444-2595158,"30 (Autosomal Recessive)","0 (No Evidence)",,,81.22,0,1,08/22/2016
G,BRAF,7:140413128-140624729,"1 (Little Evidence)","0 (No Evidence)",,,8.98,1,0.21,08/04/2014
G,BPY2,Y:25130410-25151612,"0 (No Evidence)","0 (No Evidence)",,,94.47,‐,‐,08/22/2012
G,BPTF,17:65821619-65980494,"3 (Sufficient Evidence)","0 (No Evidence)",,,36.79,1,0.1,07/12/2022
G,BPNT2,8:57870490-57906426,"30 (Autosomal Recessive)","Not Yet Evaluated",,,43.21,0.02,0.84,08/22/2016
G,BPHL,6:3118610-3153812,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,69.92,0,1.35,02/02/2021
G,BMPR2,2:203241050-203432472,"3 (Sufficient Evidence)","0 (No Evidence)",,,1.48,1,0.19,08/26/2020
G,BMPR1A,10:88516376-88687726,"3 (Sufficient Evidence)","0 (No Evidence)",,,30.17,0.9,0.36,06/24/2020
G,BMPER,7:33944527-34196039,"30 (Autosomal Recessive)","Not Yet Evaluated",,,15,0,0.66,08/22/2016
G,BMP4,14:54416454-54423609,"2 (Emerging Evidence)","0 (No Evidence)",,,0.22,0.96,0.33,11/09/2021
G,BLNK,10:97948927-98031326,"30 (Autosomal Recessive)","0 (No Evidence)",,,35.7,0.61,0.39,08/22/2016
G,BLM,15:91260577-91359396,"30 (Autosomal Recessive)","0 (No Evidence)",,,37.81,0,0.75,02/09/2022
G,BIN1,2:127805599-127864730,"30 (Autosomal Recessive)","Not Yet Evaluated",,,41.75,0.78,0.37,08/22/2016
G,BCS1L,2:219524406-219528166,"30 (Autosomal Recessive)","0 (No Evidence)",,,13.17,0,1.24,08/22/2016
G,BCR,22:23522696-23660224,"0 (No Evidence)","0 (No Evidence)",,,5.65,0.99,0.3,07/10/2012
G,BCOR,X:39910499-40036582,"3 (Sufficient Evidence)","0 (No Evidence)",,,16.71,1,0.14,10/04/2012
G,BCLAF1,6:136577765-136610984,"1 (Little Evidence)","0 (No Evidence)",,,4.44,0,0.93,06/28/2018
G,BCL2L11,2:111878491-111926022,"0 (No Evidence)","0 (No Evidence)",,,38.11,0.89,0.42,06/21/2018
G,BCL11A,2:60677655-60780789,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.61,0.97,0.32,04/13/2017
G,BCKDK,16:31119707-31124159,"30 (Autosomal Recessive)","Not Yet Evaluated",,,35.16,0,0.87,08/22/2016
G,BCKDHB,6:80816327-81055987,"30 (Autosomal Recessive)","Not Yet Evaluated",,,21.83,0,1.1,08/22/2016
G,BCHE,3:165490692-165555211,"30 (Autosomal Recessive)","Not Yet Evaluated",,,14.36,0,1.33,08/22/2016
G,BBS7,4:122745484-122791629,"30 (Autosomal Recessive)","Not Yet Evaluated",,,20.8,0,0.74,08/22/2016
G,BBS5,2:170336004-170363165,"30 (Autosomal Recessive)","0 (No Evidence)",,,9.97,0,0.89,10/12/2015
G,BBS12,4:123653859-123666094,"30 (Autosomal Recessive)","0 (No Evidence)",,,80.48,0,0.96,08/22/2016
G,BARD1,2:215590370-215674407,"3 (Sufficient Evidence)","0 (No Evidence)",,,33.35,0,1.36,05/01/2020
G,BAP1,3:52435024-52444024,"3 (Sufficient Evidence)","0 (No Evidence)",,,18.49,0.99,0.28,12/27/2019
G,BAG3,10:121410892-121437331,"3 (Sufficient Evidence)","0 (No Evidence)",,,55.47,0.62,0.45,02/12/2015
G,B9D1,17:19238008-19281226,"30 (Autosomal Recessive)","0 (No Evidence)",,,54.99,0,0.95,08/22/2016
G,B4GALT7,5:177027133-177037331,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.46,0,1.11,08/22/2016
G,B4GALT1,9:33104075-33167334,"30 (Autosomal Recessive)","0 (No Evidence)",,,58.79,0.04,0.7,08/22/2016
G,B3GALT6,1:1167617-1170421,"30 (Autosomal Recessive)","0 (No Evidence)",,,73.2,0.02,1.43,08/22/2016
G,B3GALNT2,1:235610505-235667752,"30 (Autosomal Recessive)","Not Yet Evaluated",,,60.43,0,0.84,08/22/2016
G,AXIN2,17:63524681-63557766,"3 (Sufficient Evidence)","0 (No Evidence)",,,4.92,0.57,0.4,12/08/2021
G,AVPR2,X:153168079-153172620,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.7,0.56,0.72,02/01/2021
G,AUTS2,7:69063461-70258492,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.51,1,0.25,06/24/2020
G,ATRX,X:76760358-77041702,"3 (Sufficient Evidence)","0 (No Evidence)",,,6.65,1,0.12,07/31/2012
G,ATR,3:142168077-142297575,"1 (Little Evidence)","0 (No Evidence)",,,8.61,0,0.4,06/05/2020
G,ATPAF2,17:17921335-17942482,"30 (Autosomal Recessive)","0 (No Evidence)",,,45.43,0,1.44,08/22/2016
G,ATP8A2,13:25946112-26599989,"1 (Little Evidence)","0 (No Evidence)",,,24.95,0,0.6,10/10/2014
G,ATP7B,13:52506805-52585586,"30 (Autosomal Recessive)","0 (No Evidence)",,,64.5,0,1.19,01/12/2017
G,ATP7A,X:77166190-77305892,"3 (Sufficient Evidence)","0 (No Evidence)",,,30.07,1,0.22,03/24/2021
G,ATP6V1E1,22:18074902-18111588,"0 (No Evidence)","0 (No Evidence)",,,39.36,0.53,0.51,04/26/2012
G,ATP6V0A4,7:138391039-138482941,"30 (Autosomal Recessive)","Not Yet Evaluated",,,54.41,0,1,08/22/2016
G,ATP6V0A2,12:124196900-124246302,"30 (Autosomal Recessive)","0 (No Evidence)",,,46.77,0,0.75,08/22/2016
G,ATP6AP2,X:40440222-40466100,"0 (No Evidence)","0 (No Evidence)",,,35.15,0.87,0.43,10/31/2012
G,ATP2C2,16:84402144-84497793,"0 (No Evidence)","0 (No Evidence)",,,70.21,0,1.84,09/17/2018
G,ATP2A1,16:28889809-28915787,"30 (Autosomal Recessive)","0 (No Evidence)",,,24.7,0,0.83,08/22/2016
G,ATP13A2,1:17312453-17338423,"30 (Autosomal Recessive)","Not Yet Evaluated",,,35.38,0,0.58,08/22/2016
G,ATP10A,15:25923859-26108349,"0 (No Evidence)","0 (No Evidence)",,,68.57,0,0.43,04/25/2012
G,ATM,11:108093794-108239829,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.97,0,0.71,04/08/2020
G,ATF6,1:161736110-161933860,"30 (Autosomal Recessive)","0 (No Evidence)",,,26.14,0,0.7,01/12/2017
G,ATCAY,19:3880683-3928080,"30 (Autosomal Recessive)","Not Yet Evaluated",,,64.83,0.62,0.45,08/22/2016
G,ASXL3,18:31158183-31331159,"3 (Sufficient Evidence)","0 (No Evidence)",,,13.78,1,0.2,11/22/2017
G,ASXL2,2:25956622-26101356,"0 (No Evidence)","0 (No Evidence)",,,43.83,1,0.15,06/28/2018
G,ASXL1,20:30946134-31027122,"3 (Sufficient Evidence)","0 (No Evidence)",,,20.78,0,0.79,03/14/2013
G,ASTN2,9:119185391-120177335,"1 (Little Evidence)","0 (No Evidence)",,,2.19,1,0.25,03/09/2021
G,ASPM,1:197053257-197115799,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.31,0,0.74,08/22/2016
G,ASPH,8:62413115-62627151,"30 (Autosomal Recessive)","Not Yet Evaluated",,,46.75,0,0.82,08/22/2016
G,ASPA,17:3377404-3406699,"30 (Autosomal Recessive)","0 (No Evidence)",,,37.65,0,1.1,08/22/2016
G,ASL,7:65540806-65558563,"30 (Autosomal Recessive)","Not Yet Evaluated",,,18.56,0,0.94,08/22/2016
G,ASH1L,1:155305059-155532594,"3 (Sufficient Evidence)","0 (No Evidence)",,,23.94,1,0.06,12/27/2017
G,ASAH1,8:17913501-17942470,"30 (Autosomal Recessive)","0 (No Evidence)",,,65.81,0,1.18,09/12/2017
G,ARX,X:25021811-25034082,"3 (Sufficient Evidence)","0 (No Evidence)",,,20.25,0.91,0.39,12/05/2019
G,ARSL,X:2852562-2886286,"3 (Sufficient Evidence)","0 (No Evidence)",,,89.33,0.59,0.49,07/12/2012
G,ARSD,X:2822013-2847380,"0 (No Evidence)","0 (No Evidence)",,,92.29,0,0.86,07/21/2016
G,ARSA,22:51061182-51066580,"30 (Autosomal Recessive)","0 (No Evidence)",,,63.58,0,1.34,09/05/2012
G,ARL6IP1,16:18802989-18812871,"30 (Autosomal Recessive)","Not Yet Evaluated",,,17.4,0.02,0.78,08/22/2016
G,ARL6,3:97483365-97520086,"30 (Autosomal Recessive)","0 (No Evidence)",,,10.16,0.01,0.92,08/22/2016
G,ARID2,12:46123489-46301820,"3 (Sufficient Evidence)","0 (No Evidence)",,,11.02,1,0.1,06/26/2019
G,ARID1B,6:157097160-157531913,"3 (Sufficient Evidence)","0 (No Evidence)",,,14.17,1,0.1,05/26/2021
G,ARID1A,1:27022506-27108595,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.63,1,0.07,05/27/2020
G,ARHGEF9,X:62854847-63005094,"3 (Sufficient Evidence)","0 (No Evidence)",,,10.55,1,0.15,11/25/2021
G,ARHGEF6,X:135747709-135863091,"0 (No Evidence)","0 (No Evidence)",,,14.42,1,0.14,04/25/2012
G,ARHGEF4,2:131594487-131804826,"0 (No Evidence)","0 (No Evidence)",,,65.32,0,0.55,04/05/2018
G,ARHGAP31,3:119013230-119139561,"0 (No Evidence)","0 (No Evidence)",,,37.14,1,0.19,07/18/2013
G,ARG1,6:131894366-131905469,"30 (Autosomal Recessive)","0 (No Evidence)",,,33.51,0,0.92,08/22/2016
G,ARFGEF2,20:47538248-47653230,"30 (Autosomal Recessive)","0 (No Evidence)",,,27.35,1,0.25,08/22/2016
G,ARCN1,11:118443124-118473748,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.21,1,0.1,05/10/2022
G,AR,X:66763863-66950461,"3 (Sufficient Evidence)","0 (No Evidence)",,,0.35,0.99,0.29,12/08/2020
G,APP,21:27252861-27543446,"0 (No Evidence)","2 (Emerging Evidence)",,,0.94,0.05,0.42,07/06/2012
G,APOC2,19:45449308-45452822,"30 (Autosomal Recessive)","Not Yet Evaluated",,,88.9,0.4,0.94,08/22/2016
G,APOB,2:21224301-21266945,"3 (Sufficient Evidence)","0 (No Evidence)",,,12.78,0,0.46,04/09/2020
G,APC,5:112043195-112181936,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.19,1,0.16,07/19/2021
G,AP4S1,14:31494312-31565656,"30 (Autosomal Recessive)","0 (No Evidence)",,,19.1,0,1.63,08/22/2016
G,AP4B1,1:114436816-114447650,"30 (Autosomal Recessive)","0 (No Evidence)",,,41.21,0,0.83,08/22/2016
G,AP1S2,X:15843929-15872936,"3 (Sufficient Evidence)","0 (No Evidence)",,,10.13,0.87,0.45,04/28/2021
G,ANTXR2,4:80822300-80994626,"30 (Autosomal Recessive)","0 (No Evidence)",,,4.33,0.09,0.5,08/22/2016
G,ANOS1,X:8496915-8700178,"3 (Sufficient Evidence)","0 (No Evidence)",,,60.51,1,0.25,05/26/2021
G,ANKS6,9:101494291-101558837,"30 (Autosomal Recessive)","Not Yet Evaluated",,,50.29,0,0.69,08/22/2016
G,ANKRD26,10:27293045-27389423,"0 (No Evidence)","0 (No Evidence)",,,88.32,0,0.73,04/14/2021
G,ANKRD11,16:89334038-89556969,"3 (Sufficient Evidence)","0 (No Evidence)",,,75.55,1,0.11,06/14/2022
G,ANKH,5:14704909-14871887,"0 (No Evidence)","0 (No Evidence)",,,40.3,0.28,0.5,02/23/2022
G,ANK2,4:113626778-114304892,"3 (Sufficient Evidence)","0 (No Evidence)",,,24.11,1,0.11,05/22/2019
G,ANGPTL3,1:63063191-63071984,"30 (Autosomal Recessive)","Not Yet Evaluated",,,48.8,0,1.3,08/22/2016
G,AMN,14:103389000-103397179,"30 (Autosomal Recessive)","0 (No Evidence)",,,83.83,0,0.82,08/22/2016
G,AMH,19:2249322-2252072,"30 (Autosomal Recessive)","Not Yet Evaluated",,,59.26,0,1.77,08/22/2016
G,ALX4,11:44281990-44331689,"3 (Sufficient Evidence)","0 (No Evidence)",,,8.75,0.36,0.52,07/22/2020
G,ALS2,2:202564990-202645656,"30 (Autosomal Recessive)","0 (No Evidence)",,,15.08,0,0.52,08/22/2016
G,ALMS1,2:73612886-73837046,"30 (Autosomal Recessive)","0 (No Evidence)",,,78.65,0,0.87,08/22/2016
G,ALK,2:29415640-30144452,"0 (No Evidence)","0 (No Evidence)",,,4.47,0,0.45,12/20/2019
G,ALG6,1:63833298-63904224,"30 (Autosomal Recessive)","Not Yet Evaluated",,,35.38,0,0.64,08/22/2016
G,ALG2,9:101978707-101984224,"30 (Autosomal Recessive)","Not Yet Evaluated",,,54.65,0,1.18,08/22/2016
G,ALG12,22:50293877-50312086,"30 (Autosomal Recessive)","0 (No Evidence)",,,85.41,0,1.03,08/22/2016
G,ALG1,16:5121844-5137380,"30 (Autosomal Recessive)","Not Yet Evaluated",,,67.9,0,1.5,08/22/2016
G,ALDOA,16:30075600-30081741,"30 (Autosomal Recessive)","Not Yet Evaluated",,,11.28,0,0.76,08/22/2016
G,ALDH5A1,6:24495197-24537435,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.91,0,0.94,08/22/2016
G,ALDH4A1,1:19197924-19229049,"30 (Autosomal Recessive)","0 (No Evidence)",,,47.22,0,0.71,04/09/2015
G,ALDH3A2,17:19551449-19580909,"30 (Autosomal Recessive)","Not Yet Evaluated",,,53.41,0,0.83,08/22/2016
G,ALDH1A3,15:101420036-101456831,"30 (Autosomal Recessive)","0 (No Evidence)",,,34.78,0.14,0.51,08/22/2016
G,ALAD,9:116148592-116163564,"30 (Autosomal Recessive)","Not Yet Evaluated",,,32.28,0,0.87,08/22/2016
G,AKT3,1:243651535-244014381,"1 (Little Evidence)","0 (No Evidence)",,,2.71,1,0.18,04/15/2016
G,AKT2,19:40736224-40791252,"0 (No Evidence)","0 (No Evidence)",,,4.88,0.64,0.42,05/07/2015
G,AKT1,14:105235686-105262085,"0 (No Evidence)","0 (No Evidence)",,,0.05,0.98,0.32,01/25/2022
G,AIMP1,4:107236701-107270613,"30 (Autosomal Recessive)","0 (No Evidence)",,,22.3,0,1.22,08/22/2016
G,AICDA,12:8754766-8765455,"30 (Autosomal Recessive)","Not Yet Evaluated",,,24.45,0,1.33,08/22/2016
G,AHI1,6:135604670-135818878,"30 (Autosomal Recessive)","0 (No Evidence)",,,32.57,0,0.95,09/06/2012
G,AHDC1,1:27860756-27930655,"3 (Sufficient Evidence)","0 (No Evidence)",,,18.42,1,0.08,02/28/2018
G,AHCY,20:32868074-32899608,"30 (Autosomal Recessive)","0 (No Evidence)",,,18.88,0.04,0.62,06/08/2016
G,AGXT,2:241808241-241819917,"30 (Autosomal Recessive)","Not Yet Evaluated",,,70.08,0,1.03,08/22/2016
G,AGTR2,X:115301997-115306227,"0 (No Evidence)","0 (No Evidence)",,,25.02,0.01,1.31,05/10/2012
G,AGT,1:230838269-230881329,"30 (Autosomal Recessive)","0 (No Evidence)",,,59.54,0,1.45,11/13/2014
G,AGRN,1:955500-991496,"30 (Autosomal Recessive)","0 (No Evidence)",,,71.13,0,0.44,08/22/2016
G,AGPAT2,9:139567595-139581909,"30 (Autosomal Recessive)","0 (No Evidence)",,,74.8,0,1.54,08/22/2016
G,AGK,7:141251210-141355044,"30 (Autosomal Recessive)","0 (No Evidence)",,,51.17,0,0.88,11/20/2014
G,AGA,4:178351928-178363591,"30 (Autosomal Recessive)","Not Yet Evaluated",,,51.89,0,1.04,08/22/2016
G,AFF2,X:147582137-148082193,"3 (Sufficient Evidence)","0 (No Evidence)",,,2.76,1,0.28,12/08/2020
G,ADSL,22:40742504-40783531,"30 (Autosomal Recessive)","0 (No Evidence)",,,4.7,0,1.07,11/06/2015
G,ADNP,20:49505455-49547974,"3 (Sufficient Evidence)","0 (No Evidence)",,,9.79,1,0.12,11/22/2017
G,ADGRV1,5:89854614-90460254,"30 (Autosomal Recessive)","0 (No Evidence)",,,25.58,0,0.52,08/23/2021
G,ADGRG1,16:57653650-57699479,"30 (Autosomal Recessive)","0 (No Evidence)",,,82.05,0,0.89,05/17/2012
G,ADAMTSL2,9:136397286-136440641,"30 (Autosomal Recessive)","0 (No Evidence)",,,62.46,0,0.74,08/22/2016
G,ADAMTS2,5:178537854-178772462,"30 (Autosomal Recessive)","0 (No Evidence)",,,25.76,0.97,0.31,08/22/2016
G,ADAMTS18,16:77316025-77468931,"30 (Autosomal Recessive)","0 (No Evidence)",,,48.75,0,0.93,08/22/2016
G,ADAMTS17,15:100511642-100882180,"30 (Autosomal Recessive)","0 (No Evidence)",,,44.61,0,0.73,08/22/2016
G,ADAMTS13,9:136279457-136324508,"30 (Autosomal Recessive)","Not Yet Evaluated",,,81.4,0,0.68,08/22/2016
G,ADAM9,8:38854492-38962780,"30 (Autosomal Recessive)","0 (No Evidence)",,,58.29,0.03,0.42,12/11/2014
G,ADA2,22:17659680-17702738,"30 (Autosomal Recessive)","Not Yet Evaluated",,,85.15,0,1.07,08/22/2016
G,ACVRL1,12:52301288-52317145,"3 (Sufficient Evidence)","0 (No Evidence)",,,49.42,0,0.69,11/10/2016
G,ACTL6B,7:100240720-100254071,"30 (Autosomal Recessive)","Not Yet Evaluated",,,15.91,0,0.65,11/23/2022
G,ACTC1,15:35082431-35087750,"1 (Little Evidence)","0 (No Evidence)",,,9.59,0.74,0.48,11/17/2015
G,ACTB,7:5566779-5570232,"0 (No Evidence)","0 (No Evidence)",,,1.03,0.99,0.23,02/08/2022
G,ACTA2,10:90694831-90751154,"1 (Little Evidence)","0 (No Evidence)",,,2.61,0.93,0.36,09/28/2022
G,ACSL4,X:108884564-108976486,"1 (Little Evidence)","0 (No Evidence)",,,15.6,0.98,0.31,04/28/2021
G,ACSF3,16:89160260-89222641,"30 (Autosomal Recessive)","0 (No Evidence)",,,79.2,0,1.77,08/22/2016
G,ACP5,19:11685475-11689790,"30 (Autosomal Recessive)","0 (No Evidence)",,,66.32,0.08,0.72,08/22/2016
G,ACOX1,17:73937588-73975247,"30 (Autosomal Recessive)","0 (No Evidence)",,,38.86,0.06,0.46,11/20/2014
G,ACD,16:67691415-67694163,"1 (Little Evidence)","0 (No Evidence)",,,81.12,0,1.19,10/09/2019
G,ACADVL,17:7120444-7128585,"30 (Autosomal Recessive)","0 (No Evidence)",,,33.28,0,1.05,08/22/2016
G,ACADSB,10:124768522-124817806,"30 (Autosomal Recessive)","Not Yet Evaluated",,,65.42,0,1.17,08/22/2016
G,ACADM,1:76190394-76229364,"30 (Autosomal Recessive)","0 (No Evidence)",,,29.48,0,1.15,08/22/2016
G,ACAD8,11:134123462-134135749,"30 (Autosomal Recessive)","0 (No Evidence)",,,52.61,0,1.27,12/11/2014
G,ABRAXAS1,4:84380670-84406253,"0 (No Evidence)","0 (No Evidence)",,,64,0,1.01,04/14/2021
G,ABR,17:906759-1133016,"0 (No Evidence)","0 (No Evidence)",,,10.64,0.63,0.36,09/05/2012
G,ABHD12,20:25275379-25371471,"30 (Autosomal Recessive)","0 (No Evidence)",,,52.8,0,0.76,12/11/2014
G,ABCG8,2:44066110-44110127,"30 (Autosomal Recessive)","0 (No Evidence)",,,39.74,0,1.37,08/22/2016
G,ABCG5,2:44039611-44065978,"30 (Autosomal Recessive)","Not Yet Evaluated",,,36.56,0,1.39,08/22/2016
G,ABCD1,X:152990311-153010209,"3 (Sufficient Evidence)","0 (No Evidence)",,,59.98,1,0.15,12/02/2020
G,ABCC8,11:17414045-17498392,"30 (Autosomal Recessive)","0 (No Evidence)",,,1.79,0,0.77,02/24/2012
G,ABCB11,2:169777291-169887834,"30 (Autosomal Recessive)","0 (No Evidence)",,,30.88,0,0.64,07/08/2020
G,ABAT,16:8768474-8878427,"30 (Autosomal Recessive)","Not Yet Evaluated",,,41.04,0.01,0.57,08/22/2016
G,AASS,7:121713603-121784303,"30 (Autosomal Recessive)","Not Yet Evaluated",,,45.6,0,0.81,08/22/2016
G,AARS2,6:44266468-44281084,"30 (Autosomal Recessive)","Not Yet Evaluated",,,53.33,0,0.84,08/22/2016
G,AARS1,16:70286201-70323409,"0 (No Evidence)","0 (No Evidence)",,,24.74,0,0.62,01/11/2018
G,AAGAB,15:67493005-67547536,"3 (Sufficient Evidence)","0 (No Evidence)",,,50.94,0,1.04,02/28/2013
G,A4GALT,22:43088127-43117307,"30 (Autosomal Recessive)","0 (No Evidence)",,,73.08,0,1.65,12/11/2014
R,"9q34.3 population region (gnomAD-SV_v2.1_DEL_9_106704)",9:138936849-138944500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"9q32 population region (DGV_Gold_Standard_June_2021_gssvG40321)",9:117078800-117098147,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"9q31.2 population region (gnomAD-SV_v2.1_DEL_9_104809)",9:110537534-110540595,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"9q31.1 population region (DGV_Gold_Standard_June_2021_gssvL132495)",9:107362715-107368622,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"9q21.11 population region (gnomAD-SV_v2.1_DUP_9_27462)",9:70631499-70655275,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/17/2021
R,"9q21.11 population region (gnomAD-SV_v2.1_DUP_9_27460)",9:70557057-70693525,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/10/2021
R,"9q21.11 population region (gnomAD-SV_v2.1_DEL_9_102461)",9:69418924-69435100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"9q21.11 population region (gnomAD-SV_v2.1_DEL_9_102460)",9:69398749-69405200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"9q21.11 population region (gnomAD-SV_v2.1_DEL_9_102459)",9:69375499-69388225,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"9q13 population region (gnomAD-SV_v2.1_DEL_9_102391)",9:67954499-67986500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"9q12 population region (gnomAD-SV_v2.1_DEL_9_102303)",9:65496999-65509000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p24.3 population region (gnomAD-SV_v2.1_DUP_9_26178)",9:111999-126000,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/11/2021
R,"9p13.1 population region (gnomAD-SV_v2.1_DEL_9_101840)",9:40024899-40031800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p12 population region (gnomAD-SV_v2.1_DEL_9_101967)",9:42363999-42374800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p12 population region (gnomAD-SV_v2.1_DEL_9_101925)",9:41499999-41507000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p12 population region (gnomAD-SV_v2.1_DEL_9_101915)",9:41322999-41329000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p12 population region (DGV_Gold_Standard_June_2021_gssvL130637)",9:43589946-43694171,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"9p12 population region (DGV_Gold_Standard_June_2021_gssvL130619)",9:43584760-43755000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102296)",9:47298999-47304000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102294)",9:47281174-47300125,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102236)",9:46366999-46389000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102187)",9:45728849-45746725,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102099)",9:44399899-44405000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102097)",9:44391999-44411000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102096)",9:44388999-44470300,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102085)",9:44313499-44331000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102049)",9:43915599-43920850,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102048)",9:43902774-43914325,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102047)",9:43870599-43899100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102046)",9:43870599-43876000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102043)",9:43800749-43849800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102042)",9:43795899-43804300,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102036)",9:43733799-43739000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102035)",9:43723999-43739000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102032)",9:43708999-43728000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102027)",9:43628499-43647400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102025)",9:43623999-43631000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"9p11.2 population region (gnomAD-SV_v2.1_DEL_9_102024)",9:43622999-43708000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"9p11.2 population region (DGV_Gold_Standard_June_2021_gssvG38779)",9:44283472-44840754,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"9p11.1 population region (gnomAD-SV_v2.1_DEL_9_102297)",9:47307099-47317679,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8q24.3 population region (gnomAD-SV_v2.1_DEL_8_98285)",8:145479999-145502750,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"8q24.3 population region (gnomAD-SV_v2.1_DEL_8_98283)",8:145312849-145332400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.3 population region (gnomAD-SV_v2.1_DEL_8_88408)",8:116099-129200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.3 population region (gnomAD-SV_v2.1_DEL_8_88399)",8:25899-33100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 region (DEFB gene cluster)",8:7053186-8130689,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,03/12/2014
R,"8p23.1 recurrent region (includes GATA4)",8:8100064-11766329,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,06/10/2022
R,"8p23.1 population region (gnomAD-SV_v2.1_DUP_8_23819)",8:12251799-12297400,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DUP_8_23708)",8:7736999-7743100,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/17/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89725)",8:12291199-12311050,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89706)",8:11961999-11968000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89703)",8:11903999-11926000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89357)",8:7806249-7812100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89356)",8:7798999-7824100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89355)",8:7744999-7754100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (gnomAD-SV_v2.1_DEL_8_89353)",8:7736499-7764500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"8p23.1 population region (DGV_Gold_Standard_June_2021_gssvG36644)",8:7212582-7227421,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"8p23.1 population region (DGV_Gold_Standard_June_2021_gssvG36608)",8:6828736-6878156,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"8p23.1 population region (DGV_Gold_Standard_June_2021_gssvG36607)",8:7110945-7157807,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"7q36.3 ZRS (SHH cis-regulatory) duplication region (within LMBR1 intron 5)",7:156583796-156584568,"0 (No Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,02/15/2018
R,"7q36.1 population region (DGV_Gold_Standard_June_2021_gssvL119849)",7:150286146-150307909,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q35 population region (gnomAD-SV_v2.1_DEL_7_87112)",7:143408999-143417500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"7q35 population region (DGV_Gold_Standard_June_2021_gssvL119429)",7:143880615-144075919,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q35 population region (DGV_Gold_Standard_June_2021_gssvG35898)",7:143884211-143930465,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"7q34 population region (gnomAD-SV_v2.1_DEL_7_87016)",7:141765424-141794499,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"7q34 population region (gnomAD-SV_v2.1_DEL_7_87015)",7:141754993-141780979,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/11/2021
R,"7q34 population region (DGV_Gold_Standard_June_2021_gssvL119381)",7:142461276-142474923,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q34 population region (DGV_Gold_Standard_June_2021_gssvL119380)",7:142460176-142482236,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q34 population region (DGV_Gold_Standard_June_2021_gssvL119369)",7:142099063-142108894,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q34 population region (DGV_Gold_Standard_June_2021_gssvL119360)",7:142133273-142170344,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q22.1 population region (gnomAD-SV_v2.1_DEL_7_84412)",7:102300999-102331000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7q22.1 population region (gnomAD-SV_v2.1_DEL_7_84190)",7:99461390-99463562,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7q22.1 population region (DGV_Gold_Standard_June_2021_gssvL117874)",7:101968967-102022209,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q11.23 recurrent distal region (includes HIP1, YWHAG)",7:75158048-76063176,"2 (Emerging Evidence)","1 (Little Evidence)",,,‐,‐,‐,12/31/2018
R,"7q11.23 recurrent (Williams-Beuren syndrome) region (includes ELN)",7:72744455-74142510,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,08/06/2015
R,"7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82638)",7:74468999-74476300,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82637)",7:74452999-74459200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82636)",7:74420999-74428000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7q11.23 population region (gnomAD-SV_v2.1_DEL_7_82621)",7:74223499-74230000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7q11.23 population region (DGV_Gold_Standard_June_2021_gssvL116711)",7:74378312-74480711,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q11.21 population region (gnomAD-SV_v2.1_DEL_7_81890)",7:65110999-65144000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7q11.21 population region (DGV_Gold_Standard_June_2021_gssvL116036)",7:62963166-62979392,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7q11.21 population region (DGV_Gold_Standard_June_2021_gssvL115987)",7:62687315-62723648,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7p22.1 region (includes ACTB)",7:5536848-5799722,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,02/08/2022
R,"7p22.1 population region (gnomAD-SV_v2.1_DEL_7_77893)",7:6818999-6827200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7p22.1 population region (gnomAD-SV_v2.1_DEL_7_77769)",7:5976999-5982000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7p22.1 population region (gnomAD-SV_v2.1_DEL_7_77765)",7:5940999-5953000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"7p22.1 population region (DGV_Gold_Standard_June_2021_gssvL113541)",7:6900773-6923243,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7p14.1 population region (DGV_Gold_Standard_June_2021_gssvL115094)",7:38386563-38397743,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"7p11.2 population region (DGV_Gold_Standard_June_2021_gssvL115697)",7:57062764-57088685,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"6q24 region (includes PLAGL1)","6:144243292 -144416561","1 (Little Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,05/24/2016
R,"6q13 population region (DGV_Gold_Standard_June_2021_gssvG32691)",6:74708884-74717014,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"6q13 population region (DGV_Gold_Standard_June_2021_gssvG32688)",6:74707825-74718498,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"6p25.3 population region (DGV_Gold_Standard_June_2021_gssvL104460)",6:83824-202184,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"6p22.1 population region (DGV_Gold_Standard_June_2021_gssvL105927)",6:29837200-29849273,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"6p22.1 population region (DGV_Gold_Standard_June_2021_gssvL105924)",6:29892560-29905834,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"6p21.32 population region (DGV_Gold_Standard_June_2021_gssvL106271)",6:32627550-32648423,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"6p21.32 population region (DGV_Gold_Standard_June_2021_gssvL106269)",6:32516836-32541693,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"6p21.32 population region (DGV_Gold_Standard_June_2021_gssvL106264)",6:32475856-32514239,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"5q35.3 population region (gnomAD-SV_v2.1_DEL_5_65880)",5:180787999-180857000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"5q35.3 population region (gnomAD-SV_v2.1_DEL_5_65831)",5:180375131-180430626,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"5q35.3 population region (DGV_Gold_Standard_June_2021_gssvL104429)",5:180591001-180596624,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"5q35.3 population region (DGV_Gold_Standard_June_2021_gssvL104164)",5:178348352-178353194,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"5q35 recurrent (Sotos syndrome) region (includes NSD1)",5:175728979-177047793,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,04/10/2014
R,"5q31.3 population region (gnomAD-SV_v2.1_DEL_5_63328)",5:140222136-140238931,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"5q31.3 population region (DGV_Gold_Standard_June_2021_gssvL102648)",5:140096767-140104053,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"5q31.3 population region (DGV_Gold_Standard_June_2021_gssvG31070)",5:140554513-140560187,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/16/2021
R,"5q22.1 population region (DGV_Gold_Standard_June_2021_gssvL101506)",5:110905931-110911040,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"5q13.2 population region (gnomAD-SV_v2.1_DUP_5_15442)",5:70324499-70404000,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/12/2021
R,"5q13.2 population region (gnomAD-SV_v2.1_DUP_5_15350)",5:69305399-69369100,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/12/2021
R,"5q13.2 population region (gnomAD-SV_v2.1_DEL_5_58900)",5:70326999-70335700,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"5q13.2 population region (gnomAD-SV_v2.1_DEL_5_58897)",5:70312999-70365100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"5q13.2 population region (DGV_Gold_Standard_June_2021_gssvG30124)",5:69316084-69343660,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"5p15.33 population region (DGV_Gold_Standard_June_2021_gssvG29169)",5:814446-825367,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"5p15 terminal (Cri du chat syndrome) region",5:37693-11347262,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,06/21/2016
R,"4q13.3 population region (gnomAD-SV_v2.1_DEL_4_46753)",4:75483999-75493000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"4q13.3 population region (gnomAD-SV_v2.1_DEL_4_46744)",4:75315999-75323000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"4q13.3 population region (DGV_Gold_Standard_June_2021_gssvL91223)",4:75282628-75323181,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46404)",4:70152039-70261334,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46401)",4:70138063-70247165,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46399)",4:70126481-70235359,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46398)",4:70123999-70171300,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"4q13.2 population region (gnomAD-SV_v2.1_DEL_4_46396)",4:70123650-70232337,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"4q13.2 population region (DGV_Gold_Standard_June_2021_gssvL90978)",4:70134832-70270391,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"4p16.3 terminal (Wolf-Hirschhorn syndrome) region",4:331568-2010962,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,08/11/2016
R,"4p16.1 population region (DGV_Gold_Standard_June_2021_gssvL88361)",4:9486907-9516088,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"4p16.1 population region (DGV_Gold_Standard_June_2021_gssvG27165)",4:9417997-9457368,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"4p11 population region (DGV_Gold_Standard_June_2021_gssvL90109)",4:49177189-49249875,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"4p11 population region (DGV_Gold_Standard_June_2021_gssvG27527)",4:49489242-49524812,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"3q29 recurrent region (includes DLG1)",3:195756054-197344662,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,01/21/2016
R,"3q29 population region (DGV_Gold_Standard_June_2021_gssvL86947)",3:195380278-195469564,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"3q29 population region (DGV_Gold_Standard_June_2021_gssvG26791)",3:195376588-195493533,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"3q25.31 population region (DGV_Gold_Standard_June_2021_gssvL85294)",3:155478166-155498646,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"3q24 Region (includes ZIC1)",3:136403035-148341113,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,07/19/2021
R,"3q11.2 population region (DGV_Gold_Standard_June_2021_gssvL83307)",3:97887492-97919334,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"3q11.2 population region (DGV_Gold_Standard_June_2021_gssvL83303)",3:97878295-97923426,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"3p12.3 population region (gnomAD-SV_v2.1_DEL_3_33722)",3:75767999-75796000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"3p12.3 population region (DGV_Gold_Standard_June_2021_gssvL82434)",3:75567345-75581692,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"3p12.3 population region (DGV_Gold_Standard_June_2021_gssvL82397)",3:75422907-75644624,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"3 copies: 16p centromere",16:34202088-35147508,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/01/2013
R,"3 copies: 15q telomere",15:102161480-102521392,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,11/26/2013
R,"2q37.3 terminal region (includes HDAC4)",2:239954693-242930600,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,06/13/2016
R,"2q37.3 population region (DGV_Gold_Standard_June_2021_gssvL70815)",2:242872862-243012181,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q21.2 population region (gnomAD-SV_v2.1_DUP_2_6167)",2:132853576-133213563,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"2q21.2 population region (gnomAD-SV_v2.1_DEL_2_22275)",2:132519999-132529000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q21.1 recurrent region (includes ARHGEF4, GPR148)",2:131477509-131929693,"1 (Little Evidence)","0 (No Evidence)",,,‐,‐,‐,09/30/2019
R,"2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22163)",2:131412799-131430000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22156)",2:131248899-131254600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22155)",2:131236999-131242000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22135)",2:130954938-130957387,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q21.1 population region (gnomAD-SV_v2.1_DEL_2_22133)",2:130953999-130959000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q21.1 population region (DGV_Gold_Standard_June_2021_gssvL66075)",2:130793882-130823249,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2q13 recurrent region (includes NPHP1)",2:110862108-110983703,"30 (Autosomal Recessive)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,02/25/2016
R,"2q13 recurrent region (includes BCL2L11)",2:111392193-113104742,"2 (Emerging Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,06/23/2018
R,"2q11.2 recurrent region (includes ARID5A, TMEM127)",2:96739012-97671429,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,02/21/2022
R,"2p24.3 MYCN-DDX1 duplication region",2:15708677-16185337,"Not Yet Evaluated","2 (Emerging Evidence)",,,‐,‐,‐,08/07/2017
R,"2p21 region (includes PREPL and SLC3A1)",2:44410272-44589641,"30 (Autosomal Recessive)","0 (No Evidence)",,,‐,‐,‐,03/21/2012
R,"2p15p16.1 region (includes BCL11A)",2:59139200-62488871,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,06/09/2016
R,"2p11.2 population region (gnomAD-SV_v2.1_DEL_2_19888)",2:87242199-87253600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64514)",2:90160287-90163570,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64458)",2:90044437-90061011,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64445)",2:90249376-90275932,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64421)",2:89459244-89512939,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64418)",2:90044551-90102805,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"2p11.2 population region (DGV_Gold_Standard_June_2021_gssvL64414)",2:90005834-90052218,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"22q13.1 population region (gnomAD-SV_v2.1_DEL_22_182715)",22:39358308-39388415,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181682)",22:24344399-24397000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181680)",22:24324299-24334200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181679)",22:24315999-24323000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.23 population region (gnomAD-SV_v2.1_DEL_22_181670)",22:24274143-24311297,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.23 population region (DGV_Gold_Standard_June_2021_gssvL77244)",22:24314289-24334833,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.23 population region (DGV_Gold_Standard_June_2021_gssvL77238)",22:24360812-24402386,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.23 population region (DGV_Gold_Standard_June_2021_gssvG24415)",22:25703259-25785235,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"22q11.22 population region (DGV_Gold_Standard_June_2021_gssvL77120)",22:23223448-23238992,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 recurrent (Cat eye syndrome) region (includes CECR2)",22:17392953-18591860,"0 (No Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,02/27/2014
R,"22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181532)",22:21562199-21569400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181459)",22:20693999-20699000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181452)",22:20451599-20457600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181446)",22:20366424-20371500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (gnomAD-SV_v2.1_DEL_22_181316)",22:18738599-18747000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL77050)",22:21866876-21909287,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL77049)",22:21711480-21742055,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL77047)",22:21812558-21916568,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.21 population region (DGV_Gold_Standard_June_2021_gssvL76981)",22:20428070-20499197,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"22q11.2 recurrent region (distal type III, F-G) (includes SMARCB1)",22:23831202-24632821,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,09/30/2022
R,"22q11.2 recurrent region (distal type I, D-E/F)",22:21917117-23649111,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,03/12/2015
R,"22q11.2 recurrent region (central, B/C-D) (includes CRKL)",22:20731986-21465672,"2 (Emerging Evidence)","0 (No Evidence)",,,‐,‐,‐,08/30/2022
R,"22q11.2 recurrent (DGS/VCFS) region (proximal, A-D) (includes TBX1)",22:18912231-21465672,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,08/31/2018
R,"22q11.2 recurrent (DGS/VCFS) region (proximal, A-B) (includes TBX1)",22:18912231-20287208,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,08/31/2018
R,"21q22.3 population region (gnomAD-SV_v2.1_DEL_21_181010)",21:47580927-47582908,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"21q22.3 population region (DGV_Gold_Standard_June_2021_gssvL76000)",21:44970333-44971747,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"21q22.3 population region (DGV_Gold_Standard_June_2021_gssvL75982)",21:44969018-44974013,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"21q11.2 population region (gnomAD-SV_v2.1_DEL_21_178683)",21:15012799-15034700,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"21q11.2 population region (gnomAD-SV_v2.1_DEL_21_178682)",21:14995199-15001200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"21q11.2 population region (gnomAD-SV_v2.1_DEL_21_178681)",21:14980399-14986100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"21q11.2 population region (DGV_Gold_Standard_June_2021_gssvL74506)",21:14957505-15202003,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"20q11.21 population region (DGV_Gold_Standard_June_2021_gssvL72187)",20:29509040-29536079,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"20p11.22 population region (DGV_Gold_Standard_June_2021_gssvL71898)",20:21486525-21496720,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"1q44 population region (gnomAD-SV_v2.1_DUP_1_3816)",1:248619999-248647000,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"1q44 population region (gnomAD-SV_v2.1_DEL_1_13898)",1:248806699-248819725,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q44 population region (gnomAD-SV_v2.1_DEL_1_13890)",1:248737999-248744000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q44 population region (gnomAD-SV_v2.1_DEL_1_13889)",1:248730999-248798200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q44 population region (gnomAD-SV_v2.1_DEL_1_13888)",1:248728999-248743000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q44 population region (gnomAD-SV_v2.1_DEL_1_13885)",1:248712454-248757403,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q44 population region (DGV_Gold_Standard_June_2021_gssvL8958)",1:248755655-248758478,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q44 population region (DGV_Gold_Standard_June_2021_gssvL8766)",1:248756880-248797809,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q43q44 terminal region (includes AKT3)",1:243287730-245318287,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,10/12/2016
R,"1q41 population region (DGV_Gold_Standard_June_2021_gssvL7905)",1:222373208-222381462,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q32.2 population region (gnomAD-SV_v2.1_DEL_1_11282)",1:207708749-207718050,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/16/2021
R,"1q25.2 population region (gnomAD-SV_v2.1_DEL_1_9549)",1:179455597-179458296,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q24.2 population region (DGV_Gold_Standard_June_2021_gssvL5980)",1:168024558-168025732,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q23.3 population region (gnomAD-SV_v2.1_DEL_1_8646)",1:161529258-161610923,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q23.3 population region (DGV_Gold_Standard_June_2021_gssvL5778)",1:161570323-161598180,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.3 population region (gnomAD-SV_v2.1_DEL_1_8087)",1:152760519-152771091,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.3 population region (gnomAD-SV_v2.1_DEL_1_8075)",1:152555541-152587740,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.3 population region (DGV_Gold_Standard_June_2021_gssvL5433)",1:152554926-152575348,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.3 population region (DGV_Gold_Standard_June_2021_gssvG2465)",1:152761495-152773537,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"1q21.2 region (polymorphic region)(non-unique; also maps to chromosomes 16, 7, and others in GRCh38)",1:148867551-149768855,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,10/22/2020
R,"1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7863)",1:149396649-149406100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7859)",1:149368999-149433200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7798)",1:147944999-147955500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7795)",1:147931899-147982900,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7781)",1:147559999-147630500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (gnomAD-SV_v2.1_DEL_1_7778)",1:147433599-147455000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (DGV_Gold_Standard_June_2021_gssvL5166)",1:149207851-149218151,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (DGV_Gold_Standard_June_2021_gssvL5133)",1:149152064-149204067,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.2 population region (DGV_Gold_Standard_June_2021_gssvL5122)",1:147856152-147913592,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1q21.1 recurrent region (BP3-BP4, distal) (includes GJA5)",1:146577486-147394506,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,04/14/2016
R,"1q21.1 recurrent (TAR syndrome) region (proximal, BP2-BP3) (includes RBM8A)",1:145386507-145748064,"1 (Little Evidence)","1 (Little Evidence)",,,‐,‐,‐,05/18/2017
R,"1q21.1 population region (gnomAD-SV_v2.1_DEL_1_7699)",1:146025999-146089000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.33 population region (gnomAD-SV_v2.1_DEL_1_195)",1:1640999-1647000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.33 population region (gnomAD-SV_v2.1_DEL_1_11)",1:363999-401750,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.33 population region (DGV_Gold_Standard_June_2021_gssvG23)",1:713039-756009,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"1p36.33 population region ((DGV_Gold_Standard_June_2021_gssvG23))",1:713039-756009,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (gnomAD-SV_v2.1_DUP_1_507)",1:12894999-12940000,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1100)",1:13043099-13052800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1094)",1:12989199-12998900,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1089)",1:12949999-12966000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (gnomAD-SV_v2.1_DEL_1_1085)",1:12896424-12930275,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL905)",1:12899395-12924283,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL891)",1:12886641-12942069,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL889)",1:13692847-13774442,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL1109)",1:16152667-16155517,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (DGV_Gold_Standard_June_2021_gssvL1108)",1:16151690-16155602,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.21 population region (DGV_Gold_Standard_June_2021_gssvG371)",1:12897609-12922238,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"1p36.13 population region (DGV_Gold_Standard_June_2021_gssvL1195)",1:17009445-17012777,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.12 population region (DGV_Gold_Standard_June_2021_gssvL1420)",1:22313123-22335712,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1945)",1:25654999-25661350,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1944)",1:25644399-25649500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1943)",1:25639499-25650000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1941)",1:25630899-25636000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1939)",1:25613999-25621000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1938)",1:25593699-25610200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1937)",1:25592799-25651000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"1p36.11 population region (gnomAD-SV_v2.1_DEL_1_1834)",1:24283999-24291000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"1p36 terminal region (includes GABRD)",1:834083-6289973,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,05/31/2016
R,"1p31.3 population region (DGV_Gold_Standard_June_2021_gssvL3013)",1:64839912-64851868,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p31.3 population region (DGV_Gold_Standard_June_2021_gssvL2940)",1:62654661-62657211,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p21.1 population region (gnomAD-SV_v2.1_DUP_1_1884)",1:104190999-104303200,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"1p13.3 population region (gnomAD-SV_v2.1_DEL_1_7022)",1:110230194-110254581,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p13.3 population region (gnomAD-SV_v2.1_DEL_1_6959)",1:108923349-108996100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/06/2021
R,"1p13.3 population region (DGV_Gold_Standard_June_2021_gssvG1423)",1:108917312-109000328,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/06/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173817)",19:55367999-55373100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173816)",19:55360499-55370000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173812)",19:55314899-55323600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173811)",19:55301499-55324000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173809)",19:55292999-55298000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173807)",19:55285999-55293000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/03/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173806)",19:55277999-55288000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173805)",19:55274849-55281600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173803)",19:55256999-55289000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173802)",19:55251599-55257000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173801)",19:55250753-55267130,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173800)",19:55245599-55250700,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (gnomAD-SV_v2.1_DEL_19_173749)",19:54800855-54807620,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (DGV_Gold_Standard_June_2021_gssvL59370)",19:53939389-53976651,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.42 population region (DGV_Gold_Standard_June_2021_gssvG19479)",19:56280630-56289562,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"19q13.41 population region (gnomAD-SV_v2.1_DEL_19_173549)",19:53316224-53323725,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.41 population region (gnomAD-SV_v2.1_DEL_19_173445)",19:52134299-52149000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.41 population region (gnomAD-SV_v2.1_DEL_19_173443)",19:52127999-52139400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.32 population region (DGV_Gold_Standard_June_2021_gssvL58890)",19:46622342-46628475,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.31 population region (gnomAD-SV_v2.1_DEL_19_172626)",19:43700999-43716000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.31 population region (gnomAD-SV_v2.1_DEL_19_172625)",19:43700966-43764809,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19q13.3 region (PSG gene cluster)",19:43242796-43741310,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,03/13/2014
R,"19q13.12 population region (gnomAD-SV_v2.1_DEL_19_172006)",19:35850999-35863275,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19p13.2 population region (gnomAD-SV_v2.1_DUP_19_46817)",19:7019174-7060500,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"19p13.12 population region (DGV_Gold_Standard_June_2021_gssvL57062)",19:15727731-15787718,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19p12 population region (DGV_Gold_Standard_June_2021_gssvL57428)",19:22087099-23141940,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"19p12 population region (DGV_Gold_Standard_June_2021_gssvL57316)",19:20594811-20725405,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"18q21.1 population region (DGV_Gold_Standard_June_2021_gssvG17872)",18:44542290-44558084,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"18q11.2 population region (DGV_Gold_Standard_June_2021_gssvL52661)",18:23747759-23751695,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"18p11.31 population region (DGV_Gold_Standard_June_2021_gssvL51911)",18:3568883-3571730,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"18p11.22 population region (DGV_Gold_Standard_June_2021_gssvL52196)",18:9784172-9793224,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"18p11.21 population region (DGV_Gold_Standard_June_2021_gssvG17388)",18:14432553-14565138,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"17q23.1q23.2 recurrent region (includes TBX2, TBX4)",17:58113002-60275809,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,11/20/2018
R,"17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160670)",17:44637999-44653000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160664)",17:44403899-44409900,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160663)",17:44401199-44418450,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160662)",17:44399099-44405700,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160659)",17:44381699-44387000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.31 population region (gnomAD-SV_v2.1_DEL_17_160658)",17:44368999-44380000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.3 recurrent region (includes KANSL1)",17:43705166-44164880,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,08/10/2020
R,"17q21.2 population region (gnomAD-SV_v2.1_DUP_17_44064)",17:39531966-39539289,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"17q21.2 population region (gnomAD-SV_v2.1_DEL_17_160290)",17:39421793-39432145,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.2 population region (gnomAD-SV_v2.1_DEL_17_160287)",17:39383999-39395000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49386)",17:39429150-39433594,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49384)",17:39422988-39430527,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49383)",17:39384291-39392558,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.2 population region (DGV_Gold_Standard_June_2021_gssvL49379)",17:39383317-39396444,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q21.2 population region (DGV_Gold_Standard_June_2021_gssvG16538)",17:39531718-39539732,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"17q12 recurrent (RCAD syndrome) region (includes HNF1B)",17:34815072-36192489,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,06/16/2022
R,"17q12 population region (DGV_Gold_Standard_June_2021_gssvL49126)",17:34509779-34551554,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17q12 population region (DGV_Gold_Standard_June_2021_gssvG16427)",17:34502940-34524192,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"17q11.2 recurrent region (includes NF1)",17:29097069-30264027,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,10/12/2020
R,"17p13.3 (Miller-Dieker syndrome) region (includes YWHAE and PAFAH1B1)",17:1247833-2588909,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,11/10/2016
R,"17p12 recurrent (HNPP/CMT1A) region (includes PMP22)",17:14097915-15422952,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,10/13/2016
R,"17p11.2 recurrent (SMS/PLS) region (includes RAI1)",17:16810028-20213202,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,11/21/2013
R,"17p11.2 population region (gnomAD-SV_v2.1_DEL_17_159095)",17:19014999-19054000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (gnomAD-SV_v2.1_DEL_17_159047)",17:18329998-18465150,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (DGV_Gold_Standard_June_2021_gssvL48488)",17:18359790-18376723,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (DGV_Gold_Standard_June_2021_gssvL48476)",17:18418589-18465114,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (DGV_Gold_Standard_June_2021_gssvL48375)",17:16711606-16724681,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16095)",17:18359814-18376676,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16067)",17:18361739-18423872,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16017)",17:16711572-16724682,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"17p11.2 population region (DGV_Gold_Standard_June_2021_gssvG16012)",17:16660760-16707833,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"16q23.1 population region (DGV_Gold_Standard_June_2021_gssvG15270)",16:74387937-74459162,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"16q22.2 population region (DGV_Gold_Standard_June_2021_gssvG15245)",16:72088515-72116064,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"16q22.1 population region (gnomAD-SV_v2.1_DUP_16_42449)",16:70094243-70242956,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"16p13.3 region (includes CREBBP)",16:3775056-3930121,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,06/09/2016
R,"16p13.3 population region (gnomAD-SV_v2.1_DEL_16_151010)",16:59999-65000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"16p13.3 population region (DGV_Gold_Standard_June_2021_gssvL41949)",16:1289937-1295280,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"16p13.12 population region (gnomAD-SV_v2.1_DEL_16_152600)",16:14782999-14853150,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"16p13.11 recurrent region (BP2-BP3) (includes MYH11)",16:15511711-16292265,"3 (Sufficient Evidence)","2 (Emerging Evidence)",,,‐,‐,‐,04/13/2021
R,"16p13.11 population region (gnomAD-SV_v2.1_DEL_16_152730)",16:16329599-16364350,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/23/2021
R,"16p12.3 population region (gnomAD-SV_v2.1_DEL_16_152900)",16:18414999-18421000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/12/2021
R,"16p12.2 recurrent region (proximal) (includes EEF2K, CDR2)",16:21948445-22430804,"2 (Emerging Evidence)","0 (No Evidence)",,,‐,‐,‐,03/23/2018
R,"16p12.2 recurrent region (distal)(includes OTOA)",16:21570113-21740423,"30 (Autosomal Recessive)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,11/03/2019
R,"16p12.2 population region (DGV_Gold_Standard_June_2021_gssvG14372)",16:21512076-21595577,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"16p12.1 population region (DGV_Gold_Standard_June_2021_gssvL43366)",16:25066146-25137378,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"16p11.2 recurrent region (proximal, BP4-BP5) (includes TBX6)",16:29649997-30199852,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,02/09/2017
R,"16p11.2 recurrent region (distal, BP2-BP3) (includes SH2B1)",16:28822635-29046499,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,03/09/2017
R,"16p11.2 population region (gnomAD-SV_v2.1_DUP_16_42022)",16:32019999-32096000,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"16p11.2 population region (gnomAD-SV_v2.1_DEL_16_153860)",16:32655999-32802000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"16p11.2 population region (gnomAD-SV_v2.1_DEL_16_153573)",16:28764999-28772000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"16p11.2 population region (gnomAD-SV_v2.1_DEL_16_153568)",16:28715099-28771000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"15q25.2q25.3 recurrent region (distal, LCR C-LCR D)",15:85139652-85713001,"1 (Little Evidence)","0 (No Evidence)",,,‐,‐,‐,06/26/2020
R,"15q25.2 recurrent region (proximal LCR B-LCR C)",15:83213988-84714733,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,10/13/2016
R,"15q24 recurrent region (LCR C-LCR D) (includes SIN3A)","15: 75631787-75972909","3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,01/13/2020
R,"15q24 recurrent region (LCR A-LCR D) (includes SIN3A)",15:72963715-75972909,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,08/31/2018
R,"15q24 recurrent region (LCR A-LCR C)",15:72963715-75508312,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,01/03/2020
R,"15q14 population region (gnomAD-SV_v2.1_DEL_15_146739)",15:34726357-34872885,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q14 population region (gnomAD-SV_v2.1_DEL_15_146738)",15:34710126-34856557,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q13.3 recurrent region (D-CHRNA7 to BP5) (includes CHRNA7, OTUD7A)",15:32019621-32445405,"3 (Sufficient Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,05/10/2018
R,"15q13.3 recurrent region (BP4-BP5) (includes CHRNA7)",15:31192889-32445405,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,04/28/2018
R,"15q13.3 population region (gnomAD-SV_v2.1_DUP_15_39790)",15:32690774-32734250,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/09/2021
R,"15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146627)",15:32886199-32898000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146625)",15:32864999-32898000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146614)",15:32774999-32780000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146612)",15:32743999-32755100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q13.3 population region (gnomAD-SV_v2.1_DEL_15_146609)",15:32692999-32698000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146467)",15:30847949-30883100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146464)",15:30825199-30853100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146453)",15:30432998-30883100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146452)",15:30692999-30725200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/17/2021
R,"15q13.2 population region (gnomAD-SV_v2.1_DEL_15_146428)",15:30381948-30438500,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q13.2 population region (DGV_Gold_Standard_June_2021_gssvG12633)",15:30488097-30796070,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"15q13 recurrent region (BP3-BP4) (includes APBA2)",15:29156959-30368990,"0 (No Evidence)","0 (No Evidence)",,,‐,‐,‐,03/09/2020
R,"15q11.2q13 recurrent (PWS/AS) region (Class 2,BP2-BP3)",15:23747996-28379874,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,11/26/2013
R,"15q11.2q13 recurrent (PWS/AS) region (Class 1, BP1-BP3)",15:22832519-28379874,"3 (Sufficient Evidence)","3 (Sufficient Evidence)",,,‐,‐,‐,11/26/2013
R,"15q11.2 recurrent region (BP1-BP2) (includes NIPA1)",15:22832519-23090897,"3 (Sufficient Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,04/12/2021
R,"15q11.2 population region (gnomAD-SV_v2.1_DEL_15_145837)",15:21042049-21056300,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q11.2 population region (gnomAD-SV_v2.1_DEL_15_145826)",15:20729174-20745525,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"15q11.2 population region (DGV_Gold_Standard_June_2021_gssvG12359)",15:21145101-21164300,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"15q11.2 population region (DGV_Gold_Standard_June_2021_gssvG12224)",15:20388741-22207639,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q32.33 population region (DGV_Gold_Standard_June_2021_gssvL37313)",14:107172848-107183396,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"14q32.33 population region (DGV_Gold_Standard_June_2021_gssvL37239)",14:106483725-106508484,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12150)",14:106805092-106814699,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12133)",14:107147166-107164532,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12117)",14:106826451-106850917,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q32.33 population region (DGV_Gold_Standard_June_2021_gssvG12097)",14:106118177-106145774,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q32 region associated with UPD(14) phenotypes",14:100394594-101504529,"2 (Emerging Evidence)","0 (No Evidence)",,,‐,‐,‐,05/10/2012
R,"14q13.2 population region (DGV_Gold_Standard_June_2021_gssvL34350)",14:35605396-35615320,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"14q11.2 region including CHD8 and SUPT16H",14:21826900-21861987,"2 (Emerging Evidence)","0 (No Evidence)",,,‐,‐,‐,05/09/2012
R,"14q11.2 region (TCRA region)",14:22111109-23021097,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,04/09/2015
R,"14q11.2 population region (gnomAD-SV_v2.1_DEL_14_140616)",14:24467999-24474000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"14q11.2 population region (DGV_Gold_Standard_June_2021_gssvL33589)",14:19462304-19469872,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"14q11.2 population region (DGV_Gold_Standard_June_2021_gssvL33520)",14:20190699-20425231,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10899)",14:19462329-19469848,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10827)",14:20335536-20423298,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10817)",14:20190229-20426809,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"14q11.2 population region (DGV_Gold_Standard_June_2021_gssvG10810)",14:19596713-20418095,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"13q21.33 population region (DGV_Gold_Standard_June_2021_gssvL31119)",13:72476988-72489787,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"13q21.1 population region (DGV_Gold_Standard_June_2021_gssvL30434)",13:57768508-57786942,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"13q12.12 recurrent region (includes SACS, SGCG)",13:23544582-24881361,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,04/26/2021
R,"13q12.11 population region (DGV_Gold_Standard_June_2021_gssvG9718)",13:21534913-21541123,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"12q23.3 population region (DGV_Gold_Standard_June_2021_gssvL26928)",12:105369015-105374180,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"12q12 population region (gnomAD-SV_v2.1_DEL_12_127735)",12:40874766-40876424,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"12p13.31 population region (gnomAD-SV_v2.1_DUP_12_33971)",12:8361449-8390896,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/09/2021
R,"12p13.31 population region (DGV_Gold_Standard_June_2021_gssvG7850)",12:8361522-8391789,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"12p13.31 population region (DGV_Gold_Standard_June_2021_gssvG7792)",12:8558090-8596215,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"12p13.2 population region (gnomAD-SV_v2.1_DEL_12_125610)",12:11225999-11250600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"12p13.2 population region (gnomAD-SV_v2.1_DEL_12_125568)",12:10581599-10587675,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"12p13.2 population region (gnomAD-SV_v2.1_DEL_12_125567)",12:10581544-10597003,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23231)",12:11224984-11240896,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23228)",12:11227081-11251139,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23223)",12:11191681-11217625,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"12p13.2 population region (DGV_Gold_Standard_June_2021_gssvL23179)",12:10581251-10597043,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"12p11.23 population region (gnomAD-SV_v2.1_DEL_12_126677)",12:27648141-27655163,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"12p11.23 population region (DGV_Gold_Standard_June_2021_gssvL23860)",12:27647940-27654731,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"12p11.2 population region (DGV_Gold_Standard_June_2021_gssvG23340)",21:10704853-10982352,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/03/2021
R,"12p11.1 population region (DGV_Gold_Standard_June_2021_gssvL24290)",12:34355893-34361543,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/04/2021
R,"11q22.2 population region (DGV_Gold_Standard_June_2021_gssvL21098)",11:102751106-102752862,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11q14.3 population region (gnomAD-SV_v2.1_DUP_11_33042)",11:89520077-89657031,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/09/2021
R,"11q14.3 population region (gnomAD-SV_v2.1_DEL_11_121860)",11:89762999-89783400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"11q13.4 population region (DGV_Gold_Standard_June_2021_gssvL19865)",11:71850646-71889330,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11q13.2q13.4 recurrent region (includes SHANK2, FGFs)",11:67763646-71236931,"2 (Emerging Evidence)","0 (No Evidence)",,,‐,‐,‐,09/27/2022
R,"11q12.2 population region (DGV_Gold_Standard_June_2021_gssvG6800)",11:60966146-61020399,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/04/2021
R,"11q11 population region (gnomAD-SV_v2.1_DEL_11_119564)",11:55364275-55444015,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"11q11 population region (gnomAD-SV_v2.1_DEL_11_119505)",11:55031602-55038540,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
R,"11q11 population region (DGV_Gold_Standard_June_2021_gssvL19045)",11:55434253-55443984,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11q11 population region (DGV_Gold_Standard_June_2021_gssvL19042)",11:55445709-55457776,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.5 population region (DGV_Gold_Standard_June_2021_gssvL16511)",11:1915245-1937002,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.4 population region (gnomAD-SV_v2.1_DEL_11_116241)",11:7811175-7833378,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"11p15.4 population region (gnomAD-SV_v2.1_DEL_11_116124)",11:5873988-5883493,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"11p15.4 population region (gnomAD-SV_v2.1_DEL_11_116046)",11:4967746-4976658,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16961)",11:7809752-7834885,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16881)",11:5873984-5883499,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16784)",11:4968688-4980232,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16737)",11:4255449-4278126,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.4 population region (DGV_Gold_Standard_June_2021_gssvL16732)",11:4264092-4309730,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.4 population region (DGV_Gold_Standard_June_2021_gssvG5957)",11:4255965-4278463,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"11p15.4 population region (DGV_Gold_Standard_June_2021_gssvG5919)",11:3239311-3360988,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"11p15.1 population region (DGV_Gold_Standard_June_2021_gssvL17400)",11:18941859-18964598,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"11p15.1 population region (DGV_Gold_Standard_June_2021_gssvG6192)",11:18940205-18963657,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"11p14.1 population region (DGV_Gold_Standard_June_2021_gssvG6305)",11:29007150-29012087,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"11p13 (WAGR syndrome) region",11:31803509-32510988,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,05/24/2016
R,"11p11.2 (Potocki-Shaffer syndrome) region (includes ALX4, EXT2)",11:43894800-46152450,"3 (Sufficient Evidence)","0 (No Evidence)",,,‐,‐,‐,12/12/2013
R,"10q22.3q23.2 recurrent region (LCR 3-LCR 4) (Includes BMPR1A)",10:81682843-88739388,"3 (Sufficient Evidence)","1 (Little Evidence)",,,‐,‐,‐,10/13/2016
R,"10q22.3 population region (gnomAD-SV_v2.1_DEL_10_112166)",10:81604499-81610800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q22.1 population region (DGV_Gold_Standard_June_2021_gssvL13249)",10:71282906-71291092,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"10q22.1 population region (DGV_Gold_Standard_June_2021_gssvL13247)",10:71280815-71291303,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110230)",10:51973199-51981300,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110229)",10:51967199-51974400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110225)",10:51861999-51894650,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110224)",10:51858299-51864600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110223)",10:51851849-51857400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110222)",10:51845699-51850800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110221)",10:51839699-51845100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (gnomAD-SV_v2.1_DEL_10_110193)",10:51219499-51231000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.23 population region (DGV_Gold_Standard_June_2021_gssvL12109)",10:51861706-52000736,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110072)",10:48806124-48812000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110044)",10:48251999-48258000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110043)",10:48239999-48247800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110040)",10:48197999-48248000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110031)",10:48020299-48039225,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110022)",10:47932799-47938200,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110021)",10:47927849-47935000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110019)",10:47896499-47919300,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110016)",10:47748899-47754600,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110001)",10:47211299-47216400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_110000)",10:47191199-47201400,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109999)",10:47177699-47182800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109998)",10:47171999-47177000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109958)",10:46338599-46375000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (gnomAD-SV_v2.1_DEL_10_109954)",10:46310649-46325800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10q11.22 population region (DGV_Gold_Standard_June_2021_gssvL12112)",10:48902069-48986229,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"10q11.22 population region (DGV_Gold_Standard_June_2021_gssvL12105)",10:48664595-48872432,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"10q11.22 population region (DGV_Gold_Standard_June_2021_gssvG4512)",10:47531763-47597768,"0 (No Evidence)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,08/05/2021
R,"10q11.2 recurrent region (LCR C-LCR D)",10:49389703-51053583,"1 (Little Evidence)","1 (Little Evidence)",,,‐,‐,‐,10/12/2022
R,"10p13 population region (DGV_Gold_Standard_June_2021_gssvL10668)",10:13259247-13260742,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108289)",10:18126899-18135000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108288)",10:18117799-18130100,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108283)",10:17879999-17893800,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10p12.33 population region (gnomAD-SV_v2.1_DEL_10_108282)",10:17867999-17880000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/10/2021
R,"10p12.1 population region (DGV_Gold_Standard_June_2021_gssvL11273)",10:27638256-27642180,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/05/2021
R,"1 copy: 6p telomere | 3 copies: 6p telomere",6:259528-339802,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,06/20/2014
R,"1 copy: 2q telomere|3 copies: 2q telomere",2:242930600-243102476,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,04/24/2014
R,"1 copy: 14q telomere; 3 copies: 14q telomere",14:106050000-107289540,"40 (Dosage Sensitivity Unlikely)","40 (Dosage Sensitivity Unlikely)",,,‐,‐,‐,07/31/2014
R,"16p13.12 population region (gnomAD-SV_v2.1_DEL_16_152599)",16:14782199-14805000,"40 (Dosage Sensitivity Unlikely)","0 (No Evidence)",,,‐,‐,‐,08/09/2021
,,,,,,,,,,
